بانک اطلاعات دارویی ایران

در این صفحه اطلاعات بانک دارویی ایران را بر اساس آخرین آپدیت وزرات بهداشت و درمان مشاهده می کنید.

برای پیدا کردن داروی مورد نظر کافیست نام یا اطلاعات مربوط به آن را جستجو کنید

نام دارو	ملح	شکل دارويي	مقدار دارو	راه مصرف	دسته دارو	ترکیبات	کاربرد بالینی تایید شده	سطح دسترسی	توضیحات	تاریخ
Drug Name	Salt	Dosage Form	Strengh	Route of Admin	ATC Code	Ingredient	Approved clinical indications	Access level	Remarks	Date
A.C.A		TABLET		ORAL	N02BE51	Acetaminophen 162.5mg+caffeine 32.5mg+ASA 325mg		OTC medicines
A.C.A		TABLET		ORAL	N02BE51	Acetaminophen 250mg+caffeine 65mg+ASA 250mg		OTC medicines		1387/05/06
Abacavir	AS Sulfate	TABLET	300 mg	ORAL	J05AF06		Treatment of AIDS related complex.	For Health Dept. of MOH only		1393/10/14
Abacavir+Lamivudine		TABLET		ORAL	J05AR02	Abacavir as Sulfate 600 mg+Lamivudine 300 mg	Treatment of AIDS related complex.	For Health Dept. of MOH only		1397/02/11
Abacavir+Lamivudine		TABLET		ORAL	J05AR02	Abacavir as Hydrochloride 600 mg+Lamivudine 300 mg	Treatment of AIDS related complex.	For Health Dept. of MOH only		1397/02/30
Abacavir	As Sulfate	SOLUTION	20mg/ml	ORAL	J05AF06		Treatment of AIDS related complex.	For Health Dept. of MOH only		1394/03/31
Abciximab		INJECTION	2 mg/ml	PARENTERAL	B01AC13			Hospital use only		1385/03/30
Abiraterone	Acetate	TABLET	250 mg	ORAL	L02BX03		Metastic castration resistant prostate cancer			1396/11/29
Abiraterone	Acetate	TABLET	500 mg	ORAL	L02BX03		Metastic castration resistant prostate cancer			1396/11/29
Absorption Base		BULK			V03			Bulk medicines
Acamprosate	As Calcium	TABLET, DELAYED RELEASE	300 mg	ORAL	N07BB03					1393/03/04
Acarbose		TABLET	100 mg	ORAL	A10BF01					1382/03/04
Acarbose		TABLET	50 mg	ORAL	A10BF01					1382/03/04
Acetaminophen		INJECTION, SOLUTION	10 mg/ml	INTRAVENOUS	N02BE01			Hospital use only		1386/03/23
Acetaminophen		TABLET	325 mg	ORAL	N02BE01			OTC medicines		1385/11/4
Acetaminophen		SUSPENSION	100 mg/ml	ORAL	N02BE01			OTC medicines		1385/11/18
Acetaminophen		SOLUTION	100 mg/ml	ORAL	N02BE01			OTC medicines		1372/06/20
Acetaminophen		SUSPENSION	120 mg/5ml	ORAL	N02BE01			OTC medicines		1369/08/02
Acetaminophen		SOLUTION	120 mg/5ml	ORAL	N02BE01			OTC medicines
Acetaminophen		TABLET, ORALLY DISINTEGRATING	125 mg	ORAL	N02BE01			OTC medicines	for local production only	1389/07/17
Acetaminophen		SUPPOSITORY	125 mg	RECTAL	N02BE01			OTC medicines		1369/10/30
Acetaminophen		SUPPOSITORY	75 mg	RECTAL	N02BE01					1396/12/08
Acetaminophen		INJECTION, SOLUTION, CONCENTRATE	150 mg/ml	INTRAVENOUS DRIP	N02BE01			Hospital use only
Acetaminophen		TABLET, DISPERSIBLE	160 mg	ORAL	N02BE01			OTC medicines		1389/06/29
Acetaminophen		TABLET, ORALLY DISINTEGRATING	250 mg	ORAL	N02BE01			OTC medicines	for local production only	1389/07/17
Acetaminophen		SUPPOSITORY	325 mg	RECTAL	N02BE01			OTC medicines		1369/10/30
Acetaminophen		TABLET	325 mg	ORAL	N02BE01			OTC medicines		1369/10/30
Acetaminophen		TABLET, ORALLY DISINTEGRATING	500 mg	ORAL	N02BE01			OTC medicines	for local production only	1389/07/17
Acetaminophen		TABLET, EFFERVESCENT	500 mg	ORAL	N02BE01			OTC medicines		1387/05/16
Acetaminophen		TABLET	500 mg	ORAL	N02BE01			OTC medicines		1369/10/30
Acetaminophen		CAPSULE, LIQUID FILLED	500 mg	ORAL	N02BE01			OTC medicines		1385/08/17
Acetaminophen		CAPSULE, LIQUID FILLED	325 mg	ORAL	N02BE01			OTC medicines		1395/09/13
Acetaminophen		TABLET, DISPERSIBLE	80 mg	ORAL	N02BE01			OTC medicines		1386/12/06
Acetaminophen+Caffeine		TABLET		ORAL	N02BE51	Acetaminophen 500mg + Caffeine 65 mg		OTC medicines		1387/07/07
Acetaminophen+Caffeine		TABLET, EFFERVESCENT		ORAL	N02BE51	Acetaminophen 500mg + Caffeine 65 mg		OTC medicines		1396/04/31
Acetaminophen+Caffeine+Codeine		TABLET		ORAL	N02BE51	Acetaminophen300mg + Caffeine 15 mg+ Codeine phosphate 15 mg				1395/02/02
Acetaminophen+Caffeine+Ibuprofen		CAPSULE, LIQUID FILLED		ORAL	N02BE71	Acetaminophen 325mg + Caffeine 40 mg+ Ibuprofen 200mg		OTC medicines		1390/07/04
Acetaminophen+Caffeine+Ibuprofen		CAPSULE		ORAL	N02BE71	Acetaminophen 325mg + Caffeine 40 mg+ Ibuprofen 200mg		OTC medicines		1385/02/12
Acetaminophen+Chlorpheniramine+Dextrometorphan+Phenylephrine		SYRUP		ORAL	R05X	(Acetaminophen160 mg/Chlorpheniramine Maleate 1 mg/DextrometorphanHBr 5 mg/Phenylephrine HCl 2.5mg)/5ml		OTC medicines		1392/09/25
Acetaminophen+Caffeine+Chlorpheniramine+Vitamin C		CAPSULE		ORAL	R05X	Acetaminophen 200 mg+ Caffeine 25 mg+Chlorpheniramine Maleate 2.5 mg+Vitamine C 150 mg		OTC medicines		1396/12/08
Acetaminophen+Codeine		CAPSULE, LIQUID FILLED		ORAL	N02BE71	Acetaminophen 300mg + Codeine Phosphate 20mg				1393/10/14
Acetaminophen+Codeine		TABLET		ORAL	N02BE71	Acetaminophen 300mg + Codeine Phosphate 20mg				1393/10/14
Acetaminophen+Diphenhydramine+Phenylephrine		SYRUP		ORAL	R05X	(Acetaminophen 160 mg/DiphenhydramineHCl 12.5mg/phenylephrine HCl 2.5 mg)/5ml		OTC medicines		1391/06/13
Acetaminophen+Guaifensine+Phenylephrine		SYRUP		ORAL	R05X	Acetaminophen 125/Guaifenesine 50mg/phenylephrine 2.5/5ml		OTC medicines		1392/05/01
Acetaminophen+Ibuprofen		TABLET		ORAL	N02BE51	Acetaminophen 500 mg+Ibuprofen 200 mg				1397/04/03
Acetaminophen+Oxycodone		TABLET		ORAL	N02AJ17	Acetaminophen 325mg + Oxycodone Hydrochloride 5 mg		Accessible only in Hospital, Universities and Elected Pharmacies		1397/02/02
Acetaminophen+Oxycodone		TABLET		ORAL	N02AJ17	Acetaminophen 325mg + Oxycodone Hydrochloride 10 mg		Accessible only in Hospital, Universities and Elected Pharmacies		1397/02/02
Acetazolamide		TABLET	250 mg	ORAL	S01EC01
Acetazolamide	As Sodium	INJECTION, POWDER	500 mg	PARENTERAL	S01EC01			Hospital use only
Acetic Acid		BULK			V03			Bulk medicines
Acetone		BULK			V03			Bulk medicines
Acetylcholine	Chloride	INJECTION	1%	OPHTHALMIC	S01EB09			Hospital use only		1360/09/15
Acetylcysteine		SOLUTION	100 mg/ml	RESPIRATORY	R05CB01			Hospital use only	Nebulisation	1393/10/14
Acetylcysteine		SOLUTION, CONCENTRATE	20%	ORAL	R05CB01					1397/02/11
Acetylcysteine		SOLUTION	10%	ORAL	R05CB01					1397/02/11
Acetylcysteine		TABLET	200 mg	ORAL	R05CB01					1378/05/10
Acetylcysteine		TABLET	600 mg	ORAL	R05CB01		Mucolytic			1395/06/31
Acetylcysteine		TABLET, EFFERVESCENT	200 mg	ORAL	R05CB01					1386/08/09
Acetylcysteine		INJECTION	200 mg/ml	PARENTERAL	V03AB23			Hospital use only
Acetylcysteine		INJECTION	100 mg/ml	PARENTERAL	V03AB23			Hospital use only		1395/12/07
Acetylcysteine		POWDER	600 mg	ORAL	R05CB01				Sachet	1388/03/13
Acetylcysteine		GRANULE	100 mg	ORAL	R05CB01				Sachet	1397/02/11
Acetylcysteine		GRANULE	200 mg	ORAL	R05CB01				Sachet	1397/02/11
Acetylcysteine		TABLET, EFFERVESCENT	600 mg	ORAL	R05CB01					1380/06/25
Acetylcysteine+Ascorbic Acid		POWDER		ORAL	R05CB	(Acetylcysteine 600mg + Vitamin C 75mg)/sachet				1387/03/08
Aciclovir		OINTMENT	3%	OPHTHALMIC	S01AD03					1363/10/02
Aciclovir		CREAM	5%	TOPICAL	D06BB03					1363/10/02
Aciclovir		TABLET	200 mg	ORAL	J05AB01					1363/10/02
Aciclovir		INJECTION, POWDER, LYOPHILIZED	250 mg	PARENTERAL	J05AB01					1363/10/02
Aciclovir		TABLET	400 mg	ORAL	J05AB01					1371/08/24
Aciclovir		INJECTION, POWDER	500 mg	PARENTERAL	J05AB01					1382/04/29
Aciclovir		TABLET	800 mg	ORAL	J05AB01					1387/05/06
Acitretin		CAPSULE	10 mg	ORAL	D05BB02					1376/03/11
Acitretin		CAPSULE	25 mg	ORAL	D05BB02					1376/03/11
Aclidinium+Formoterol		INHALATION, POWDER		RESPIRATORY	R03AL05	(Aclidinium Bromide 396 mcg+Formoterol Fumarate Dihydrate 11.8 mcg)/ dose				1396/09/12
Activated Prothrombin Complex (concentrated)		INJECTION, POWDER, LYOPHILIZED	1000 U	PARENTERAL	B02BD03
Activated Prothrombin Complex (concentrated)		INJECTION, POWDER, LYOPHILIZED	500U	PARENTERAL	B02BD03
Adalimumab		INJECTION, SOLUTION	40mg/0.8ml	PARENTERAL	L04AB04					1391/12/23
Adapalene		CREAM	0.10%	TOPICAL	D10AD03					1384/12/09
Adapalene		GEL	0.10%	TOPICAL	D10AD03					1383/09/02
Adapalene		LOTION	0.10%	TOPICAL	D10AD03					1386/01/22
Adapalene		SOLUTION	0.10%	TOPICAL	D10AD03					1383/02/13
Adapalene		GEL	0.30%	TOPICAL	D10AD03					1397/02/02
Adapalene+Benzoyl Peroxide		GEL		TOPICAL	D10AD53	Adapalene 0.1%+Benzoyl Peroxide 2.5%				1396/11/29
Adefovir	Dipivoxil	TABLET	10 mg	ORAL	J05AF08					1385/02/12
Adenosine		INJECTION	3 mg/ml	PARENTERAL	C01EB10			Hospital use only		1377/11/18
Adult Cold Preparations_1: (Decongestant+ Analgesic)		CAPSULE, LIQUID FILLED		ORAL	R05X	As Decongestant: Phenylephrine HCl (5, 10 mg) or Pseudoephedrine HCl (30mg ,120mg) ,As Analgesic: Acetaminophen ( 250,325, 500, 650 mg) or Ibuprofen(200mg) or Naproxen sodium( 200mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia , if 120 mg Pseudoephedrine is in formulation it would be extended release	1388/10/30
Adult Cold Preparations_1: (Decongestant+ Analgesic)		POWDER FOR SOLUTION		ORAL	R05X	As Decongestant: Phenylephrine HCl (5, 10 mg) or Pseudoephedrine HCl (30mg ,120mg) ,As Analgesic: Acetaminophen ( 250,325, 500, 650 mg) or Ibuprofen(200mg) or Naproxen sodium( 200mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia , if 120 mg Pseudoephedrine is in formulation it would be extended release	1397/04/30
Adult Cold Preparations_1: (Decongestant+ Analgesic)		TABLET		ORAL	R05X	As Decongestant: Phenylephrine HCl (5, 10 mg) or Pseudoephedrine HCl (30mg ,120mg) ,As Analgesic: Acetaminophen ( 250,325, 500, 650 mg) or Ibuprofen(200mg) or Naproxen sodium( 200mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia, if 120 mg Pseudoephedrine is in formulation it would be extended release	1388/10/30
Adult Cold Preparations_2: (Decongestant + Expectorant+ Analgesic)		CAPSULE, LIQUID FILLED		ORAL	R05X	As Decongestant: Pseudoephedrine HCl (30 mg),As Expectorant : Guaifenesin ( 200 mg), As Analgesic: Acetaminophen ( 325 mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_2: (Decongestant + Expectorant+ Analgesic)		TABLET		ORAL	R05X	As Decongestant: Pseudoephedrine HCl (30 mg),As Expectorant : Guaifenesin ( 200 mg), As Analgesic: Acetaminophen ( 325 mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_3: (Antihistamine + Analgesic )		TABLET		ORAL	R05X	As Antihistamine: Chlorpheniramine maleate(2mg) or Diphenhydramine HCl (12.5 ,25mg), As Analgesic : Acetaminophen ( 325, 500 mg) or Ibuprofen (200 mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_3: (Antihistamine + Analgesic )		CAPSULE, LIQUID FILLED		ORAL	R05X	As Antihistamine: Chlorpheniramine maleate(2mg) or Diphenhydramine HCl (12.5 ,25mg), As Analgesic : Acetaminophen ( 325, 500 mg) or Ibuprofen (200 mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_4: (Decongestant +Antihistamine+ Analgesic)		TABLET		ORAL	R05X	As Analgesic: Acetaminophen ( 162.5 , 300,325, 500, 650 mg) ,As Decongestant: Phenylephrine HCl (5,10 mg) or Pseudoephedrine (30,60mg) , As Antihistamine: Diphenhydramine HCl (12.5, 25 mg) or Chlorpheniramine maleate (2 , 4 mg) or Clemastine fumarate (0.335mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_4: (Decongestant +Antihistamine+ Analgesic)		POWDER FOR SOLUTION		ORAL	R05X	As Analgesic: Acetaminophen ( 162.5 , 300,325, 500, 650 mg) ,As Decongestant: Phenylephrine HCl (5,10 mg) or Pseudoephedrine (30,60mg) , As Antihistamine: Diphenhydramine HCl (12.5, 25 mg) or Chlorpheniramine maleate (2 , 4 mg) or Clemastine fumarate (0.335mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1397/05/10
Adult Cold Preparations_4: (Decongestant +Antihistamine+ Analgesic)		CAPSULE, LIQUID FILLED		ORAL	R05X	As Analgesic: Acetaminophen ( 162.5 ,250, 300,325, 500, 650 mg) ,As Decongestant: Phenylephrine HCl (5,10 mg) or Pseudoephedrine (30,60mg) , As Antihistamine: Diphenhydramine HCl (12.5, 25 mg) or Chlorpheniramine maleate (2 , 4 mg) or Clemastine fumarate (0.335mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/09/04
Adult Cold Preparations_5: (Antitussive + Decongestant + Analgesic )		TABLET		ORAL	R05X	As Antitussive: Dextromethorphan HBr (10,15, 20mg) , As Decongestant : Pseudoephedrine HCl (30 mg) or Phenylephrine HCl (5, 10 mg), As Analgesic: Acetaminophen (325-650 )		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_5: (Antitussive + Decongestant + Analgesic )		CAPSULE, LIQUID FILLED		ORAL	R05X	As Antitussive: Dextromethorphan HBr (10,15, 20mg) , As Decongestant : Pseudoephedrine HCl (30 mg) or Phenylephrine HCl (5, 10 mg), As Analgesic: Acetaminophen (325-650 )		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_5: (Antitussive + Decongestant + Analgesic )		POWDER FOR SOLUTION		ORAL	R05X	As Antitussive: Dextromethorphan HBr (10,15, 20mg) , As Decongestant : Pseudoephedrine HCl (30 mg) or Phenylephrine HCl (5, 10 mg), As Analgesic: Acetaminophen (325-650 )		OTC medicines	The combinations to be exist in international Pharmacopoeia	1397/05/10
Adult Cold Preparations_6: (Antitussive+ Antihistamine+ Analgesic )		CAPSULE, LIQUID FILLED		ORAL	R05X	As Analgesic : Acetaminophen(300, 500 mg), As antihistamine: Chlorpheniramine maleate (2 mg ) , As Antitussive: Dextromethorphan(15 mg )		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_6: (Antitussive+ Antihistamine+ Analgesic )		TABLET		ORAL	R05X	As Analgesic : Acetaminophen(300, 500 mg), As antihistamine: Chlorpheniramine maleate (2 mg ) , As Antitussive: Dextromethorphan(15 mg )		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_7 :(Antitussive+ Antihistamine+ Decongestant+ Analgesic)		TABLET		ORAL	R05X	As Antitussive : Dextromethorphan(10,15, 20 mg), As Antihistamine: Chlorpheniramine maleate (2 mg) , As Decongestant : Pseudoephedrine (30 mg) or Phenylephrine HCl (5, 10 mg), As Analgesic: Acetaminophen (250, 325,500, 650 mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_7 :(Antitussive+ Antihistamine+ Decongestant+ Analgesic)		CAPSULE, LIQUID FILLED		ORAL	R05X	As Antitussive : Dextromethorphan(10,15, 20 mg), As Antihistamine: Chlorpheniramine maleate (2 mg) , As Decongestant : Pseudoephedrine (30 mg) or Phenylephrine HCl (5, 10 mg), As Analgesic: Acetaminophen (250, 325,500, 650 mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_8: (Antitussive+ Expectorant+ Decongestant+ Analgesic)		CAPSULE, LIQUID FILLED		ORAL	R05X	As Antitussive : Dextromethorphan (10, 15 mg), As Expectorant : Guaifenesin (100, 200 mg), As Decongestant : Pseudoephedrine HCl (30mg) or Phenylephrine HCl (5mg), As Analgesic: Acetaminophen(250, 325 mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/07
Adult Cold Preparations_8: (Antitussive+ Expectorant+ Decongestant+ Analgesic)		TABLET		ORAL	R05X	As Antitussive : Dextromethorphan (10, 15 mg), As Expectorant : Guaifenesin (100, 200 mg), As Decongestant : Pseudoephedrine HCl (30mg) or Phenylephrine HCl (5mg), As Analgesic: Acetaminophen(250, 325 mg)		OTC medicines	The combinations to be exist in international Pharmacopoeia	1388/05/7
Aflibercept		INJECTION, SOLUTION	40mg/ml	PARENTERAL	S01LA05		Macular Oedema	Hospital use only		1395/08/02
Agomelatine		TABLET	25 mg	ORAL	N06AX22					1396/09/12
Albendazole		TABLET, CHEWABLE	200 mg	ORAL	P02CA03		Treatment of hydatid disease (cystic echinococcosis due to E. granulosus larvae or alveolar echinococcosis due to E. multilocularis larvae).
Albendazole		SUSPENSION	200 mg/5ml	ORAL	P02CA03		Treatment of hydatid disease (cystic echinococcosis due to E. granulosus larvae or alveolar echinococcosis due to E. multilocularis larvae).
Albendazole		TABLET, CHEWABLE	400 mg	ORAL	P02CA03		Treatment of hydatid disease (cystic echinococcosis due to E. granulosus larvae or alveolar echinococcosis due to E. multilocularis larvae).			1370/10/01
Albumin (Human)		INJECTION, SOLUTION	25%	PARENTERAL	B05AA01			Hospital use only		1396/04/18
Albumin (Human)		INJECTION, SOLUTION	20%, 100ml	PARENTERAL	B05AA01			Hospital use only
Albumin (Human)		INJECTION, SOLUTION	20%, 10ml	PARENTERAL	B05AA01			Hospital use only
Albumin (Human)		INJECTION, SOLUTION	20%, 250ml	PARENTERAL	B05AA01			Hospital use only		1385/08/17
Albumin (Human)		INJECTION, SOLUTION	20%, 500ml	PARENTERAL	B05AA01			Hospital use only		1385/08/17
Albumin (Human)		INJECTION, SOLUTION	20%, 50ML	PARENTERAL	B05AA01			Hospital use only
Albumin (Human)		INJECTION, SOLUTION	5%, 100ML	PARENTERAL	B05AA01			Hospital use only
Albumin (Human)		INJECTION, SOLUTION	5%, 250ml	PARENTERAL	B05AA01			Hospital use only		1385/08/17
Albumin (Human)		INJECTION, SOLUTION	5%, 500ml	PARENTERAL	B05AA01			Hospital use only		1385/08/17
Alemtuzumab		INJECTION, SOLUTION, CONCENTRATE	30 mg/ ml	INTRAVENOUS DRIP	L04AA34					1388/04/21
Alemtuzumab		INJECTION, SOLUTION, CONCENTRATE	10 mg/ ml	INTRAVENOUS DRIP	L04AA34		Relapsing Remitting Multiple Sclerosis	Orphan medicines		1395/09/01
Alendronate		TABLET	10 mg	ORAL	M05BA04
Alendronate	As Sodium	TABLET	35 mg	ORAL	M05BA04					1381/12/27
Alendronate	As Sodium	TABLET	70 mg	ORAL	M05BA04					1381/12/27
Alendronate	As Sodium	EFFERVESCEN TABLET	70 mg	ORAL	M05BA04					1397/02/11
Alendronic acid+Colecalciferol		TABLET		ORAL	M05BB03	Alendronic acid 70mg+Colecalciferol 70mcg			for local production only	1390/03/09
Alendronic acid+Colecalciferol		TABLET		ORAL	M05BB03	Alendronic acid 70mg+Colecalciferol 140mcg				1390/01/29
Alfentanil		INJECTION	0.5 mg/ml	PARENTERAL	N01AH02	As HCl		Hospital use only
Alglucosidase Alfa		INJECTION, POWDER	50 mg	PARENTERAL	A16AB07			Orphan medicines		1390/07/05
Allopurinol		TABLET	100 mg	ORAL	M04AA01
Allopurinol		TABLET	300 mg	ORAL	M04AA01					1378/05/10
Alprazolam		TABLET	0.5 mg	ORAL	N05BA12					1373/09/20
Alprazolam		TABLET	1 mg	ORAL	N05BA12					1373/09/20
Alteplase		INJECTION, POWDER	10 mg	PARENTERAL	B01AD02		Acute Ischemic Strock Acute Myocardial Infarction Pulmonary Embolism		for local production only	1387/09/09
Alteplase		INJECTION, POWDER	20 mg	PARENTERAL	B01AD02		Acute Ischemic Strock Acute Myocardial Infarction Pulmonary Embolism			1387/09/09
Alteplase		INJECTION, POWDER	50 mg	PARENTERAL	B01AD02		Acute Ischemic Strock Acute Myocardial Infarction Pulmonary Embolism			1387/09/09
Aluminium Chloride		BULK			V03			Bulk medicines		1361/11/17
Aluminium Hydroxide		TABLET, CHEWABLE	300 mg	ORAL	A02AB01			OTC medicines; as Dried Gel		1369/06/11
Aluminium Hydroxide		SUSPENSION	320 mg/5ml	ORAL	A02AB01			OTC medicines; Gel		1369/06/11
Aluminium/Magnesium/Simethicone		SUSPENSION		ORAL	A02AF02	(Aluminium hydroxide 225mg+magnesium hydroxide 200mg+simethicone 25mg)/5ml		OTC medicines		1369/10/30
Aluminium+Magnesium		SUSPENSION		ORAL	A02AX	(Aluminium hydroxide 225mg+magnesium hydroxide 200)/5ml		OTC medicines		1369/10/30
Aluminium+Magnesium		SUSPENSION		ORAL	A02AX	(Aluminium hydroxide 225mg+magnesium hydroxide 200mg)/5ml Sachet		OTC medicines		1369/10/30
Aluminium+Magnesium		POWDER, FOR SUSPENSION		ORAL	A02AX	(Aluminium hydroxide 564mg + Magnesium hydroxide 174mg)/sachet		OTC medicines		1363/10/23
Aluminium+Magnesium		TABLET, CHEWABLE		ORAL	A02AX	Aluminium hydroxide 200mg + magnesium hydroxide 200mg		OTC medicines		1369/10/30
Aluminium+Magnesium+Simethicone		SUSPENSION		ORAL	A02AF02	(Aluminium hydroxide 225mg+magnesium hydroxide 200mg+simethicone 25mg)/5ml/sachet		OTC medicines		1369/10/30
Aluminium+Magnesium+Simethicone		TABLET, CHEWABLE		ORAL	A02AF02	Aluminium hydroxide 200mg+magnesium hydroxide 200mg+simethicone 25mg		OTC medicines		1369/10/30
Amantadine	HCl	CAPSULE	100 mg	ORAL	N04BB01
Ambenonium	Chloride	TABLET	10 mg	ORAL	N07AA30
Amikacin	As Sulfate	INJECTION	250 mg/ml	PARENTERAL	J01GB06		Treatment of bronchopulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients	Hospital use only
Amikacin	As Sulfate	INJECTION	50 mg/ml	PARENTERAL	J01GB06			Hospital use only
Amiloride+Hyrochlorothiazide		TABLET		ORAL	C03EA01	Amiloride as dihydrate 5 mg+Hyrochlorothiazide 50 mg				1369/10/16
Amino Caproic Acid		INJECTION	250 mg/ml	PARENTERAL	B02AA01			Hospital use only		1382/03/04
Amino Caproic Acid		INJECTION	400 mg/ml	PARENTERAL	B02AA01			Hospital use only		1382/03/04
Aminoacid		INJECTION, SOLUTION	5%	INTRAVENOUS DRIP	B05BA01			Hospital use only	Total weight of Amino Acids equal to 50g/l	1390/02/21
Aminoacid		INJECTION, SOLUTION, CONCENTRATE	10%	INTRAVENOUS DRIP	B05BA01			Hospital use only	Total weight of Amino Acids equal to 100g/l	1389/08/24
Aminoacid		INJECTION, SOLUTION	10%	INTRAVENOUS DRIP	B05BA01			Hospital use only	Total weight of Amino Acids equal to 100g/l	1391/05/04
Aminoacid		INJECTION, SOLUTION	15%	INTRAVENOUS DRIP	B05BA01			Hospital use only	Total weight of Amino Acids equal to 150g/l	1396/12/08
Aminoacid+ Electrolyte		INJECTION, SOLUTION	5%	INTRAVENOUS DRIP	B05BA01	Isoleucine 2.55g+Leucine 4.45g+lysine HCl 3.50g+Methionine 1.90g+Phenylalanine 2.55g+Threonine 2.05g+Tryptophane 0.90g+Valine 2.40g+Arginine 4.60g+Histidine 2.60g+Alanine 6.85g+Glycine 3.95g+Asparagine H2O 1.86g+Asparatic acid 0.65g+Acetylcysteine 0.34g+Glutamic acid 2.30g+Ornithine HCl 1.60g+Proline 4.45g+Serine 1.20g+Tyrosine 0.30g+Acetyltyrosine 0.43g+Sodium acetate 3H2O 3.95g+Potassium acetate 2.454g+Magnesium acetate 4H2O 0.558g+Sodium dihydrogen phosphate dihydrate 1.4g+Malic acid 1.01g+Sodium hydroxide 0.2g Water for inj. Q.S. to 1000 ml		Hospital use only		1389/11/04
Aminoacid+Electrolyte		INJECTION, SOLUTION	5%	INTRAVENOUS DRIP	B05BA01	Isoleucine 2.50g+Leucine 4.45g+lysine HCl 4.28g+Methionine 2.20g+Phenylalanine 2.35g+Threonine 2.10g+Tryptophane 0.80g+Valine 3.10g+Arginine 5.75g+Histidine 1.50g+Alanine 5.25g+Glycine 6.00g+ Asparatic acid 2.80g+ Glutamic acid 3.60g +Proline 2.75g+Serine 1.15g+Tyrosine 0.40g+ Sodium acetate 3H2O 1.361g+ Sodium chloride 0.964g + Sodium hydroxide 0.140g+potassium acetate 2.453g+ Magnesium chloride 6H2O 0.508g+Disodium phosphate dodecahydrate 3.581g+ Water for inj. Q.S. to 1000 ml		Hospital use only		1390/1/29
Aminoacid+Electrolyte		INJECTION, SOLUTION	10%	INTRAVENOUS DRIP	B05BA01	{Isoleucine (0.77-13.80)mg+leucine (1.10-15.76)mg+Lysine HCL(1.08-15.75)mg+Methionine (0.40-8.80)mg+Phenylalanine (0.75-8.80)mg+Threonine (0.50-9.00)mg+Tryptophane (0.23-3.00)mg+ Valine (0.75-12.40)mg+ Arginine (0.93-20.00)mg+ Histidine (0.65-9.80)mg+ Alanine (0.846-82.00)mg+ Glycine (0.31-19.20)mg + Asparatic acid (0.65-10.50)mg + Glutamic acid (1.14-11.07)mg+Proline (1.15-17.00)mg + Serine (0.60-14.10)mg+ Tyrosine (0.05-10.16)mg+Sodium Acetate 3H2O 2.858mg+Sodium Hydroxide 0.360mg+Pottassium Acetate 2.453mg + Magnesium Chloride 6H2O 0.508mg+Disodium Phosphate dodecahydrate 3.581mg}/ml		Hospital use only		1390/1/29
Aminoacid+Electrolyte		INJECTION, SOLUTION, CONCENTRATE	10%	INTRAVENOUS DRIP	B05BA01	{Isoleucine (0.77-13.80)mg+leucine (1.10-15.76)mg+Methionine (0.40-8.80)mg+Phenylalanine (0.75-8.80)mg+Threonine (0.50-9.00)mg+Tryptophane (0.23-3.00)mg+ Valine (0.75-12.40)mg+ Arginine (0.93-20.00)mg+ Histidine (0.65-9.80)mg+ Alanine (0.846-82.00)mg+ Taurine (0.12-2.00)mg+Proline (1.15-17.00)mg+ Serine (0.60-14.10)mg+ Tyrosine (0.05-10.16)mg+ Cysteine (0.074-2.00)mg+ Asparagine (0.32-4.09)mg+ Asparatic acid (0.65-10.50)mg+ Glycine (0.31-19.20)mg+ Glutamic acid (1.14-11.07)mg+ Lysine hydrochloride (1.08-15.75)mg+ Lysine acetate (3.34-9.31)mg+Ornithine (0.63-3.75)mg +Glutamine (1.20-22.08)mg +Acetylcysteine 0.68 mg+N-Acetyltyrosine 1.23 mg+Sodium Acetate 3H2O 3.95mg+Pottassium Acetate 2.454mg+Magnesium Acetate 4H2O 0.56mg+Sodium Dihydrogen Phosphate dihydrate 1.404mg+Malic Acid 1.01mg+Sodium Hydroxide 0.2mg}/ml		Hospital use only		1389/11/04
Aminoacid+Lipid+Glucose 1		INJECTION,EMULSION		INTRAVENOUS DRIP	B05BA10	nutriflex lipid plus: Isoleucine 2.26g +Leucine 3.01g+Lysine HCl 2.73g +Methionine 1.88g+Phenylalanine3.37g+Threonine 1.74g+Tryptophane 0.54g+Valine 2.50g+Arginine 2.59g+Histidine HCl monohydrate 1.62g+Alanine 4.66g+Glycine 1.58g+Aspartic acid 1.44g+Glutamic acid 3.37 g+Proline 3.26g+Serine 2.88+ Sodium Chloride 0.402g+Sodium acetate trihydrate 0.222g+ Potassium acetate 2.747g+ Magnesium Acetate tetrahydrate 0.686g + Calcium Chloride dihydrate 0.470g + Sodium hydroxide 0.781 g+Glucose monohydrate 132g+Sodium dihydrogen phosphate dihydrate 1.872g+Zinc acetate dihydrate 5.264g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml		Hospital use only		1389/11/4
Aminoacid+Lipid+Glucose 2		INJECTION, EMULSION		INTRAVENOUS DRIP	B05BA10	nutriflex lipid special: Isoleucine 3.28g + Leucine 4.38g + Lysine HCl 3.98g + Methionine 2.74g + Phenylalanine4.92g + Threonine 2.54g + Tryptophane 0.8g + Valine 3.6g + Arginine 3.780g + Histidine HCl monohydrate 2.37g + Alanine 6.79g + Glycine 2.31g + Aspartic acid 2.1g + Glutamic acid 4.91g +Proline 4.76g +Serine 4.2g + Sodium Chloride 0.378g+Sodium acetate trihydrate 0.25g+ Potassium acetate 3.689g+ Magnesium Acetate tetrahydrate 0.91g + Calcium Chloride dihydrate 0.623g + Sodium hydroxide 1.171 g+Glucose monohydrate 158.4g+Sodium dihydrogen phosphate dihydrate 2.496g+Zinc acetate dihydrate 7.02g+Triglyceride,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml		Hospital use only		1389/11/4
Aminoacid+Lipid+Glucose 3		INJECTION,EMULSION		INTRAVENOUS DRIP	B05BA10	nutriflex lipid peri: Isoleucine 1.872g +Leucine 2.504g+Lysine HCl 2.272g +Methionine 1.568g+Phenylalanine2.808g+Threonine 1.456g+Tryptophane 0.456g+Valine 2.08g+Arginine 2.160g+Histidine HCl monohydrate 1.352g+Alanine 3.88g+Glycine 1.32g+Aspartic acid 1.20g+Glutamic acid 2.80 g+Proline 2.72g+Serine 2.40g+ Sodium Hydroxide 0.64g + Sodium Chloride 0.865g+Sodium acetate trihydrate 0.435g+ Potassium acetate 2.354g+ Magnesium Acetate 4H2o 0.515g + Calcium Chloride dihydrate 0.353g + Glucose monohydrate 70.4g +Sodium dihydrogen phosphate dihydrate 0.936g+Zinc acetate dihydrate 5.28g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml		Hospital use only		1389/11/04
Aminobenzoic Acid+Padimate		LOTION		TOPICAL	D02BA	Para Aminobenzoic Acid 5% w/w + Padimate O 3.2% w/w( Paba-p)
Aminobenzoic Acid		LOTION	5%	TOPICAL	D02BA01	Paba				1362/8/15
Aminoglutethimide		TABLET	250 mg	ORAL	L02BG01
Aminophylline		INJECTION	25 mg/ml	PARENTERAL	R03DA05			Hospital use only
Amiodarone	HCl	INJECTION, SOLUTION	150 mg/100ml	PARENTERAL	C01BD01		For the acute treatment and prophylaxis of life-threatening ventricular tachycardia or ventricular fibrillation.	Hospital use only		1391/10/03
Amiodarone	HCl	TABLET	200 mg	ORAL	C01BD01
Amiodarone	HCl	INJECTION	50 mg/ml	PARENTERAL	C01BD01		For the acute treatment and prophylaxis of life-threatening ventricular tachycardia or ventricular fibrillation.	Hospital use only		1364/11/06
Amitriptyline	HCl	TABLET	10 mg	ORAL	N06AA09					1377/05/25
Amitriptyline	HCl	TABLET	100 mg	ORAL	N06AA09					1371/06/08
Amitriptyline	HCl	TABLET	25 mg	ORAL	N06AA09					1377/5/25
Amitriptyline	HCl	TABLET	50 mg	ORAL	N06AA09					1372/5/24
Amlodipine	As Besilate	TABLET	10 mg	ORAL	C08CA01					1386/08/09
Amlodipine	As Besilate	TABLET	2.5 mg	ORAL	C08CA01					1386/08/09
Amlodipine	As Besilate	TABLET	5 mg	ORAL	C08CA01
Amlodipine+Atorvastatin		TABLET		ORAL	C10BX03	Amlodipine (As Besilate0 10mg+ Atorvastatin As Calcium10mg				1388/08/20
Amlodipine+Atorvastatin		TABLET		ORAL	C10BX03	Amlodipine (As Besilate) 5mg+ Atorvastatin As Calcium 20mg				1385/10/26
Amlodipine+Atorvastatin		TABLET		ORAL	C10BX03	Amlodipine (As Besilate) 5mg+ Atorvastatin As Calcium10mg				1387/03/08
Amlodipine+Bisoprolol		TABLET		ORAL	C07FB07	Amlodipine (As Besilate) 5mg+ Bisoprolol Fumarate 5mg				1397/04/30
Amlodipine+Bisoprolol		TABLET		ORAL	C07FB07	Amlodipine (As Besilate) 5mg+ Bisoprolol Fumarate10mg				1397/04/30
Amlodipine+Bisoprolol		TABLET		ORAL	C07FB07	Amlodipine (As Besilate) 10 mg+ Bisoprolol Fumarate 5 mg				1397/04/30
Amlodipine+Bisoprolol		TABLET		ORAL	C07FB07	Amlodipine (As Besilate)10 mg+ Bisoprolol Fumarate10 mg				1397/04/30
Amlodipine+Valsartan		TABLET		ORAL	C09DB01	Amlodipine (As Besilate) 10 mg/ Valsartan 160 mg			for local production only	1390/07/04
Amlodipine+Valsartan		TABLET		ORAL	C09DB01	Amlodipine (As Besilate) 10 mg/ Valsartan 320 mg			for local production only	1390/07/04
Amlodipine+Valsartan		TABLET		ORAL	C09DB01	Amlodipine (As Besilate) 5 mg/ Valsartan 160 mg			for local production only	1390/07/04
Amlodipine+Valsartan		TABLET		ORAL	C09DB01	Amlodipine (As Besilate) 5 mg/ Valsartan 320 mg			for local production only	1390/07/04
Amlodipine+Valsartan		TABLET		ORAL	C09DB01	Amlodipine (As Besilate) 5 mg/ Valsartan 80 mg			for local production only	1390/07/04
Amlodipine+Valsartan+Hydrochlortiazid		TABLET		ORAL	C09DX01	Amlodipine (As Besilate) 10 mg+ Valsartan 160 mg+Hydrochlortiazid 12.5mg			for local production only	1392/03/11
Amlodipine+Valsartan+Hydrochlortiazid		TABLET		ORAL	C09DX01	Amlodipine (As Besilate) 10 mg+ Valsartan 160 mg+Hydrochlortiazid 25mg			for local production only	1392/03/11
Amlodipine+Valsartan+Hydrochlortiazid		TABLET		ORAL	C09DX01	Amlodipine (As Besilate) 5 mg+ Valsartan 160 mg+Hydrochlortiazid 12.5mg			for local production only	1392/03/11
Amlodipine+Valsartan+Hydrochlortiazid		TABLET		ORAL	C09DX01	Amlodipine (As Besilate) 5 mg+ Valsartan 160 mg+Hydrochlortiazid 25mg			for local production only	1392/03/11
Ammonium Alum		BULK			V03			Bulk medicines
Ammonium Chloride		TABLET, DELAYED RELEASE	500 mg	ORAL	G04BA01
Ammonium Chloride		BULK			V03			Bulk medicines		1362/01/21
Ammonium Hydroxide		BULK			V03			Bulk medicines		1376/12/10
Amoxicillin		POWDER, FOR SUSPENSION	125 mg/5ml	ORAL	J01CA04
Amoxicillin		TABLET, DISPERSIBLE	125mg	ORAL	J01CA04
Amoxicillin		POWDER, FOR SUSPENSION	200 mg/5ml	ORAL	J01CA04
Amoxicillin		POWDER, FOR SUSPENSION	250 mg	ORAL	J01CA04
Amoxicillin		TABLET, CHEWABLE	250 mg	ORAL	J01CA04
Amoxicillin		TABLET, DISPERSIBLE	250 mg	ORAL	J01CA04
Amoxicillin		CAPSULE	250 mg	ORAL	J01CA04
Amoxicillin		POWDER, FOR SUSPENSION	250 mg/5ml	ORAL	J01CA04
Amoxicillin		POWDER, FOR SUSPENSION	400 mg/5ml	ORAL	J01CA04
Amoxicillin		TABLET	500 mg	ORAL	J01CA04
Amoxicillin		TABLET	875 mg	ORAL	J01CA04					1396/06/12
Amoxicillin		CAPSULE	500 mg	ORAL	J01CA04
Amoxicillin		TABLET, EXTENDED RELEASE	775 mg	ORAL	J01CA04					1397/05/10
Amphotericin-B		GEL	0.4%	TOPICAL	A01AB04				Nanoliposomal	1392/04/04
Amphotericin-B		INJECTION, POWDER, LYOPHILIZED	50 mg	PARENTERAL	J02AA01			Hospital use only
Amphotericin-B	As Complex with Sodium Cholesteryl Sulphate	INJECTION, POWDER, LYOPHILIZED	50 mg	PARENTERAL	J02AA01			Hospital use only
Amphotericin-B Liposome		INJECTION, POWDER	50 mg	PARENTERAL	J02AA01		Treatment of invasive protothecosis. Treatment of invasive sporotrichosis. Treatment of invasive coccidioidomycosis. Treatment of invasive zygomycosis. Treatment of invasive candidiasis. Treatment of invasive fungal infections.	for Health Dept. of MOH only		1385/09/07
Ampicillin	As Sodium	INJECTION, POWDER	1 g	PARENTERAL	J01CA01
Ampicillin		POWDER, FOR SUSPENSION	125 mg/5ml	ORAL	J01CA01
Ampicillin	As Sodium	INJECTION, POWDER	250 mg	PARENTERAL	J01CA01
Ampicillin		CAPSULE	250 mg	ORAL	J01CA01
Ampicillin		POWDER, FOR SUSPENSION	250 mg/5ml	ORAL	J01CA01
Ampicillin	As Sodium	INJECTION, POWDER	500 mg	PARENTERAL	J01CA01					1360/08/24
Ampicillin		CAPSULE	500 mg	ORAL	J01CA01
Ampicillin+Sulbactam		INJECTION, POWDER	1.5 g	PARENTERAL	J01CR01	1 g Ampicillin + 0.5 g Sulbactam				1382/04/01
Ampicillin+Sulbactam		INJECTION, POWDER	3 g	PARENTERAL	J01CR01	2 g Ampicillin +1 g Sulbactam				1382/04/01
Amyl Nitrite		INHALER		RESPIRATORY	V03AB22		Treatment of cyanide poisoning	Orphan medicines		1377/05/25
Anagrelide	HCl	CAPSULE	500 mcg	ORAL	L01XX35			Orphan medicines		1388/02/27
Anakinra		INJECTION, SOLUTION	100mg/0.67 ml	PARENTERAL	L04AC03		Arthritis rheumatoid in combination with Methotrexate not responded to Methotrexate alone, CAPS, SJIA	Orphan medicines		1396/11/29
Anthocyanoside A		TABLET		ORAL	C04A	Myrtillus Anthocyanosidic Extract of Vaccinium Myrtillus 100mg + Betacarotene 5mg				1380/04/17
Anticoagulant		POWDER			B01	(Sodium citrate dehydrate 2.63 g + Citric acid anhydrous 0.299 g + Sodium biphosphate monohydrate 0.222 g + Dextrose monohydrate 3.19 g + Adenine 0.0275 g ) /100 ml BLOOD PACK
Anticoagulant		SOLUTION			B01	(Sodium citrate dehydrate 2.63 g + Citric acid anhydrous 0.299 g + Sodium biphosphate monohydrate 0.222 g + Dextrose monohydrate 3.19 g + Adenine 0.0275 g ) /100 ml BLOOD PACK				1397/08/15
Anti-D Immunoglobulin		INJECTION	250 mcg	INTRAMUSCULAR	J06BB01			Hospital use only		1373/11/23
Anti-D Immunoglobulin		INJECTION, POWDER, LYOPHILIZED	250 mcg	INTRAMUSCULAR	J06BB01			Hospital use only		1373/11/23
Anti-D Immunoglobulin		INJECTION	300 mcg	INTRAMUSCULAR	J06BB01			Hospital use only
Anti-D Immunoglobulin		INJECTION, POWDER, LYOPHILIZED	300 mcg	INTRAMUSCULAR	J06BB01			Hospital use only
Anti-D Immunoglobulin		INJECTION	50 mcg/ml	INTRAVENOUS	J06BB01		Treatment of immune thrombocytopenic purpura.	Hospital use only
Antihemorrhoid		OINTMENT		RECTAL	N01BB52	(Lidocaine 50mg+hydrocortisone acetate 2.75mg+aluminium subacetate 35mg+zinc oxide 180mg)/g		OTC medicines
Antihemorrhoid		SUPPOSITORY		RECTAL	N01BB52	Lidocaine 60mg+hydrocortisone acetate 5mg+aluminium subacetate 50mg+zinc oxide 400mg		OTC medicines
Antihistamine Decongestant		TABLET		ORAL	R01BA53	Chlorpheniramine Maleate4mg/phenylephrine HCL 10mg		OTC medicines
Antihistamine Decongestant		CAPSULE, EXTENDED RELEASE		ORAL	R01BA51	Brompheniramine Maleate 12mg+ Pseudoephedrine HCl 120 mg		OTC medicines		1383/09/02
Antihistamine Decongestant		TABLET, EXTENDED RELEASE		ORAL	R01BA51	Brompheniramine Maleate 12mg+ Pseudoephedrine HCl 120 mg		OTC medicines		1383/09/02
Antihistamine Decongestant		CAPSULE, LIQUID FILLED		ORAL	R01BA51	Chlorpheniramine maleate 2 mg + Pseudoephedrine HCl 30 mg		OTC medicines		1385/11/04
Antihistamine Decongestant		TABLET		ORAL	R01BA51	Chlorpheniramine maleate 2 mg + Pseudoephedrine HCl 30 mg		OTC medicines		1383/09/02
Antilymphocyte Immunoglobulin		INJECTION	20 mg/ml	PARENTERAL	L04AA03			Hospital use only
Antilymphocyte Immunoglobulin		INJECTION	50 mg/ml	PARENTERAL	L04AA03			Hospital use only
Antiscorpion Venom Serum		INJECTION		PARENTERAL	J06AA					1368/03/07
Antisnake Venom Serum		INJECTION		PARENTERAL	J06AA03
Antithymocyte Immunoglobulin		INJECTION	20 mg/ml	PARENTERAL	L04AA04		(rabbit); myelodys plastic syndrom(mds); allograft rejection, including solid organ(kidney,liver,heart,lung,pancreas)and bone marrow transplantation.	Hospital use only
Antithymocyte Immunoglobulin		INJECTION, POWDER, LYOPHILIZED	25 mg	PARENTERAL	L04AA04		Treatment of myelodysplastic syndrome (MDS)	Hospital use only
Antithymocyte Immunoglobulin		INJECTION	50 mg/ml	PARENTERAL	L04AA04		Treatment of myelodysplastic syndrome (MDS)	Hospital use only
Apixaban		TABLET	2.5 mg	ORAL	B01AF02		Antithrombotic			1397/07/28
Apixaban		TABLET	5 mg	ORAL	B01AF02		Antithrombotic			1397/07/28
Apomorphine	HCl	INJECTION	10 mg/ml	PARENTERAL	N04BC07		Treatment of the on-off fluctuations associated with late-stage Parkinson's disease. For the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain injury (traumatic or spontaneous)	Hospital use only
Apomorphine	HCl	INJECTION	5 mg/ml	PARENTERAL	N04BC07		Treatment of the on-off fluctuations associated with late-stage Parkinson's disease.	Hospital use only	For Infusion, For Subcutaneous use	1396/03/21
Aprepitant		CAPSULE	125 mg	ORAL	A04AD12					1387/06/26
Aprepitant		CAPSULE	80 mg	ORAL	A04AD12					1387/06/26
Aprotinin		INJECTION	10,000 KIU/ml	PARENTERAL	B02AB01		For prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing cardiopulmonary bypass surgery in the course of repeat coronary artery bypass graft surgery, and in selected cases of primary c	Hospital use only
Aprotinin		INJECTION	20,000 KIU/ml	PARENTERAL	B02AB01		For prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing cardiopulmonary bypass surgery in the course of repeat coronary artery bypass graft surgery, and in selected cases of primary c	Hospital use only		1376/06/30
Arginine	HCl	POWDER	100 g	ORAL	B05XB01		Treatment of hyperamonemia	Orphan medicines		1387/10/15
Arginine	HCl	INJECTION	100 mg/ml	PARENTERAL	B05XB01		Treatment of hyperamonemia	Orphan medicines		1387/10/15
Arginine	HCl	INJECTION	950 mOsmol/L	PARENTERAL	B05XB01			Hospital use only		1361/09/14
Arginine	HCl	INJECTION		PARENTERAL	B05XB01		Treatment of sickle cell disease and beta thalassemia.	Orphan medicines
Aripiprazole		TABLET	10 mg	ORAL	N05AX12					1387/12/21
Aripiprazole		TABLET	15 mg	ORAL	N05AX12					1387/12/21
Aripiprazole		TABLET	5 mg	ORAL	N05AX12					1388/02/30
Arsenic Trioxide		INJECTION	0.10%	PARENTERAL	L01XX27		Treatment of malignant glioma Treatment of chronic myeloid leukemia Treatment of acute promyelocytic leukemia Treatment of multiple myeloma. Treatment of liver cancer Treatment of chronic lymphocytic leukemia Treatment of myelodysplastic syndrome.	Hospital use only		1382/03/04
Artemether		CAPSULE	40 mg	ORAL	P01BE02		Acute treatment of malaria	for Health Dept. of MOH only		1383/04/07
Artemether		INJECTION	80 mg	PARENTERAL	P01BE02		Acute treatment of malaria	for Health Dept. of MOH only		1383/04/07
Artemether+ Lumefantrine		TABLET		ORAL	P01BF01	Artemether 20 mg+ Lumefantrine 120mg	Acute treatment of malaria	for Health Dept. of MOH only		1394/03/31
Artesunate		TABLET	50 mg	ORAL	P01BE03			for Health Dept. of MOH only		1397/03/01
Artesunate		TABLET	100 mg	ORAL	P01BE03			for Health Dept. of MOH only
Artesunate		TABLET	200 mg	ORAL	P01BE03		Immediate treatment of malaria	for Health Dept. of MOH only; Orphan medicine		1385/09/07
Artesunate		INJECTION	200 mg	PARENTERAL	P01BE03		Immediate treatment of malaria	for Health Dept. of MOH only; Orphan medicine
Artesunate		SUPPOSITORY	50 mg	RECTAL	P01BE03		Immediate treatment of malaria	for Health Dept. of MOH only
Artesunate		SUPPOSITORY	200 mg	RECTAL	P01BE03		Immediate treatment of malaria	for Health Dept. of MOH only		1394/11/13
Artesunate		INJECTION	60 mg/ml	PARENTERAL	P01BE03		Immediate treatment of malaria	for Health Dept. of MOH only		1386/04/27
Articaine+Epinephrine		INJECTION		PARENTERAL	N01BB58	Articaine Hydrochloride 4% + Epinephrine 1/100000				1385/06/14
Articaine+Epinephrine		INJECTION		PARENTERAL	N01BB58	Articaine Hydrochloride 4% + Epinephrine 1/200000				1385/06/14
Artificial Saliva		SPRAY		ORAL	A16AX			OTC medicines		1381/12/04
Artificial Saliva		GEL		ORAL	A16AX			OTC medicines		1381/12/04
ASA (Acetylsalicylic Acid)		TABLET, CHEWABLE	100 mg	ORAL	N02BA01	N02BA01
ASA (Acetylsalicylic Acid)		TABLET	325 mg	ORAL	N02BA01			OTC medicines		1369/10/23
ASA (Acetylsalicylic Acid)		TABLET, EFFERVESCENT	325 mg	ORAL	N02BA01			OTC medicines		1374/07/30
ASA (Acetylsalicylic Acid)		TABLET, DELAYED RELEASE	325 mg	ORAL	N02BA01					1369/10/23
ASA (Acetylsalicylic Acid)		SUPPOSITORY	325 mg	RECTAL	N02BA01					1369/10/23
ASA (Acetylsalicylic Acid)		TABLET	500 mg	ORAL	N02BA01			OTC medicines	Microcoated	1369/10/23
ASA (Acetylsalicylic Acid)		TABLET	100 mg	ORAL	N02BA01			OTC medicines
ASA (Acetylsalicylic Acid)		TABLET, DELAYED RELEASE	80 mg	ORAL	B01AC06			OTC medicines		1373/03/22
ASA (Acetylsalicylic Acid)		TABLET , DELAYED RELEASE	81 mg	ORAL	B01AC06			OTC medicines		1391/11/02
ASA (Acetylsalicylic Acid)		TABLET , ORALLY DISINTEGRATING	300 mg	ORAL	B01AC06			OTC medicines		1396/08/02
ASA (Acetylsalicylic Acid)+ Atorvastatin+Enalapril+Hydrochlorthiazide		TABLET		ORAL	C09BA02	ASA 81 mg+ Atorvastatin (As Calcium) 20 mg+ Enalapril Maleate 5 mg+ Hydrochlorthiazide 12.5 mg (Polypill E)				1393/10/14
ASA (Acetylsalicylic Acid)+Atorvastatin+Hydrochlorthiazide+Valsartan		TABLET		ORAL	C09DA03	ASA 81 mg+ Atorvastatin (As Calcium) 20 mg+ Hydrochlorthiazide 12.5 mg+ Valsartan 40 mg (Polypill V)				1393/10/14
ASA+Ascorbic acid		TABLET, EFFERVESCENT		ORAL	N02BA51	ASA 400mg+Ascorbic acid 240mg		OTC medicines
ASA+Codeine		TABLET		ORAL	N02BA71	ASA 500mg + -Codeine phosphate 10mg
Asparaginase		INJECTION, POWDER		PARENTERAL	L01XX02
Atazanavir	Sulphate	CAPSULE	150 mg	ORAL	J05AE08			For Health Dept. of MOH only		1393/10/14
Atazanavir	As Sulphate	CAPSULE	200 mg	ORAL	J05AE08			For Health Dept. of MOH only		1397/02/11
Atazanavir	Sulphate	CAPSULE	300 mg	ORAL	J05AE08			For Health Dept. of MOH only		1393/10/14
Atazanavir+Ritonavir		TABLET		ORAL	J05	Atazanavir Sulfate 300mg+Ritonavir 100mg		For Health Dept. of MOH only		1396/05/28
Atenolol		TABLET	100 mg	ORAL	C07AB03					1361/02/26
Atenolol		TABLET	50 mg	ORAL	C07AB03					1366/02/06
Atomoxetine	HCl	CAPSULE	10 mg	ORAL	N06BA09					1391/02/07
Atomoxetine	HCl	CAPSULE	18 mg	ORAL	N06BA09					1391/02/07
Atomoxetine	HCl	CAPSULE	25 mg	ORAL	N06BA09					1391/02/07
Atomoxetine	HCl	CAPSULE	40 mg	ORAL	N06BA09					1391/02/07
Atomoxetine	HCl	CAPSULE	60 mg	ORAL	N06BA09					1391/02/07
Atorvastatin	As Calcium	TABLET	10 mg	ORAL	C10AA05					1379/12/07
Atorvastatin	As Calcium	TABLET	20 mg	ORAL	C10AA05					1379/12/07
Atorvastatin	As Calcium	TABLET	40 mg	ORAL	C10AA05					1379/12/07
Atorvastatin	As Calcium	TABLET	80 mg	ORAL	C10AA05					1395/06/24
Atorvastatin+Ezetimibe		TABLET		ORAL	C10BA05	Atorvastatin (As Calcium) 10 mg+Ezetimibe 10 mg				1396/11/29
Atorvastatin+Ezetimibe		TABLET		ORAL	C10BA05	Atorvastatin (As Calcium) 20 mg+Ezetimibe 10 mg				1396/11/29
Atorvastatin+Ezetimibe		TABLET		ORAL	C10BA05	Atorvastatin (As Calcium) 40 mg+Ezetimibe 10 mg				1396/11/29
Atorvastatin+Ezetimibe		TABLET		ORAL	C10BA05	Atorvastatin (As Calcium) 80 mg+Ezetimibe 10 mg				1396/11/29
Atovaquone+Chloroghanide		TABLET		ORAL	P01AX	Atovaquone 250mg+Chloroghanide Hydrochloride100 mg	Prevention of Pneumocystis carinii pneumonia (PCP) in high-risk, HIV-infected patients
Atovaquone+Chloroghanide		TABLET		ORAL	P01AX	Atovaquone 62.5mg+Chloroghanide Hydrochloride25 mg	Prevention of Pneumocystis carinii pneumonia (PCP) in high-risk, HIV-infected patients
Atovaquone+Proguanil		TABLET		ORAL	P01AX	Atovaquone 250 mg + Proguanil Hydrochloride 100 mg		For Health Dept. of MOH only
Atovaquone+Proguanil		TABLET		ORAL	P01AX	Atovaquone 62.5 mg + Proguanil Hydrochloride 25 mg		For Health Dept. of MOH only
Atracurium	Besylate	INJECTION	10 mg/ml	PARENTERAL	M03AC04			Hospital use only
Atropine	Sulfate	SOLUTION/ DROPS	0.50%	OPHTHALMIC	S01FA01					1361/12/23
Atropine	Sulfate	SOLUTION/ DROPS	1%	OPHTHALMIC	S01FA01
Atropine	Sulfate	OINTMENT	1%	OPHTHALMIC	S01FA01
Atropine	Sulfate	TABLET	0.5 mg	ORAL	A03BA01
Atropine	Sulfate	INJECTION	0.5 mg/ml	PARENTERAL	A03BA01			Hospital use only		1361/11/10
Atropine	Sulfate	INJECTION	1 mg/ml	PARENTERAL	A03BA01			Hospital use only		1381/04/23
Atropine	Sulfate	INJECTION	10 mg/ml	PARENTERAL	A03BA01			Hospital use only		1379/05/24
Atropine	Sulfate	INJECTION	2.5 mg/ml	PARENTERAL	A03BA01			Hospital use only
Azathioprine		TABLET	25 mg	ORAL	L04AX01					1388/08/20
Azathioprine	As Sodium	INJECTION, POWDER	50 mg	PARENTERAL	L04AX01
Azathioprine		TABLET	50 mg	ORAL	L04AX01
Azelaic Acid		CREAM	20%	TOPICAL	D10AX03					1383/05/04
Azelaic Acid		BULK			V03			Bulk medicines
Azelastine	As HCl	SPRAY	125 mcg/Puff	NASAL	R01AC03				0.10%	1391/02/07
Azelastine+Fluticasone		SPRAY		NASAL	R01AD58	(Azelastine HCl 137 mcg+Fluticasone Prppionate 50 mcg)/ Puff				1397/09/27
Azithromycin		SOLUTION/ DROPS	1%	OPHTHALMIC	S01AA26					1390/01/29
Azithromycin		SOLUTION/ DROPS	1.5%	OPHTHALMIC	S01AA26					1395/09/01
Azithromycin		POWDER, FOR SUSPENSION	1 g	ORAL	J01FA10					1392/03/21
Azithromycin		POWDER, FOR SUSPENSION	100 mg/5ml	ORAL	J01FA10
Azithromycin		POWDER, FOR SOLUTION	2 g	ORAL	J01FA10
Azithromycin		POWDER, FOR SUSPENSION	200 mg/5ml	ORAL	J01FA10					1373/12/21
Azithromycin		CAPSULE	250 mg	ORAL	J01FA10					1373/12/21
Azithromycin		TABLET	250 mg	ORAL	J01FA10
Azithromycin		CAPSULE	500 mg	ORAL	J01FA10
Azithromycin		INJECTION, POWDER	500 mg	PARENTERAL	J01FA10					1385/10/26
Azithromycin		TABLET	500 mg	ORAL	J01FA10
Bacitracin		OINTMENT	500 U/g	OPHTHALMIC	D06AX05
Baclofen		TABLET	10 mg	ORAL	M03BX01					1361/06/21
Baclofen		TABLET	25 mg	ORAL	M03BX01					1362/02/18
Barium	Sulfate	POWDER, FOR SUSPENSION	135 g	ORAL	V08BA02				sachet	1364/11/27
Barium	Sulfate	SUSPENSION	240 g/240 ml	ORAL	V08BA02					1390/06/14
Bedaquiline	As Fumarate	TABLET	100 mg	ORAL	J04AK05			For Health Dept. of MOH only		1396/05/28
BCG		INJECTION, POWDER, LYOPHILIZED		INTRAVESICAL	L03AX03
BCG		INJECTION, POWDER, LYOPHILIZED		INJECTION, POWDER	J07AN
Beclomethasone	Dipropionate	NEBULISATION	0.8 mg/2ml	RESPIRATORY	R03BA01					1386/07/18
Beclomethasone	Dipropionate	AEROSOL	100 mcg/dose	RESPIRATORY	R03BA01				HFA Only	1389/08/24
Beclomethasone	Dipropionate	AEROSOL	250 mcg/dose	RESPIRATORY	R03BA01					1389/08/24
Beclomethasone	Dipropionate	INHALER	50 mcg/dose	RESPIRATORY	R03BA01					1389/08/24
Beclomethasone	Dipropionate	INHALER	50 mcg/dose	NASAL	R01AD01
Beclomethasone+ Formoterol		AEROSOL, METERED		RESPIRATORY	R03AK08	(Beclomethasone Dipropionate 100 mcg+ Formoterol Fumarate 6 mcg)/metered dose			Extrafine Beclomethasone	1396/09/12
Beclomethasone+ Formoterol		AEROSOL, METERED		RESPIRATORY	R03AK08	(Beclomethasone Dipropionate 200 mcg+ Formoterol Fumarate 6 mcg)/metered dose			Extrafine Beclomethasone	1396/12/08
Belladonna Pb		ELIXIR		ORAL	A03CB02	(Atropine Sulfate 19.4mcg+Hyoscine HBr 6.5mcg+Hyoscyamine Sulfate 103.7mcg+Phenobarbital 16.2mg)/5ml
Belladonna Pb		TABLET		ORAL	A03CB02	Atropine Sulfate 19.4mcg+Hyoscine HBr 6.5mcg+Hyoscyamine Sulfate 103.7mcg+Phenobarbital 16.2mg
Bendamustine	HCl	INJECTION, POWDER	25 mg	PARENTERAL	L01AA09		Non-Hodgkin's lymphoma			1395/03/09
Bendamustine	HCl	INJECTION, POWDER	100 mg	PARENTERAL	L01AA09		Non-Hodgkin's lymphoma			1395/03/09
Bendamustine	HCl	INJECTION	25 mg/ml	PARENTERAL	L01AA09		Non-Hodgkin's lymphoma			1396/04/27
Benzocaine		OINTMENT	5%	TOPICAL	D04AB04			OTC medicines		1369/10/30
Benzocaine		GEL	7.50%	BUCCAL	D04AB04					1390/1/29
Benzoic Acid		BULK			V03			Bulk medicines		1376/12/10
Benzoin Tincture		BULK			V03			Bulk medicines		1376/12/10
Benzoyl Peroxide		SOAP	5%	TOPICAL	D10AE01				w/w
Benzoyl Peroxide		LOTION	5%	TOPICAL	D10AE01				w/w or w/v	1381/06/31
Benzoyl Peroxide		GEL	5%	TOPICAL	D10AE01					1369/10/30
Benzoyl Peroxide		SOAP	10%	TOPICAL	D10AE01				w/w
Benzoyl Peroxide		LOTION	10%	TOPICAL	D10AE01				w/w or w/v	1369/10/30
Benzoyl Peroxide		GEL	10%	TOPICAL	D10AE01					1369/10/30
Benzoyl Peroxide+Clindamycin		GEL		TOPICAL	D10AF51	Benzoyl Peroxide 5%+Clindamycin (As Phosphate) 1%				1396/08/02
Benztropine	Mesylate	TABLET	2 mg	ORAL	N04AC01
Benzydamine	HCl	MOUTHWASH	0.15%	IRRIGATION	A01AD02					1376/07/27
Benzyl Benzoate		LOTION	25%	TOPICAL	P03AX01					1365/04/15
Benzyl Benzoate		BULK			V03			Bulk medicines
Bephenium	Hydroxynaphthoate	GRANULE	5 g/sachet	ORAL	P02CX02
Beractant		CAPSULE	15 mg	ORAL	A11CA02			OTC medicines
Beractant		INJECTION, SUSPENSION	25 mg/ ml	INTRATRACHEAL	R07AA		Treatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis. (Survanta)	Hospital use only		1381/12/04
Betacarotene		CAPSULE	25 mg	ORAL	A11CA02
Betacarotene		CAPSULE	30 mg	ORAL	A11CA02					1361/10/19
Betahistine	Dihydrochloride	TABLET	16 mg	ORAL	N07CA01					1386/09/07
Betahistine	Dihydrochloride	TABLET	8 mg	ORAL	N07CA01					1362/05/02
Betahistine	Dihydrochloride	TABLET	24 mg	ORAL	N07CA01					1397/06/24
Betaine		POWDER FOR SOLUTION	1g	ORAL	A16AA06		Treatment of hemocysteonuria	Orphan medicines		1387/10/15
Betamethasone	As Valerate	CREAM	0.1%	TOPICAL	D07AC01
Betamethasone	As Valerate	LOTION	0.1%	TOPICAL	D07AC01
Betamethasone	As Valerate	OINTMENT	0.1%	TOPICAL	D07AC01
Betamethasone	As Disodium Phosphate	SOLUTION/ DROPS	0.1%	OPHTHALMIC and OTIC and NASAL DROPS	S03
Betamethasone	As Disodium Phosphate	OINTMENT	0.1%	OPHTHALMIC	S01BA06
Betamethasone		TABLET	0.5 mg	ORAL	H02AB01					1359/11/08
Betamethasone	As Disodium Phosphate	INJECTION	4 mg/ml	PARENTERAL	H02AB01
Betamethasone		BULK			V03			Bulk medicines
Betamethasone		INJECTION, SUSPENSION, EXTENDED RELEASE		PARENTERAL	H02AB01	(Betamethasone acetate 3mg+Betamethasone(as disodium phosphate) 3mg)/ml				1359/06/08
Betaxolol	As HCl	SOLUTION/ DROPS	0.50%	OPHTHALMIC	S01ED02					1374/09/12
Bethanechol	Chloride	TABLET	10 mg	ORAL	N07AB02
Bethanechol	Chloride	TABLET	25 mg	ORAL	N07AB02					1388/08/20
Bevacizumab		INJECTION, SOLUTION, CONCENTRATE	25 mg/ml	PARENTERAL	L01XC07			Orphan medicines. Hospital use only		1385/06/14
Bicalutamide		TABLET	150 mg	ORAL	L02BB03					1392/5/29
Bicalutamide		TABLET	50 mg	ORAL	L02BB03					1388/04/21
Bicarbonate Concentrate		POWDER	500 mg	NOT APPLICABLE	B05ZA				For Haemodyalysis Machine	1385/06/14
Bicarbonate Concentrate		POWDER	650 mg	NOT APPLICABLE	B05ZA				For Haemodyalysis Machine	1385/06/14
Bicarbonate Concentrate		POWDER	750 mg	NOT APPLICABLE	B05ZA				For Haemodyalysis Machine	1385/06/14
Bimatoprost		SOLUTION/ DROPS	0.01%	OPHTALMIC	S01EE03					1393/01/24
Bimatoprost		SOLUTION/ DROPS	0.03%	OPHTALMIC	S01EE03		Hypotrichosis		With applicator	1396/05/28
Biotin		TABLET	5 mg	ORAL	L01XC07			Orphan medicines		1387/10/15
Biotin		TABLET	100 mg	ORAL	A11HA05		PPMS	Orphan medicines		1396/12/13
Biotin		INJECTION, SOLUTION	5 mg /ml	INTRAMUSCULAR	A11HA05					1392/04/04
Biperiden	HCl	TABLET	2 mg	ORAL	N04AA02
Biperiden	HCl	TABLET, EXTENDED RELEASE	4 mg	ORAL	N04AA02					1372/08/09
Biperiden	Lactate	INJECTION	5 mg/ml	PARENTERAL	N04AA02
Bisacodyl		SUPPOSITORY	10 mg	RECTAL	A06AB02			OTC medicines		1369/10/30
Bisacodyl		TABLET, DELAYED RELEASE	5 mg	ORAL	A06AB02			OTC medicines		1369/10/30
Bisacodyl		SUPPOSITORY	5 mg	RECTAL	A06AB02					1369/10/30
Bismuth	Subcitrate	TABLET	120 mg	ORAL	A02BX05			OTC medicines
Bismuth	Subcitrate	TABLET	Equ. To Bismuth Oxide 120 mg	ORAL	A02BX05					1372/07/11
Bismuth		BULK			V03			Bulk medicines
Bisoprolol	Fumarate	TABLET	2.5 mg	ORAL	C07AB07		Hypertension, Angina			1394/07/05
Bisoprolol	Fumarate	TABLET	5 mg	ORAL	C07AB07		Hypertension, Angina			1394/07/05
Bisoprolol	Fumarate	TABLET	10 mg	ORAL	C07AB07		Hypertension, Angina			1394/07/05
Bisoprolol+Hydrochlorthiazide		TABLET		ORAL	C07BB07	Bisoprolol Fumarate 2.5 mg+ Hydrochlorthiazide 6.25 mg				1397/04/31
Bisoprolol+Hydrochlorthiazide		TABLET		ORAL	C07BB07	Bisoprolol Fumarate 5 mg+ Hydrochlorthiazide 6.25 mg				1397/04/31
Bisoprolol+Hydrochlorthiazide		TABLET		ORAL	C07BB07	Bisoprolol Fumarate 10 mg+ Hydrochlorthiazide 6.25 mg				1397/04/31
Bisoprolol+Hydrochlorthiazide		TABLET		ORAL	C07BB07	Bisoprolol Fumarate 5 mg+ Hydrochlorthiazide 12.5 mg				1397/04/31
Bisoprolol+Hydrochlorthiazide		TABLET		ORAL	C07BB07	Bisoprolol Fumarate 10 mg+ Hydrochlorthiazide 25 mg				1397/04/31
Bleomycin		INJECTION	15 IU	PARENTERAL	L01DC01				Equal with 15,000 U in UK (Pancreatic cancer)
Bleomycin		INJECTION, POWDER	15 U	PARENTERAL	L01DC01		Treatment of malignant pleural effusion. Treatment of pancreatic cancer.
Borax		BULK			V03			Bulk medicines		1376/12/10
Boric Acid		BULK			V03			Bulk medicines		1376/12/10
Bortezomib		INJECTION, POWDER, LYOPHILIZED	3.5mg	PARENTERAL	L01XX32			Orphan medicines; hospital use only		1387/06/26
Bortezomib		INJECTION, POWDER, LYOPHILIZED	1mg	PARENTERAL	L01XX32			Orphan medicines; hospital use only		1395/10/08
Bosentan		TABLET	125 mg	ORAL	C02KX01					1387/12/18
Bosentan		TABLET	62.5 mg	ORAL	C02KX01					1387/12/18
Botulinum A Toxin		INJECTION		PARENTERAL	M03AX01		Treatment of dynamic muscle contractures in pediatric cerebral palsy patients. Treatment of essential blepharospasm. Treatment of spasmodic torticollis (cervical dystonia).
Botulinum A Toxin		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	M03AX01		Treatment of dynamic muscle contractures in pediatric cerebral palsy patients. Treatment of essential blepharospasm. Treatment of spasmodic torticollis (cervical dystonia).
Botulism Monovalent		INJECTION		PARENTERAL	J06AA04	Antitoxin		For Health Dept. of MOH only		1361/08/20
Botulism Polyvalent (A+B+E)		INJECTION		PARENTERAL	J06AA04	Antitoxin		For Health Dept. of MOH only
Bovactant		INJECTION	50 mg/1.2ml	INTRATRACHEAL	R07AA30		Treatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis.	Hospital use only
Bovine Lung Surfactant		INJECTION, POWDER, LYOPHILIZED	120 mg	INTRATRACHEAL	R07AA				Newfactan
Brentuximab	Vedotin	INJECTION, POWDER	50 mg	PARENTERAL	L01XC12		Refractory CD-30 positive Hodgkin's (autologous stem cell transplant following) and systematic anplastic large cell lymphoma	Orphan medicines		1396/11/29
Brimonidine	Tartrate	SOLUTION/ DROPS	0.2%	OPHTHALMIC	S01EA05		Treatment of anterior ischemic optic neuropathy.	Orphan medicines		1379/06/20
Brimonidine+Timolol		SOLUTION/ DROPS		OPHTHALMIC	S01ED51	Brimonidine tartrate 0.2%+Timolol (As Maleate) 0.5%				1397/05/10
Brimonidine	As Tartrate	GEL	3 mg/g	TOPICAL	D11AX21		Facial Erythema in Rosacea		0.33%	1396/11/29
Brinzolamide		SUSPENSION/ DROPS	1%	OPHTHALMIC	S01EC04					1379/05/02
Brinzolamide+Timolol		SUSPENSION/ DROPS		OPHTHALMIC	S01ED51	Brinzolamide 10mg/ml + Timolol (as maleate) 5mg/ml				1391/07/25
Bromhexine	HCl	INJECTION	2 mg/ml	PARENTERAL	R05CB02
Bromhexine	HCl	ELIXIR	4 mg/5ml	ORAL	R05CB02			OTC medicines
Bromhexine	HCl	TABLET	8 mg	ORAL	R05CB02			OTC medicines
Bromocriptine	As Mesylate	TABLET	2.5 mg	ORAL	G02CB01
Budesonide		NEBULISATION	0.5 mg/2ml	RESPIRATORY	R03BA02					1385/03/23
Budesonide		NEBULISATION	1 mg/2ml	RESPIRATORY	R03BA02					1385/03/23
Budesonide		INHALER	100 mcg/dose	RESPIRATORY	R03BA02					1385/03/23
Budesonide		INHALER	200 mcg/dose	RESPIRATORY	R03BA03					1385/03/23
Budesonide		INHALER	400 mcg/dose	RESPIRATORY	R03BA02					1385/03/23
Budesonide		INHALER	64 mcg/dose	NASAL	R01AD05					1385/03/23
Budesonide		INHALER	100 mcg/dose	NASAL	R01AD05					1396/03/21
Budesonide		CAPSULE, DELAYED RELEASE	3 mg	ORAL	A07EA06		Crohn's disease			1397/07/28
Budesonide		CAPSULE, DELAYED RELEASE	9 mg	ORAL	A07EA06		Crohn's disease			1397/07/28
Budesonide		TABLET, EXTENDED RELEASE	9 mg	ORAL	A07EA06		Crohn's disease			1397/09/03
Budesonide+Formoterol		INHALER		RESPIRATORY	R03AK07	(Budesonide 160mcg + Formoterol Fumarate 4.5mcg)/dose				1387/06/13
Budesonide+Formoterol		INHALER		RESPIRATORY	R03AK07	(Budesonide 320mcg + Formoterol Fumarate 9mcg)/dose				1387/06/13
Budesonide+Formoterol		INHALER		RESPIRATORY	R03AK07	(Budesonide 80mcg + Formoterol Fumarate 4.5mcg)/dose				1387/06/13
Bupivacaine	HCl	INJECTION	0.25%	PARENTERAL	N01BB01			Hospital use only		1361/12/01
Bupivacaine	HCl	INJECTION	0.50%	PARENTERAL	N01BB01			Hospital use only		1381/05/20
Bupivacaine	HCl	INJECTION	0.5%, 4ml	INTRASPINAL	N01BB01			Hospital use only		1381/05/20
Bupivacaine+Epinephrine		INJECTION		PARENTERAL	N01BB51	Cartridge: Bupivacaine Hydrochloride 0.5%+ Epinephrine 1:200000 (5 mcg/ml)				1393/10/14
Buprenorphine	As HCl	INJECTION	0.3 m/ml	PARENTERAL	N02AE01			Hospital use only		1370/12/18
Buprenorphine	As HCl	CAPSULE	0.4 mg	SUBLINGUAL	N02AE01
Buprenorphine	As HCl	TABLET	0.4 mg	SUBLINGUAL	N07BC01
Buprenorphine	As HCl	TABLET	2 mg	SUBLINGUAL	N07BC01					1383/09/28
Buprenorphine	As HCl	TABLET	8 mg	SUBLINGUAL	N07BC01					1383/09/28
Buprenorphine+Naloxone		TABLET		SUBLINGUAL	N07BC51	Buprenorphine (As Hydrochloride) 2 mg + Naloxone (As Hydrochloride) 0.5 mg				1385/06/14
Buprenorphine+Naloxone		TABLET		SUBLINGUAL	N07BC51	Buprenorphine (As Hydrochloride) 8 mg + Naloxone (As Hydrochloride) 2 mg				1385/06/14
Buprenorphine+Naloxone		FILM		SUBLINGUAL	N07BC51	Buprenorphine (As Hydrochloride) 2 mg + Naloxone (As Hydrochloride) 0.5 mg				1395/12/22
Buprenorphine+Naloxone		FILM		SUBLINGUAL	N07BC51	Buprenorphine (As Hydrochloride) 8 mg + Naloxone (As Hydrochloride) 2 mg				1395/12/22
Bupropion	HCl	TABLET	100 mg	ORAL	N06AX12					1379/02/04
Bupropion	HCl	TABLET, EXTENDED RELEASE	150 mg	ORAL	N06AX12					1379/02/04
Bupropion	HCl	TABLET	75 mg	ORAL	N06AX12					1379/02/04
Burn Ointment		OINTMENT		TOPICAL	D03AA	Cod liver oil 50%+Zinc oxide 30%		OTC medicines		1360/02/09
Buserelin		INJECTION	1 mg/ml	PARENTERAL	L02AE01	As Acetate				1372/06/07
Buserelin		SPRAY	150 mcg/dose	NASAL	L02AE01	As Acetate
Buspirone	HCl	TABLET	10 mg	ORAL	N05BE01					1382/09/03
Buspirone	HCl	TABLET	5 mg	ORAL	N05BE01
Busulfan		TABLET	2 mg	ORAL	L01AB01
Busulfan		INJECTION	6 mg/ml	PARENTERAL	L01AB01		As preparative therapy in the treatment of malignancies with bone marrow transplantation. Treatment of primary brain malignancies.			1385/04/13
C1-Esterase inhibitor		INJECTION, POWDER	500 U	PARENTERAL	B06AC01		Hereditary angioedema	Hospital use only, Orphan medicines	Use based on guideline	1395/03/09
C1-Esterase inhibitor		INJECTION, POWDER	2100 U	PARENTERAL	B06AC01		Hereditary angioedema	Hospital use only, Orphan medicines	Use based on guideline, Recambinant	1396/12/08
C-14 Urea		CAPSULE	1 mCi	ORAL	V09				Radiopharmaceuticals	1397/02/18
C-14 Urea		SOLUTION	1 mCi	ORAL	V09				Radiopharmaceuticals	1397/02/18
Cabergoline		TABLET	0.5 mg	ORAL	G02CB03					1382/03/04
Cabergoline		TABLET	1 mg	ORAL	G02CB03					1382/03/04
Cabergoline		TABLET	2 mg	ORAL	N04BC06
Cade Oil		BULK			V03			Bulk medicines
Caffeine	As Citrate	INJECTION, SOLUTION	10mg/ml	PARENTERAL	N06BC01			hospital use only		1386/11/03
Caffeine	As Citrate	SOLUTION	10mg/ml	ORAL	N06BC01			hospital use only
Calamine		CREAM	8%	TOPICAL	D02AB			OTC medicines
Calamine		LOTION	8%	TOPICAL	D02AB			OTC medicines
Calcipotriol		OINTMENT	50 mcg/g	TOPICAL	D05AX02					1379/11/09
Calcipotriol		SOLUTION	50 mcg/ml	TOPICAL	D05AX02					1385/09/29
Calcipotriol+Betamethasone		GEL		TOPICAL	D05AX52	Calcipotriol 0.005% + Betamethasone (as Dipropionate) 0.05%				1390/03/09
Calcipotriol+Betamethasone		OINTMENT		TOPICAL	D05AX52	Calcipotriol 0.005% + Betamethasone (as Dipropionate) 0.05%				1389/07/17
Calcitonin		INJECTION	100 IU/ml	PARENTERAL	H05BA03		Treatment of symptomatic Paget's disease
Calcitonin		INJECTION	50 IU/ml	PARENTERAL	H05BA03		Treatment of symptomatic Paget's disease
Calcitonin, Salmon		SPRAY	100 IU/dose	NASAL	H05BA01		Treatment of symptomatic Paget's disease			1373/05/30
Calcitonin, Salmon		SPRAY	200 IU/dose	NASAL	H05BA01		Treatment of symptomatic Paget's disease			1378/02/19
Calcitriol		CAPSULE	0.25 mcg	ORAL	A11CC04					1361/09/14
Calcitriol		INJECTION	1 mcg/ml	PARENTERAL	A11CC04			Hospital use only		1387/06/13
Calcitriol		INJECTION	2 mcg/ml	PARENTERAL	A11CC04			Hospital use only		1387/06/13
Calcium Acetate		TABLET	667 mg	ORAL	A12AA12					1384/09/20
Calcium Chloride		INJECTION	100 mg/m	PARENTERAL	A12AA07					1377/02/09
Calcium Dobesilate		TABLET	250 mg	ORAL	C05BX01					1380/04/17
Calcium Dobesilate		CAPSULE	500 mg	ORAL	C05BX01					1388/09/04
Calcium Dobesilate		TABLET	500 mg	ORAL	C05BX01					1386/03/23
Calcium Folinate		INJECTION	10 mg/ml		V03AF03			Hospital use only	Folinic Acid 10 mg (as Calcium Folinate)	1390/01/29
Calcium Folinate		INJECTION, POWDER	100 mg	PARENTERAL	V03AF03			Hospital use only	Folinic Acid 100mg (as Calcium Folinate)	1385/03/23
Calcium Folinate		INJECTION	25 mg/ml	PARENTERAL	V03AF03
Calcium Folinate		TABLET	15 mg	ORAL	V03AF03
Calcium Folinate		CAPSULE	15 mg	ORAL	V03AF03					1396/03/21
Calcium Folinate		TABLET	25 mg	ORAL	V03AF03
Calcium Folinate		INJECTION	3 mg/ml	PARENTERAL	V03AF03
Calcium Folinate		INJECTION, POWDER	30 mg	PARENTERAL	V03AF03
Calcium Folinate		INJECTION, POWDER	350 mg	PARENTERAL	V03AF03					1396/04/27
Calcium Folinate		INJECTION, POWDER	50 mg	PARENTERAL	V03AF03					1396/04/27
Calcium Folinate		TABLET	5 mg	ORAL	V03AF03
Calcium Gluconate		GEL	2.50%	TOPICAL	D11AX03				for local production only	1390/07/05
Calcium Gluconate		INJECTION	10%	PARENTERAL	A12AA03
Calcium Pantothenate		TABLET	100 mg	ORAL	A11HA31			OTC medicines		1369/10/30
Calfactant		SUSPENSION	35 mg/ml	INTRATRACHEAL	R07AA02					1395/12/22
Camphor		BULK			V03			Bulk medicines
Capecitabine		TABLET	150 mg	ORAL	L01BC06					1383/08/10
Capecitabine		TABLET	500 mg	ORAL	L01BC06					1383/08/10
Capreomycin	As Sulfate	INJECTION, POWDER	1g	INTRAMUSCULAR	J04AB30			Hospital use only		1369/01/26
Captopril		TABLET	25 mg	ORAL	C09AA01					1369/10/16
Captopril		TABLET	50 mg	ORAL	C09AA01					1369/10/16
Carbamazepine		SUSPENSION	100 mg/5ml	ORAL	N03AF01					1385/02/12
Carbamazepine		SYRUP	100 mg/5ml	ORAL	N03AF01
Carbamazepine		TABLET	200 mg	ORAL	N03AF01
Carbamazepine		TABLET, EXTENDED RELEASE	200 mg	ORAL	N03AF01					1374/04/18
Carbamazepine		TABLET, EXTENDED RELEASE	400 mg	ORAL	N03AF01					1374/06/26
Carbetocin		INJECTION, SOLUTION	100 mcg	PARENTERAL	H01BB03					1393/06/02
Carboplatin		INJECTION	10 mg/ml	PARENTERAL	L01XA02					1374/07/09
Carboplatin		INJECTION, SOLUTION, CONCENTRATE	10 mg/ml	PARENTERAL	L01XA02					1385/03/23
Carboplatin		INJECTION, SOLUTION	150 mg	INTRAVENOUS DRIP	L01XA02					1371/04/14
Carboplatin		INJECTION, SOLUTION	50 mg	INTRAVENOUS DRIP	L01XA02					1371/04/14
Carboprost	As Tromethamine	INJECTION	250 mcg/ml	PARENTERAL	G02AD04					1385/10/26
Carglumic Acid		TABLET, DISPERSIBLE	200 mg	ORAL	A16AA05			Orphan medicines		1393/01/24
Carmustine		INJECTION, POWDER	100 mg	PARENTERAL	L01AD01		Treatment of intracranial malignancies			1374/08/21
Carvedilol		TABLET	12.5 mg	ORAL	C07AG02					1382/10/07
Carvedilol		TABLET	25 mg	ORAL	C07AG02					1382/10/07
Carvedilol		TABLET	3.125 mg	ORAL	C07AG02					1388/08/20
Carvedilol		TABLET	6.25 mg	ORAL	C07AG02					1382/10/07
Casoni Test		INJECTION		PARENTERAL	V04			Hospital use only		1361/08/20
Caspofungin	As Acetate	INJECTION, POWDER	50 mg	PARENTERAL	J02AX04					1385/09/07
Caspofungin	As Acetate	INJECTION, POWDER	70 mg	PARENTERAL	J02AX04					1385/09/07
Cefalexin		POWDER, FOR SUSPENSION	125 mg	ORAL	J01DB01				Sachet	1365/01/24
Cefalexin		POWDER, FOR SUSPENSION	125 mg/5ml	ORAL	J01DB01
Cefalexin		POWDER, FOR SUSPENSION	250 mg	ORAL	J01DB01				Sachet	1365/01/24
Cefalexin		CAPSULE	250 mg	ORAL	J01DB01
Cefalexin		TABLET	250 mg	ORAL	J01DB01
Cefalexin		POWDER, FOR SUSPENSION	250 mg/5ml	ORAL	J01DB01
Cefalexin		CAPSULE	500 mg	ORAL	J01DB01
Cefalexin		TABLET	500 mg	ORAL	J01DB01
Cefazolin	As Sodium	INJECTION, POWDER	1 g	PARENTERAL	J01DB04
Cefazolin	As Sodium	INJECTION, POWDER	250 mg	PARENTERAL	J01DB04
Cefazolin	As Sodium	INJECTION, POWDER	500 mg	PARENTERAL	J01DB04
Cefepime	As HCl or DiHCl	INJECTION, POWDER	1 g	PARENTERAL	J01DE01			Hospital use only		1381/12/04
Cefepime	As HCl or DiHCl	INJECTION, POWDER	2 g	PARENTERAL	J01DE01			Hospital use only		1381/12/04
Cefepime	As HCl or DiHCl	INJECTION, POWDER	500mg	PARENTERAL	J01DE01			Hospital use only		1381/12/04
Cefixime		POWDER, FOR SUSPENSION	100 mg	ORAL	J01DD08					1379/02/04
Cefixime		POWDER, FOR SUSPENSION	200 mg	ORAL	J01DD08					1395/06/24
Cefixime		POWDER, FOR SUSPENSION	100 mg	ORAL	J01DD08					1395/06/24
Cefixime		TABLET	200 mg	ORAL	J01DD08					1379/02/04
Cefixime		CAPSULE	400 mg	ORAL	J01DD08
Cefixime		TABLET	400 mg	ORAL	J01DD08					1379/02/04
Cefixime		POWDER, FOR SUSPENSION	50 mg	ORAL	J01DD08				Sachet	1373/03/22
Cefotaxime	As Sodium	INJECTION, POWDER	1 g	PARENTERAL	J01DD01			Hospital use only		1376/06/30
Cefotaxime	As Sodium	INJECTION, POWDER	500 mg	PARENTERAL	J01DD01			Hospital use only		1372/03/30
Ceftazidime	As Pentahydrate	INJECTION, POWDER	1 g	PARENTERAL	J01DD02			Hospital use only		1372/07/11
Ceftazidime	As Pentahydrate	INJECTION, POWDER	2 g	PARENTERAL	J01DD02			Hospital use only		1374/04/31
Ceftazidime	As Pentahydrate	INJECTION, POWDER	500 mg	PARENTERAL	J01DD02			Hospital use only		1372/07/11
Ceftizoxime	As Sodium	INJECTION, POWDER	1 g	PARENTERAL	J01DD07			Hospital use only		1368/06/19
Ceftizoxime	As Sodium	INJECTION, POWDER	500 mg	PARENTERAL	J01DD07			Hospital use only		1368/06/19
Ceftriaxone	As Sodium	INJECTION, POWDER	1 g	PARENTERAL	J01DD04					1370/11/20
Ceftriaxone	As Sodium	INJECTION, POWDER	2 g	PARENTERAL	J01DD04					1388/02/30
Ceftriaxone	As Sodium	INJECTION, POWDER	250 mg	PARENTERAL	J01DD04					1371/08/24
Ceftriaxone	As Sodium	INJECTION, POWDER	500 mg	PARENTERAL	J01DD04					1370/11/20
Cefuroxime	As Sodium	INJECTION, POWDER	1.5 g	PARENTERAL	J01DC02					1381/07/28
Cefuroxime	As Axetil	TABLET	125 mg	ORAL	J01DC02					1379/12/07
Cefuroxime	As Axetil	POWDER, FOR SUSPENSION	125 mg/5ml	ORAL	J01DC02					1379/12/07
Cefuroxime	As Sodium	INJECTION, POWDER	250 mg	PARENTERAL	J01DC02					1381/07/28
Cefuroxime	As Axetil	TABLET	250 mg	ORAL	J01DC02					1379/12/07
Cefuroxime	As Axetil	POWDER, FOR SUSPENSION	250 mg/5ml	ORAL	J01DC02
Cefuroxime	As Axetil	TABLET	500 mg	ORAL	J01DC02					1379/12/07
Cefuroxime	As Sodium	INJECTION, POWDER	750 mg	PARENTERAL	J01DC02					1381/07/28
Celecoxib		CAPSULE	100 mg	ORAL	M01AH01					1379/10/11
Celecoxib		CAPSULE	200 mg	ORAL	M01AH01					1380/06/03
Cephalothin	As Sodium	INJECTION, POWDER	1 g	PARENTERAL	J01DA04			Hospital use only
Cetirizine	HCl	TABLET	10 mg	ORAL	R06AE07
Cetirizine	HCl	CAPSULE, LIQUID FILLED	10 mg	ORAL	R06AE07					1386/07/18
Cetirizine	HCl	TABLET	5 mg	ORAL	R06AE07					1381/02/09
Cetirizine	HCl	SYRUP	5mg/5ml	ORAL	R06AE07					1381/02/09
Cetirizine+Pseudoephedrine		TABLET, EXTENDED RELEASE		ORAL	R06AE	Cetirizine Dihydrochloride 5mg (Immediate Relaese )+Pseudoephedrine Hydrochloride 120mg				1385/11/18
Cetrorelix	As Acetate	INJECTION, POWDER	250 mcg	PARENTERAL	H01CC02
Cetrorelix	As Acetate	INJECTION, POWDER	3 mg	PARENTERAL	H01CC02
Cetuximab		INJECTION	2mg/ml	PARENTERAL	L01XC06		Treatment of neck and head cancer for 65 Yrs old pateints with Karnofsky Performance status >90%			1387/11/06
Cetuximab		INJECTION	5mg/ml	PARENTERAL	L01XC06		Treatment of neck and head cancer for 65 Yrs old pateints with Karnofsky Performance status >90%			1389/03/31
Charcoal Activated		TABLET	250 mg	ORAL	A07BA01			OTC medicines		1375/07/01
Charcoal Activated		SUSPENSION	30 g/240ml	ORAL	A07BA01			OTC medicines		1369/10/30
Charcoal Activated		POWDER, FOR SUSPENSION	50 g	ORAL	A07BA01			OTC medicines		1376/12/10
Charcoal Activated		SUSPENSION	0.2 g/ml	ORAL	A07BA01			OTC medicines		1395/10/07
Chloral Hydrate		SOLUTION	250 mg/5ml	ORAL	N05CC01					1386/04/26
Chlorambucil		TABLET	2 mg	ORAL	L01AA02
Chlorambucil		CAPSULE	2 mg	ORAL	L01AA02					1396/04/18
Chloramphenicol		SOLUTION/ DROPS	0.50%	OPHTHALMIC	S01AA01
Chloramphenicol	As Sodium Succinate	INJECTION, POWDER	1 g	PARENTERAL	J01BA01			Hospital use only
Chloramphenicol	As Palmitate	SUSPENSION	150 mg/5ml	ORAL	J01BA01
Chloramphenicol		CAPSULE	250 mg	ORAL	J01BA01
Chlordiazepoxide		TABLET	10 mg	ORAL	N05BA02
Chlordiazepoxide		TABLET	5 mg	ORAL	N05BA02
Chlorhexidine Gluconate		SOLUTION	4%	TOPICAL	D08AC02					1387/05/16
Chlormadinone+Ethinyl Estradiol		TABLET		ORAL	G03FB03	Chlormadinone Acetate 2 mg + Ethinyl Estradiol 0.03 mg				1385/08/09
Chlormethine (Nitrogen mustard)	HCl	INJECTION, POWDER	10 mg	PARENTERAL	L01AA05					1362/09/27
Chloroacetic Acid		BULK			V03			Bulk medicines
Chloroquine	As Sulfate	SYRUP	25 mg/5ml	ORAL	P01BA01
Chloroquine	Phosphate	TABLET	250 mg	ORAL	P01BA01					1360/02/02
Chloroquine	AS Phosphate	TABLET	150 mg	ORAL	P01BA01					1397/03/27
Chloroquine	As Phosphate	INJECTION	30 mg/ml	PARENTERAL	P01BA01
Chloroquine	As Phosphate	INJECTION	40 mg/ml	PARENTERAL	P01BA01
Chloroquine	As Sulfate	SYRUP	50 mg/5ml	ORAL	P01BA01					1369/05/21
Chloroquine	As Phosphate	SUSPENSION	80 mg/5ml	ORAL	P01BA01			For Health Dept. of MOH only		1396/05/28
Chloroquine	Sulfate	INJECTION	50 mg/ml	PARENTERAL	P01BA01
Chlorpheniramine	Maleate	INJECTION	10 mg/ml	PARENTERAL	R06AB04
Chlorpheniramine	Maleate	SYRUP	2 mg/5ml	ORAL	R06AB04			OTC medicines		1378/01/22
Chlorpheniramine	Maleate	TABLET	4 mg	ORAL	R06AB04			OTC medicines		1369/10/30
Chlorpheniramine	Maleate	TABLET, EXTENDED RELEASE	8 mg	ORAL	R06AB04			OTC medicines		1360/09/29
Chlorpheniramine +phenylephrine		SYRUP		ORAL	R01BA53	(Chlorpheniramine Maleate1mg+phenylephrine HCL 2.5mg)/ 5ml		OTC medicines		1395/07/28
Chlorpheniramine+Dextromethorphan+Phenylephrin		SYRUP		ORAL	R05DA20	(Chlorpheniramine Maleate 2mg+Dextromethorphan HBr 15mg+Phenylephrine 5mg)/ 5ml		OTC medicines		1395/08/12
Chlorpheniramine+Guaifenesin+Phenylephrin		SYRUP		ORAL	R05DA20	(Chlorpheniramine Maleate 2mg+Guaifenesin 100mg+Phenylephrine 5mg)/ 5ml		OTC medicines		1395/10/07
Codeine+Guaifenesin+Phenylephrin		SYRUP		ORAL	R05DA20	(Codeine 10 mg+Guaifenesin 100mg+Phenylephrine 5mg)/ 5ml				1395/10/07
Chlorpromazine	HCl	TABLET	100 mg	ORAL	N05AA01					1379/01/29
Chlorpromazine	HCl	TABLET	25 mg	ORAL	N05AA01					1379/01/29
Chlorpromazine	HCl	INJECTION	25 mg/ml	INTRAMUSCULAR	N05AA01
Chlorpropamide		TABLET	250 mg	ORAL	A10BB02
Chlorthalidone		TABLET	100 mg	ORAL	C03BA04
Cholera Vaccine		SUSPENSION		ORAL	J07AE01				Inactivated	1393/06/02
Cholestyramine		POWDER, FOR SUSPENSION	4 g	ORAL	C10AC01				sachet
Choriogonadotropin Alfa		INJECTION	500 mcg/ml	PARENTERAL	G03GA08				Recombinant	1385/11/24
Chorionic Gonadotrophin (Human)		INJECTION, POWDER	1500 U	PARENTERAL	G03GA01
Chorionic Gonadotrophin (Human)		INJECTION, POWDER	500 U	PARENTERAL	G03GA01
Chorionic Gonadotrophin (Human)		INJECTION, POWDER	5000 U	PARENTERAL	G03GA01
Ciclesonide		AEROSOL, METERED	160mcg/puff	INHALATION	R03BA08				Need to be assessed by clinical trial before registration. For local production only	1389/05/30
Ciclesonide		SPRAY, SUSPENSION	50mcg/Actuation	INTRANASAL	R01AD13				For local production only	1390/07/04
Ciclesonide		AEROSOL, METERED	80mcg/puff	INHALATION	R03BA08				Need to be assessed by clinical trial before registration. For local production only	1389/05/30
Ciclosporin		SOLUTION	0.05%	OPHTHALMIC	S01XA18					1386/04/27
Ciclosporin		SOLUTION	2%	OPHTHALMIC	S01XA18		Treatment of patients at high risk of graft rejection following penetrating keratoplasty. For use in corneal melting syndromes of known or presumed immunologic etiopathogenesis, including Mooren's ulcer.
Ciclosporin		CAPSULE	100 mg	ORAL	L04AA01		Kidney, liver and heart transplantation, rheumatoid arthritis, psoriasis
Ciclosporin		SOLUTION	100 mg/ml	ORAL	L04AA01					1363/04/31
Ciclosporin		CAPSULE	25 mg	ORAL	L04AA01		Kidney, liver and heart transplantation, rheumatoid arthritis, psoriasis
Ciclosporin		CAPSULE	50 mg	ORAL	L04AA01		Kidney, liver and heart transplantation, rheumatoid arthritis, psoriasis
Ciclosporin		INJECTION, SOLUTION	50 mg/ml	INTRAVENOUS DRIP	L04AA01
Cimetidine	As HCl	INJECTION	100 mg/ml	PARENTERAL	A02BA01
Cimetidine	As HCl	TABLET	200 mg	ORAL	A02BA01
Cimetidine	As HCl	SYRUP	200 mg/5ml	ORAL	A02BA01					1374/07/30
Cinacalcet	As HCl	TABLET	30 mg	ORAL	H05BX01					1391/02/07
Cinacalcet	As HCl	TABLET	60 mg	ORAL	H05BX01					1391/02/07
Cinacalcet	As HCl	TABLET	90 mg	ORAL	H05BX01					1391/02/07
Cinnarizine		TABLET	25 mg	ORAL	N07CA02
Cinnarizine		TABLET	75 mg	ORAL	N07CA02
Ciprofloxacin	As HCl	SOLUTION/ DROPS	0.30%	OPHTHALMIC	S01AE03					1373/11/09
Ciprofloxacin	As HCl	OINTMENT	0.30%	OPHTHALMIC	S01AE03
Ciprofloxacin	As Lacate	INJECTION, SOLUTION	10 mg/ml	INTRAVENOUS	J01MA02
Ciprofloxacin	As Lacate	INJECTION, SOLUTION	2 mg/ml	INTRAVENOUS DRIP	J01MA02			Hospital use only		1372/08/09
Ciprofloxacin	As HCl	TABLET	250 mg	ORAL	J01MA02					1372/08/09
Ciprofloxacin		SUSPENSION	250 mg/5ml	ORAL	J01MA02					1390/12/22
Ciprofloxacin	As HCl	TABLET	500 mg	ORAL	J01MA02					1372/08/09
Ciprofloxacin	As HCl	TABLET	750 mg	ORAL	J01MA02					1396/07/22
Ciprofloxacin		TABLET, EXTENDED RELEASE	500 mg	ORAL	J01MA02	Containing both Ciprofloxacin base and Ciprofloxacin Hydrochloride			Bilayer tablet	1396/07/22
Ciprofloxacin		TABLET, EXTENDED RELEASE	1000 mg	ORAL	J01MA02	Containing both Ciprofloxacin base and Ciprofloxacin Hydrochloride			Bilayer tablet	1396/07/22
Ciprofloxacin+Dexamethasone		SUSPENSION/ DROPS		OTIC	S02AA	Ciprofloxacin (As Hydrochloride) 0.3% + Dexamethasone 0.1%				1386/12/26
Cisatracurium	As Besylate	INJECTION	2 mg/ml	PARENTERAL	M03AC11			Hospital use only
Cisatracurium	As Besylate	INJECTION	5 mg/ml	PARENTERAL	M03AC11			Hospital use only
Cisplatin		INJECTION, SOLUTION ,CONCENTRATE	0.5 mg/ml	INTRAVENOUS DRIP	L01XA01
Cisplatin		INJECTION, SOLUTION,CONCENTRATE	1 mg/ml	INTRAVENOUS DRIP	L01XA01					1391/11/02
Cisplatin		INJECTION, POWDER	10 mg	INTRAVENOUS DRIP	L01XA01
Cisplatin		INJECTION, POWDER	50 mg	INTRAVENOUS DRIP	L01XA01
Citalopram	As HBr	TABLET	20 mg	ORAL	N06AB04					1379/12/07
Citalopram	As HBr	TABLET	40 mg	ORAL	N06AB04					1379/12/07
Citalopram	As HCl	SOLUTION/ DROPS	40 mg/ml	ORAL	N06AB04					1379/12/07
Citicoline	As Sodium	INJECTION	125 mg/ml	PARENTERAL	N06BX06			Hospital use only		1365/10/14
Citric Acid		BULK			V03			Bulk medicines
Cladribine		INJECTION, SOLUTION	1mg/ml	INTRAVENOUS DRIP	L01BB04		Treatment of acute myeloid leukemia. Treatment of the chronic progressive form of MS Treatment of non-Hodgkin's lymphoma.	Orphan medicines		1374/03/28
Cladribine		INJECTION, SOLUTION	2 mg/ml	INTRAVENOUS DRIP	L01BB04		Treatment of acute myeloid leukemia. Treatment of the chronic progressive form of MS Treatment of non-Hodgkin's lymphoma.	Orphan medicines		1381/07/28
Clarithromycin		POWDER, FOR SUSPENSION	125 mg/5ml	ORAL	J01FA09					1379/10/11
Clarithromycin		GRANULE, FOR SUSPENSION	250 mg	ORAL	J01FA09				sachet	1384/04/20
Clarithromycin		TABLET	250 mg	ORAL	J01FA09					1379/10/11
Clarithromycin		POWDER, FOR SUSPENSION	250 mg/5ml	ORAL	J01FA09					1386/06/28
Clarithromycin		TABLET	500 mg	ORAL	J01FA09					1380/06/25
Clarithromycin		TABLET, EXTENDED RELEASE	500 mg	ORAL	J01FA09					1397/06/24
Clemastine	As Fumarate	INJECTION	1 mg/ml	PARENTERAL	R06AA04			Hospital use only
Clemastine	As Fumarate	TABLET	1mg	ORAL	R06AA04			OTC medicines
Clidinium+Chlordiazepoxide		TABLET		ORAL	A03CA02	Clidinium bromide 2.5mg + Chlordiazepoxide 5mg
Clindamycin	As Phosphate	CREAM	2%	VAGINAL	G01AA10					1397/03/12
Clindamycin	As HCl	CAPSULE	150 mg	ORAL	J01FF01
Clindamycin	As Phosphate	INJECTION	150 mg/ml	PARENTERAL	J01FF01		Treatment of Pneumocystis carinii pneumonia associated with AIDS patients.	Hospital use only
Clindamycin	As HCl	CAPSULE	300 mg	ORAL	J01FF01					1386/03/23
Clindamycin	As Palmitate Hydrochloride	SUSPENSION	75 mg/5ml	ORAL	J01FF01
Clindamycin	As Palmitate Hydrochloride	POWDER, FOR SOLUTION	75 mg/5ml	ORAL	J01FF01					1395/09/01
Clindamycin	As Phosphate	GEL	1%	TOPICAL	D10AF01					1377/06/22
Clindamycin	As Phosphate	SWAB	1%	TOPICAL	D10AF01					1397/09/27
Clindamycin	As Phosphate	SOLUTION	10 mg/ml	TOPICAL	D10AF01					1374/09/12
Clindamycin	As Phosphate	SUPPOSITORY	100 mg	VAGINAL	G01AA10
Clindamycin	As Phosphate	BULK			V03			Bulk medicines		1376/12/10
Clindamycin+Clotrimazole		CREAM		VAGINAL	G01A	Clindamycin(as Phosphate ) 2% + Clotrimazole2% W/W				1392/03/21
Clindamycin+Tretinoin		GEL		TOPICAL	D10AF51	Clindamycin Phosphate 1.2% + Tretinoin 0.025%				1386/12/26
Clobazam		TABLET	10 mg	ORAL	N05BA09					1371/08/03
Clobetasol	Propionate	CREAM	0.05%	TOPICAL	D07AD01					1359/07/13
Clobetasol	Propionate	LOTION	0.05%	TOPICAL	D07AD01
Clobetasol	Propionate	OINTMENT	0.05%	TOPICAL	D07AD01
Clobutinol	HCl	INJECTION	10 mg/ml	PARENTERAL	R05DB03			Hospital use only		1363/08/06
Clobutinol	HCl	TABLET	40 mg	ORAL	R05DB03
Clobutinol	HCl	SOLUTION/ DROPS	60 mg/ml	ORAL	R05DB03
Clofazimine		CAPSULE	100 mg	ORAL	J04BA01		Treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.	Orphan medicines		1362/09/20
Clofazimine		CAPSULE	50 mg	ORAL	J04BA01		Treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.	Orphan medicines		1368/06/19
Clofibrate		CAPSULE	500 mg	ORAL	C10AB01
Clomiphene	Citrate	TABLET	50 mg	ORAL	G03GB02
Clomipramine	HCl	TABLET	10 mg	ORAL	N06AA04
Clomipramine	HCl	TABLET	25 mg	ORAL	N06AA04
Clomipramine	HCl	TABLET	50 mg	ORAL	N06AA04
Clomipramine	HCl	TABLET	75 mg	ORAL	N06AA04					1375/07/01
Clonazepam		TABLET	1 mg	ORAL	N03AE01
Clonazepam		TABLET	2 mg	ORAL	N03AE01					1379/04/13
Clonidine	HCl	TABLET	0.2 mg	ORAL	C02AC01
Clonidine	HCl	PATCH, EXTENDED RELEASE	0.2 mg/24h	TRANSDERMAL	C02AC01
Clopidogrel	as Bisulfate	TABLET	300 mg	ORAL	B01AC04			Hospital use only		1390/03/09
Clopidogrel	as Bisulfate	TABLET	75 mg	ORAL	B01AC04					1380/05/07
Clotrimazole		CREAM	1%	TOPICAL	D01AC01
Clotrimazole		SOLUTION	1%	TOPICAL	D01AC01
Clotrimazole		CREAM	1%	VAGINAL	G01AF02			OTC medicines
Clotrimazole		CREAM	2%	VAGINAL	G01AF02			OTC medicines		1381/02/09
Clotrimazole		SUPPOSITORY	100 mg	VAGINAL	G01AF02			OTC medicines
Clotrimazole		TABLET	100 mg	VAGINAL	G01AF02			OTC medicines
Clotrimazole		SUPPOSITORY	200 mg	VAGINAL	G01AF02			OTC medicines
Clotrimazole		SUPPOSITORY	500 mg	VAGINAL	G01AF02					1381/07/28
Clotrimazole		TABLET	500 mg	VAGINAL	G01AF02
Clotrimazole		CAPSULE, LIQUID FILLED	500 mg	VAGINAL	G01AF02					1393/06/02
Clotrimazole+Betamethasone		CREAM		TOPICAL	D07CC01	Clotrimazole 1% + Betamethasone (As Dipropionate) 0.05%				1387/02/04
Clotrimazole+Betamethasone		LOTION		TOPICAL	D07CC01	Clotrimazole 1% + Betamethasone (As Dipropionate) 0.05%				1385/03/23
Clotrimazole+Hydrocortisone		CREAM		TOPICAL	D01AC20	Clotrimazole 1% + Hydrocortison 1%				1396/06/25
Cloxacillin	As Sodium	INJECTION, POWDER	1g	PARENTERAL	J01CF02					1377/10/20
Cloxacillin	As Sodium	CAPSULE	250 mg	ORAL	J01CF02					1371/09/15
Cloxacillin	As Sodium	INJECTION, POWDER	250 mg	PARENTERAL	J01CF02
Cloxacillin	As Sodium	TABLET	250 mg	ORAL	J01CF02
Cloxacillin	As Sodium	CAPSULE	500 mg	ORAL	J01CF02					1371/09/15
Cloxacillin	As Sodium	INJECTION, POWDER	500 mg	PARENTERAL	J01CF02
Cloxacillin	As Sodium	TABLET	500 mg	ORAL	J01CF02
Clozapine		TABLET	100 mg	ORAL	N05AH02
Clozapine		TABLET	25 mg	ORAL	N05AH02
Coal Tar		LOTION	5%	TOPICAL	D05AA
Coal Tar		OINTMENT	2%	TOPICAL	D05AA					1396/03/21
Coal Tar		BULK			V03			Bulk medicines
Co-amoxiclav		POWDER, FOR SUSPENSION		ORAL	J01CR02	(Amoxicillin(as trihydrate) 600mg+Clavulanic acid(as potassium) 42.9mg)/ 5ml			for local production only	1390/03/09
Co-amoxiclav		POWDER, FOR SUSPENSION		ORAL	J01CR02	(Amoxicillin(as trihydrate) 125mg+Clavulanic acid(as potassium) 31.25mg)/5ml
Co-amoxiclav		POWDER, FOR SUSPENSION		ORAL	J01CR02	(Amoxicillin(as trihydrate) 125mg+Clavulanic acid(as potassium) 31.25mg)/Sachet
Co-amoxiclav		POWDER, FOR SUSPENSION		ORAL	J01CR02	(Amoxicillin(as trihydrate) 200mg+Clavulanic acid(as potassium) 28.5 mg)/5ml
Co-amoxiclav		POWDER, FOR SUSPENSION		ORAL	J01CR02	(Amoxicillin(as trihydrate) 250mg+Clavulanic acid(as potassium) 62.5mg)/5ml
Co-amoxiclav		POWDER, FOR SUSPENSION		ORAL	J01CR02	(Amoxicillin(as trihydrate) 250mg+Clavulanic acid(as potassium) 62.5mg)/Sachet
Co-amoxiclav		POWDER, FOR SUSPENSION		ORAL	J01CR02	(Amoxicillin(as trihydrate) 400mg+Clavulanic acid(as potassium) 57 mg)/5ml
Co-amoxiclav		INJECTION, POWDER, FOR SOLUTION		PARENTERAL	J01CR02	Amoxicillin(as sodium)1000mg+Clavulanic acid(as potassium)200mg				1392/03/21
Co-amoxiclav		INJECTION, POWDER, FOR SOLUTION		PARENTERAL	J01CR02	Amoxicillin(as sodium)500mg+Clavulanic acid(as potassium)100mg				1392/03/21
Co-amoxiclav		TABLET		ORAL	J01CR02	Amoxicillin(as trihydrate) 250mg+Clavulanic acid(as potassium) 125mg
Co-amoxiclav		TABLET		ORAL	J01CR02	Amoxicillin(as trihydrate) 250mg+Clavulanic acid(as potassium) 125mg
Co-amoxiclav		TABLET, DISPERSIBLE		ORAL	J01CR02	Amoxicillin(as trihydrate) 500mg+Clavulanic acid(as potassium) 125mg				1387/03/28
Co-amoxiclav		TABLET		ORAL	J01CR02	Amoxicillin(as trihydrate) 875mg+Clavulanic acid(as potassium) 125mg				1396/06/12
Co-amoxiclav		TABLET, EXTENDED RELEASE		ORAL	J01CR02	Amoxicillin(as trihydrate) 1000 mg+Clavulanic acid(as potassium) 62.5 mg				1397/07/28
Co-amoxiclav		TABLET		ORAL	J01CR02	Amoxicillin(as trihydrate) 500mg+Clavulanic acid(as potassium) 125mg
Co-amoxiclav		TABLET		ORAL	J01CR02	Dispersible Amoxicillin(as trihydrate) 500mg+Clavulanic acid(as potassium) 125mg
Cobicistat+Elvitegravir+Emtricitabine+Tenofovir		TABLET		ORAL	J05AR09	Cobicistat 150 mg+Elvitegravir 150 mg+Emtricitabine 200 mg+Tenofovir disoproxil (as fumarate) 245 mg	HIV infection	For Health Dept. of MOH only	Tenofovir disoproxil fumarate 300 mg	1394/03/31
Codeine	Phosphate	TABLET	30 mg	ORAL	R05DA04
Codeine+Guaifenesine		SYRUP		ORAL	R05DA20	(Codeine phosphate 10mg+Guaifenesine 100mg)/5ml				1395/08/12
Codeine+Guaifenesine		SYRUP		ORAL	R05DA20	(Codeine phosphate 8mg+Guaifenesine 200mg)/5ml				1395/08/12
Codeine+Guaifenesine		SYRUP		ORAL	R05DA20	(Codeine phosphate 7.5mg+Guaifenesine 225mg)/5ml				1395/08/12
Codeine+Guaifenesin+Phenylephrin		SYRUP		ORAL	R05DA20	(Codeine phosphate 10 mg+Guaifenesin 100mg+Phenylephrine 5mg)/ 5ml				1395/10/07
Colchicine		TABLET	1 mg	ORAL	M04AC01		Treatment of familial Mediterranean fever For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis. For the treatment of Behcet's Syndrome.
Colchicine		TABLET	0.6 mg	ORAL	M04AC01		Treatment of familial Mediterranean fever For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis. For the treatment of Behcet's Syndrome.			1395/07/17
Colistimethate	Sodium	INJECTION, POWDER	1,000,000 U	PARENTERAL	J01XB01		Antibiotic, misellaneous	Hospital use only		1394/11/13
Colistimethate	Sodium	INJECTION, POWDER	2,000,000 U	PARENTERAL	J01XB01		Antibiotic, misellaneous	Hospital use only		1394/11/13
Colistimethate	Sodium	INJECTION, POWDER	4,500,000 U	PARENTERAL	J01XB01		Antibiotic, misellaneous	Hospital use only		1395/03/19
Collagen		BULK			V03			Bulk medicines
Collodion		SOLUTION		TOPICAL	V03	(Pyroxylin 40g+Ether 750 ml+Alcohol 250 ml )/1000 ml		OTC medicines
Collodion		BULK			V03	(Pyroxylin 40g+Ether 750 ml+Alcohol 250 ml)/1000 ml		Bulk medicines
Conjugated Estrogens		TABLET	0.625 mg	ORAL	G03CA57
Conjugated Estrogens		TABLET	0.3 mg	ORAL	G03CA57					1395/09/01
Conjugated Estrogens		TABLET	0.45 mg	ORAL	G03CA57					1395/09/01
Conjugated Estrogens		TABLET	0.9 mg	ORAL	G03CA57					1395/09/01
Conjugated Estrogens		CREAM	0.625 mg/g	VAGINAL	G03CA57
Conjugated Estrogens		TABLET	1.25 mg	ORAL	G03CA57
Conjugated Estrogens		INJECTION	5 mg/ml	PARENTERAL	G03CA57
Contraceptive DE		TABLET		ORAL	G03AA09	Desogestrel 0.15mg+Ethinylestradiol 20mcg			With obstetricians and General Practitioners prescriptions only	1391/05/02
Contraceptive DE		TABLET		ORAL	G03AA09	Desogestrel 0.15mg+Ethinylestradiol 30mcg			With obstetricians and General Practitioners prescriptions only	1377/06/22
Contraceptive Four-phasic		TABLET		ORAL	G03AB08	2 Tab: (Estradiol Valerate 3mg)+ 5 Tab: (Estradiol Valerate 2mg+ Dienogest 2mg)+ 17 Tab: (Estradiol Valerate 2mg+ Dienogest 3mg)+ 2 Tab: (Estradiol Valerate 1mg)+ 2 Tab: Inactive			With obstetricians and General Practitioners prescriptions only	1393/06/02
Contraceptive HD		TABLET		ORAL	G03FA04	Norgestrel (or 1/2 amount of levonorgestrel) 0.5mg+Ethinylestradiol 50mcg			With obstetricians prescriptions only
Contraceptive LD		TABLET		ORAL	G03FA04	Norgestrel (or 1/2 amount of levonorgestrel) 0.3mg+Ethinylestradiol 30mcg			With obstetricians and General Practitioners prescriptions only
Contraceptive LD		TABLET		ORAL	G03FA04	Norgestrel (or 1/2 amount of levonorgestrel) 0.1mg+Ethinylestradiol 20mcg			With obstetricians and General Practitioners prescriptions only	1397/02/11
Contraceptive LD+Fe		TABLET		ORAL	G03AA06	21 Tab. [Norgestrel (or 1/2 amount of levonorgestrel) 0.3mg+Ethinylestradiol 30mcg] + [ 7 Tab. of 24.65 mg Iron as Ferrous Sulfate or Fumarate )]			With obstetricians and General Practitioners prescriptions only	1379/11/25
Contraceptive Triphasic		TABLET		ORAL	G03AA06	6 Tab: (Levonorgestrel 0.05mg + Ethinylestradiol 30mcg) + 5 Tab: (Levonorgestrel 0.075mg + Ethinylestradiol 40mcg) + 10 Tab: (Levonorgestrel 0.125mg + Ethinylestrdiol 30mcg)			With obstetricians and General Practitioners prescriptions only	1368/04/18
Copper Sulfate		BULK			V03			Bulk medicines
Copper+Zinc		LOTION		TOPICAL	D11	Copper Sulfate 1 g + Zinc Sulfate 1.5 g + Concentrated Comphor Water 2.5 ml + water qs to 100 ml		OTC medicines
Corifollitropin Alfa		INJECTION, SOLUTION	200 mcg/ml	PARENTERAL	G03GA09		Overian Stimulation			1396/12/08
Corifollitropin Alfa		INJECTION, SOLUTION	300 mcg/ml	PARENTERAL	G03GA09		Overian Stimulation			1396/12/08
Corticotrophin		INJECTION	40 U/ml	PARENTERAL	H01AA01			Hospital use only		1366/11/04
Corticotrophin		INJECTION	80 U/ml	PARENTERAL	H01AA01			Hospital use only		1375/07/29
Co-trimoxazole		INJECTION, SOLUTION		INTRAVENOUS DRIP	J01EE01	(Sulfamethoxazole 400mg+Trimethoprim 80mg)/5ml		Hospital use only		1361/11/17
Co-trimoxazole		SUSPENSION		ORAL	J01EE01	(Sulfamethoxazole 200mg+Trimethoprim 40mg)/5ml
Co-trimoxazole		TABLET		ORAL	J01EE01	Sulfamethoxazole 100mg+Trimethoprim 20mg
Co-trimoxazole		TABLET		ORAL	J01EE01	Sulfamethoxazole 400mg+Trimethoprim 80mg
Co-trimoxazole		TABLET		ORAL	J01EE01	Sulfamethoxazole 800mg+Trimethoprim 160mg				1384/02/12
Cream Base		BULK			V03			Bulk medicines
Cresol		BULK			V03			Bulk medicines
Cromolyn	Sodium	INHALER	1 mg/dose	RESPIRATORY	R03BC01					1369/08/06
Cromolyn	Sodium	NEBULISATION	10 mg/ml	RESPIRATORY	R03BC01					1374/06/26
Cromolyn	Sodium	INHALER	20 mg/capsule	RESPIRATORY	R03BC01
Cromolyn	Sodium	SOLUTION	20 mg/ml	OPHTHALMIC	S01GX01		Treatment of vernal keratoconjunctivitis.			1369/08/06
Cromolyn	Sodium	SPRAY	20 mg/ml	NASAL	R01AC01					1365/02/21
Crotamiton		CREAM		TOPICAL	P03AX			OTC medicines
Cyclopentolate	HCl	SOLUTION	1%	OPHTHALMIC	S01FA04
Cyclophosphamide		INJECTION, POWDER	200 mg	PARENTERAL	L01AA01		Rheumatoid arthritis
Cyclophosphamide		TABLET	50 mg	ORAL	L01AA01		Rheumatoid arthritis
Cyclophosphamide		INJECTION, POWDER	500 mg	PARENTERAL	L01AA01		Rheumatoid arthritis
Cyclophosphamide		INJECTION, POWDER	1 g	PARENTERAL	L01AA01		Rheumatoid arthritis			1395/04/08
Cycloserine		CAPSULE	250 mg	ORAL	J04AB01					1361/03/23
Cycloserine		TABLET	250 mg	ORAL	J04AB01
Cyproheptadine	HCl	SOLUTION	2 mg/5 ml	ORAL	R06AX02				For local prodcution only	1390/09/21
Cyproheptadine	HCl	TABLET	4 mg	ORAL	R06AX02
Cyproterone	Acetate	TABLET	100 mg	ORAL	G03HA01				For local prodcution only	1391/02/25
Cyproterone	Acetate	TABLET	50 mg	ORAL	G03HA01		Treatment of severe hirsutism.			1359/10/24
Cyproterone Compound		TABLET		ORAL	G03HB01	Cyproterone acetate 2mg+Ethinylestradiol 35mcg			With obstetricians and General Practitioners prescriptions only
Cysteamine	As Bitartarte	CAPSULE	150 mg	ORAL	A16AA04		Treatment of corneal cystine crystal accumulation in cystinosis patients. Treatment of nephropathic cystinosis.	Orphan medicines
Cysteamine	As Bitartarte	CAPSULE	50 mg	ORAL	A16AA04			Orphan medicines		1387/10/15
Cytarabine		INJECTION, POWDER	1 g	PARENTERAL	L01BC01					1381/06/31
Cytarabine		INJECTION, POWDER	100 mg	PARENTERAL	L01BC01
Cytarabine		INJECTION, SOLUTION	20 mg/ml	PARENTERAL	L01AX04
Cytarabine		INJECTION, SOLUTION	50 mg/ml	PARENTERAL	L01AX04
Cytarabine		INJECTION, SOLUTION	100 mg/ml	PARENTERAL	L01AX04					1395/06/24
Cytarabine		INJECTION, POWDER	500 mg	PARENTERAL	L01BC01					1391/07/25
Dabigatran Etexilate	As Mesylate	CAPSULE	110 mg	ORAL	B01AE07					1390/03/07
Dabigatran Etexilate	As Mesylate	CAPSULE	150 mg	ORAL	B01AE07					1390/09/21
Dabigatran Etexilate	As Mesylate	CAPSULE	75 mg	ORAL	B01AE07					1390/03/07
Dacarbazine		INJECTION, POWDER	100 mg	PARENTERAL	L01AX04
Dacarbazine		INJECTION, POWDER	200 mg	PARENTERAL	L01AX04
Dacarbazine		INJECTION, POWDER	500 mg	PARENTERAL	L01AX04
Daclatasvir	As Dihydrochloride	TABLET	30 mg	ORAL	J05AX14		Hepatitis C infection			1394/07/05
Daclatasvir	As Dihydrochloride	TABLET	60 mg	ORAL	J05AX14		Hepatitis C infection			1394/07/05
Daclatasvir+Sofosbuvir		TABLET		ORAL	J05AX	Daclatasvir (As Dihydrochloride) 60 mg+Sofosbuvir 400 mg	Hepatitis C infection			1394/07/05
Dactinomycin		INJECTION, POWDER	0.5 mg	PARENTERAL	L01DA01
Dalteparin	Sodium	INJECTION	10000 U/ml	PARENTERAL	B01AB04
Dalteparin	Sodium	INJECTION	12500 U/ml	PARENTERAL	B01AB04
Dalteparin	Sodium	INJECTION	25000 U/ml	PARENTERAL	B01AB04
Dalteparin	Sodium	INJECTION	7500 U/0.3 ml	PARENTERAL	B01AB04
Danaparoid	Sodium	INJECTION	1250 U/ml	PARENTERAL	B01AB09					1385/10/26
Danazol		CAPSULE	100 mg	ORAL	G03XA01					1361/12/15
Danazol		CAPSULE	200 mg	ORAL	G03XA01					1361/12/15
Dantrolene	Sodium	INJECTION, POWDER	20 mg	PARENTERAL	M03CA01		Treatment of the neuroleptic malignant syndrome.	Hospital use only; Orphan medicines
Dantrolene	Sodium	CAPSULE	25 mg	ORAL	M03CA01			Orphan medicines
Dapagliflozin	As Propanediol	TABLET	5 mg	ORAL	A10BK01		Diabetes Mellitus type 2			1397/09/03
Dapagliflozin	As Propanediol	TABLET	10 mg	ORAL	A10BK01		Diabetes Mellitus type 2			1396/11/29
Dapagliflozin+Metformin		TABLET, EXTENDED RELEASE		ORAL	A10BD15	Dapagliflozin as Propanediol 5 mg+Metformin HCl 1000 mg	Diabetes Mellitus type 2			1396/11/29
Dapagliflozin+Metformin		TABLET, EXTENDED RELEASE		ORAL	A10BD15	Dapagliflozin as Propanediol 10 mg+Metformin HCl 1000 mg	Diabetes Mellitus type 2			1396/11/29
Dapoxetine	As HCl	TABLET	30 mg	ORAL	G04BX14		Premature ejaculation			1395/03/09
Dapoxetine	As HCl	TABLET	60 mg	ORAL	G04BX14		Premature ejaculation			1396/03/13
Dapsone		GEL	5%	TOPICAL	D10AX05					1392/04/04
Dapsone		TABLET	100 mg	ORAL	J04BA02		For the combination treatment of Pneumocystis carinii pneumonia in conjunction with trimethoprim.	Orphan medicines
Dapsone		TABLET	50 mg	ORAL	J04BA02		For the combination treatment of Pneumocystis carinii pneumonia in conjunction with trimethoprim.	Orphan medicines		1368/09/19
Darunavir	As Ethanolate	TABLET	600 mg	ORAL	J05AE10	Treatment of AIDS related complex.		For Health Dept. of MOH only		1393/10/14
Darunavir	As Ethanolate	TABLET	300 mg	ORAL	J05AE10	Treatment of AIDS related complex.		For Health Dept. of MOH only		1394/03/31
Darunavir	As Ethanolate	TABLET	150 mg	ORAL	J05AE10	Treatment of AIDS related complex.		For Health Dept. of MOH only		1395/05/03
Dasatinib		TABLET	20 mg	ORAL	L01XE06		CML		Local production only	1397/10/04
Dasatinib		TABLET	50 mg	ORAL	L01XE06		CML		Local production only	1397/10/04
Dasatinib		TABLET	70 mg	ORAL	L01XE06		CML		Local production only	1397/10/04
Dasatinib		TABLET	80 mg	ORAL	L01XE06		CML		Local production only	1397/10/04
Dasatinib		TABLET	100 mg	ORAL	L01XE06		CML		Local production only	1397/10/04
Dasatinib		TABLET	140 mg	ORAL	L01XE06		CML		Local production only	1397/10/04
Daunorubicin	As HCl	INJECTION, POWDER	20 mg	PARENTERAL	L01DB02
Deferasirox		TABLET, DISPERSIBLE	125 mg	ORAL	V03AC03					1385/08/09
Deferasirox		TABLET, DISPERSIBLE	250 mg	ORAL	V03AC03					1385/08/09
Deferasirox		TABLET, DISPERSIBLE	500 mg	ORAL	V03AC03					1385/08/09
Deferasirox		TABLET	90 mg	ORAL	V03AC03					1395/11/12
Deferasirox		TABLET	180 mg	ORAL	V03AC03					1395/11/12
Deferasirox		TABLET	360 mg	ORAL	V03AC03					1395/11/12
Deferiprone		TABLET, EFFERVESCENT	500 mg	ORAL	V03AC02					1393/05/12
Deferiprone		TABLET, DELAYED RELEASE	500 mg	ORAL	V03AC02					1389/09/22
Deferiprone		SOLUTION	100 mg/ ml	ORAL	V03AC02					1395/12/22
Deferoxamine	Mesylate	INJECTION, POWDER	500 mg	PARENTERAL	V03AC01
Deferoxamine	Mesylate	INJECTION, POWDER LYOPHILIZED	2 g	PARENTERAL	V03AC01
Denosumab		INJECTION. SOLUTION	60 mg/ml	PARENTERAL	M05BX04		Prevention of Osteoporotic Fractures			1394/07/05
Denosumab		INJECTION. SOLUTION	120 mg/1.7ml	PARENTERAL	M05BX04		Reduction of bone damage in patients with bone metastasis frome solid tumours			1395/04/09
Desipramine	HCl	TABLET	25 mg	ORAL	N06AA01					1371/06/08
Desloratadine		TABLET	5 mg	ORAL	R06AX27					1396/09/12
Desloratadine		SYRUP	2.5 mg/5ml	ORAL	R06AX27					1396/09/12
Desmopressin	As Acetate	TABLET	0.1 mg	ORAL	H01BA02					1380/02/30
Desmopressin	As Acetate	TABLET	0.2 mg	ORAL	H01BA02					1380/02/30
Desmopressin	As Acetate	SPRAY	10 mcg/dose	NASAL	H01BA02
Desmopressin	As Acetate	TABLET	120 mcg	SUBLINGUAL	H01BA02					1385/12/02
Desmopressin	As Acetate	INJECTION	15 mcg/ml	PARENTERAL	H01BA02			Hospital use only		1376/07/27
Desmopressin	As Acetate	TABLET	240 mcg	SUBLINGUAL	H01BA02
Desmopressin	As Acetate	INJECTION	4 mcg/ml	PARENTERAL	H01BA02			Hospital use only		1376/07/27
Desmopressin	As Acetate	TABLET	60 mcg	SUBLINGUAL	H01BA02					1385/12/02
Desmopressin	As Acetate	TABLET	25 mcg	SUBLINGUAL	H01BA02					1396/08/29
Desmopressin	As Acetate	TABLET	50 mcg	SUBLINGUAL	H01BA02					1396/08/29
Desogestrel		TABLET	75mcg	ORAL	G03AC09			OTC medicines		1390/12/22
Desonide		CREAM	0.05%	TOPICAL	D07AB08					1389/10/25
Desonide		OINTMENT	0.05%	TOPICAL	D07AB08					1397/06/24
Dexamethasone	As Disodium Phosphate	INJECTION	4 mg/ml	PARENTERAL	H02AB02
Dexamethasone		TABLET	0.5 mg	ORAL	H02AB02
Dexamethasone		TABLET	4 mg	ORAL	H02AB02					1395/08/02
Dexamethasone	As Acetate	TABLET	40 mg	ORAL	H02AB02					1396/06/07
Dexamethasone		ELIXIR	0.5 mg/5ml	ORAL	H02AB02
Dexamethasone		SOLUTION	2 mg/5ml	ORAL	H02AB02					1395/09/01
Dexamethasone		BULK			V03			Bulk medicines
Dexmedetomidine	As HCl	INJECTION, CONCENTRATE	100mcg/ml	PARENTERAL	N05CM18			Hospital use only		1391/02/07
Dexmedetomidine	As HCl	INJECTION, SOLUTION	4 mcg/ml	PARENTERAL	N05CM18			Hospital use only		1395/08/02
Dexpanthenol		CREAM	5%	TOPICAL	D03AX03			OTC medicines		1369/10/30
Dexpanthenol		INJECTION, SOLUTION	250mg/ml	PARENTERAL	A11HA30					1392/09/25
Dextran+NaCl		INJECTION, SOLUTION	500 ml	INTRAVENOUS DRIP	B05BB02	Dextran70 6%+ NaCl 0.9%		Hospital use only
Dextroamphetamine	Sulfate	TABLET	10 mg	ORAL	N06BA02					1379/12/21
Dextroamphetamine	Sulfate	TABLET	5 mg	ORAL	N06BA02					1379/12/21
Dextromethorphan	HBr	TABLET	15 mg	ORAL	R05DA09			OTC medicines		1359/06/08
Dextromethorphan	HBr	CAPSULE, LIQUID FILLED	15 mg	ORAL	R05DA09			OTC medicines		1385/09/15
Dextromethorphan	HBr	SYRUP	15 mg/5ml	ORAL	R05DA09			OTC medicines		1369/10/30
Dextromethorphan	HBr	SOLUTION/ DROPS	4 mg/ml	ORAL	R05DA09			OTC medicines
Dextromethorphan+Pseudoephedrine		SYRUP		ORAL	R05DA20	(Dextromethorphan HBr 15mg+Pseudoephedrine HCl 30mg)/5ml		OTC medicines
Dextromethorphan+Guaifenisin+Phenylephrin		SYRUP		ORAL	R05CA	(Dextromethorphan HBr 10mg+Guaifenisin 100mg+Phenylephrin 5mg)/5ml		OTC medicines		1395/08/12
Dextromethorphan+Guaifenisin+Phenylephrin		SYRUP		ORAL	R05CA	(Dextromethorphan HBr 20mg+Guaifenisin 100mg+Phenylephrin HCl 10mg)/5ml		OTC medicines		1395/08/12
Dextromethorphan+Guaifenisin+Phenylephrin		SYRUP		ORAL	R05CA	(Dextromethorphan HBr 30mg+Guaifenisin HCl 200mg+Phenylephrin HCl 10mg)/5ml		OTC medicines		1395/08/12
Dextromethorphan+Guaifenisin+Phenylephrin		SYRUP		ORAL	R05CA	(Dextromethorphan HBr 15mg+Guaifenisin HCl 350mg+Phenylephrin HCl 10mg)/5ml		OTC medicines		1395/08/12
Dextromethorphan+Guaifenisin+Pseudoephedrine		SYRUP		ORAL	R05CA	(Dextromethorphan HBr 15mg+Guaifenisin HCl 200mg+Pseudoephedrine HCl 30 mg)/5ml		OTC medicines	For Adults	1397/07/14
Dextromethorphan+Guaifenisin		SYRUP		ORAL	R05CA	(Dextromethorphan HBr 5mg+Guaifenisin HCl 100mg)/5 ml				1396/06/25
Dextrose		INJECTION, SOLUTION	10%, 500ml	INTRAVENOUS DRIP	B05BA03	Dextrose anhydrous or monohydrate Eq. to 10 g Dextrose/100 ml
Dextrose		INJECTION, SOLUTION	20% , 50ml	INTRAVENOUS DRIP	B05CX03	Dextrose anhydrous or monohydrate Eq. to 20 g Dextrose/100 ml
Dextrose		INJECTION, SOLUTION	20%, 1lit	INTRAVENOUS DRIP	B05CX03	Dextrose anhydrous or monohydrate Eq. to 20 g Dextrose/100 ml				1373/10/18
Dextrose		INJECTION, SOLUTION	20%, 500ml	INTRAVENOUS DRIP	B05CX03	Dextrose anhydrous or monohydrate Eq. to 20 g Dextrose/100 ml
Dextrose		INJECTION, SOLUTION	5% , 250ml	PARENTERAL	B05BA03	Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/ 100 ml				1384/02/12
Dextrose		SOLUTION	5%, 100ml	INTRAVENOUS DRIP	B05BA03	Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/ 100 ml
Dextrose		INJECTION, SOLUTION	5%, 1lit	INTRAVENOUS DRIP	B05BA03	Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/ 100 ml
Dextrose		INJECTION, SOLUTION	5%, 500ml	INTRAVENOUS DRIP	B05BA03	Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/ 100 ml
Dextrose		INJECTION, SOLUTION, CONCENTRATE	50%, 1lit	INTRAVENOUS DRIP	B05BA03	Dextrose anhydrous or monohydrate Eq. to 50 g Dextrose/100 ml_ In 2000 ml Container
Dextrose		INJECTION, SOLUTION, CONCENTRATE	50%, 200ml in 2 litr bag	INTRAVENOUS DRIP	B05BA03					1389/02/01
Dextrose		INJECTION, SOLUTION, CONCENTRATE	50%, 400ml in 2 litr bag	INTRAVENOUS DRIP	B05BA03					1389/02/01
Dextrose		INJECTION, SOLUTION, CONCENTRATE	50%, 500ml	INTRAVENOUS DRIP	B05CX01	Dextrose anhydrous or monohydrate Eq. to 50 g Dextrose/100 ml_In 1000 ml Container				1373/10/18
Dextrose		INJECTION, SOLUTION, CONCENTRATE	50%, 50ml	INTRAVENOUS DRIP	B05CX01	Dextrose anhydrous or monohydrate Eq. to 50 g Dextrose/100 ml
Dextrose		INJECTION, SOLUTION, CONCENTRATE	70%, 1lit	PARENTERAL	B05CX01				In 2000 ml Container	1385/11/24
Dextrose/ Ehthanol		INJECTION, SOLUTION	5/5%, 1000ml	INTRAVENOUS DRIP	B05BA10	Dextrose 5% + EHTHANOL 5%		Hospital use only
Dextrose/ NaCl		INJECTION, SOLUTION	3.33/0.3%, 1000ml	INTRAVENOUS DRIP	B05BB02	Dextrose 3.33% NaCl 0.3% Dextrose anhydrous or monohydrate Eq. to 3.33% Dextrose/100 ml				1387/08/15
Dextrose/ NaCl		INJECTION, SOLUTION	3.33/0.3%, 500ml	INTRAVENOUS DRIP	B05BB02	Dextrose 3.33% NaCl 0.3% Dextrose anhydrous or monohydrate Eq. to 3.33% Dextrose/100 ml				1387/08/15
Dextrose/ NaCl		INJECTION, SOLUTION	5/0.45%, 1000ml	INTRAVENOUS DRIP	B05BB02	Dextrose 5% NaCl 0.45% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml
Dextrose/ NaCl		INJECTION, SOLUTION	5/0.45%, 500ml	INTRAVENOUS DRIP	B05BB02	Dextrose 5% NaCl 0.45% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml
Dextrose/ NaCl		INJECTION, SOLUTION	5/0.9%, 1000ml	INTRAVENOUS DRIP	B05BB02	Dextrose 5% NaCl 0.9% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml
Dextrose/ NaCl l		INJECTION, SOLUTION	5/0.9%, 250m	INTRAVENOUS DRIP	B05BB02	Dextrose 5% NaCl 0.9% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml				1384/02/12
Dextrose/ NaCl		INJECTION, SOLUTION	5/0.9%, 500ml	INTRAVENOUS DRIP	B05BB02	Dextrose 5% NaCl 0.9% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml
Dextrose/ NaCl		INJECTION, SOLUTION	5/0.9%, 500ml	INTRAVENOUS DRIP	B05BB02	Dextrose 5% NaCl 0.9% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml
Dextrose		BULK			V03			Bulk medicines
Diacetyl-bis(N4-methylthiosemicarbazone) (ATSM)		INJECTION, SOLUTION	(5-10) mCi (64Cu)	PARENTERAL	V10					1389/10/25
Diazepam		ENEMA	10 mg	RECTAL	N05BA01		For the management of selected, refractory, patients with epilepsy, on stable regimens of antiepileptic drugs (AEDs), who require intermittent use of diazepam to control bouts of increased seizure activity.			1372/08/23
Diazepam		SUPPOSITORY	10 mg	RECTAL	N05BA01
Diazepam		TABLET	10 mg	ORAL	N05BA01					1382/03/04
Diazepam		TABLET	2 mg	ORAL	N05BA01
Diazepam		SOLUTION	2 mg/5ml	ORAL	N05BA01
Diazepam		ENEMA	5 mg	RECTAL	N05BA01					1372/08/23
Diazepam		SUPPOSITORY	5 mg	RECTAL	N05BA01
Diazepam		TABLET	5 mg	ORAL	N05BA01
Diazepam		INJECTION	5 mg/ml	PARENTERAL	N05BA01
Diazoxide		CAPSULE	100 mg	ORAL	C02DA01
Diazoxide		INJECTION	15 mg/ml	PARENTERAL	V03AH01			Hospital use only
Diazoxide		CAPSULE	50 mg	ORAL	V03AH01					1361/09/14
Dichloroacetic Acid		BULK			V03			Bulk medicines
Diclofenac	Sodium	SOLUTION/ DROPS	0.10%	OPHTHALMIC	S01BC03					1378/03/30
Diclofenac	Diethylammonium	GEL	1%	TOPICAL	D11AX18			OTC medicines		1371/10/27
Diclofenac	Sodium	SOLUTION	1.50%	TOPICAL	M01AB05					1389/06/15
Diclofenac	Sodium	CAPSULE, EXTENDED RELEASE, PELLETS	100 mg	ORAL	M01AB05
Diclofenac	Sodium	TABLET, EXTENDED RELEASE	100 mg	ORAL	M01AB05					1371/08/24
Diclofenac	Sodium	SUPPOSITORY	100 mg	RECTAL	M01AB05					1379/03/02
Diclofenac	Diethylamine	PLASTER	120 mg	TOPICAL	M02AA15					1392/05/29
Diclofenac	Epolamine	PATCH	1.30%	TOPICAL	M02AA15					1395/10/07
Diclofenac	Sodium	SOLUTION	2.00%	TOPICAL	M02AA15					1396/09/18
Diclofenac	Potassium	CAPSULE, LIQUID FILLED	25 mg	ORAL	M01AB05					1393/03/25
Diclofenac	Sodium	TABLET, DELAYED RELEASE	25 mg	ORAL	M01AB05					1361/06/28
Diclofenac	Sodium	INJECTION	25 mg/ml	PARENTERAL	M01AB05			Hospital use only		1367/12/14
Diclofenac	Potassium	TABLET	50 mg	ORAL	M01AB05					1388/08/20
Diclofenac	Sodium	SUPPOSITORY	50 mg	RECTAL	M01AB05					1372/09/07
Diclofenac	Sodium	TABLET, DELAYED RELEASE	50 mg	ORAL	M01AB05
Diclofenac	Sodium	TABLET, EXTENDED RELEASE	75 mg	ORAL	M01AB05					1389/03/31
Dicyclomine	HCl	ELIXIR	10 mg/5ml	ORAL	A03AA07					1359/11/08
Dicyclomine	HCl	TABLET	10 mg	ORAL	A03AA07
Dicyclomine	HCl	INJECTION	10 mg/ml	PARENTERAL	A03AA07					1361/02/05
Didanosine		CAPSULE	200 mg	ORAL	J05AF02			For Health Dept. of MOH only
Didanosine		CAPSULE, DELAYED RELEASE	200 mg	ORAL	J05AF02			For Health Dept. of MOH only		1396/04/18
Didanosine		TABLET	200 mg	ORAL	J05AF02			Hospital use only
Dienestrol		CREAM	0.01%	VAGINAL	G03CB01
Dienestrol		TABLET	2mg	ORAL	G03DB08					1393/06/02
Dienogest		TABLET	2mg	ORAL	G03DB08			OTC medicines		1391/02/07
Dienogest+Ethinylestradiol		TABLET		ORAL	G03AA16	Dienogest 2mg+ Ethinylestradiol 0.03 mg			With obstetricians and General Practitioners prescriptions only	1391/02/07
Digestive		TABLET, DELAYED RELEASE		ORAL	A09AA	Pancreatin+simethicone 40 mg		OTC medicines
Digoxin		ELIXIR	0.05 mg/ml	ORAL	C01AA05					1362/03/29
Digoxin		TABLET	0.25 mg	ORAL	C01AA05
Digoxin		INJECTION	0.25 mg/ml	PARENTERAL	C01AA05			Hospital use only
Digoxin		SOLUTION/ DROPS	0.5 mg/ml	ORAL	C01AA05
Digoxin Specific Antibody		INJECTION	40 mg	PARENTERAL	V03AB24		Treatment of digitalis intoxication; refractory to management by conventional therapy.	Orphan medicines		1385/11/24
Dihydroergotamine	Mesylate	INJECTION	1 mg/ml	PARENTERAL	N02CA01
Dihydroergotamine	Mesylate	TABLET	1.5 mg	ORAL	N02CA01
Dihydroergotamine	Mesylate	TABLET	2.5 mg	ORAL	N02CA01
Dihydrotachysterol		SOLUTION	0.25 mg/ml	ORAL	A11CC02
Dihydrotachysterol		SOLUTION	1 mg/ml	ORAL	A11CC02					1396/12/08
Diloxanide	Furoate	TABLET	500 mg	ORAL	P01AC01					1369/10/30
Diltiazem	HCl	GEL	2%	TOPICAL	C05AE					1390/09/21
Diltiazem	HCl	INJECTION, POWDER	100 mg	PARENTERAL	C08DB01			Hospital use only
Diltiazem	HCl	INJECTION, SOLUTION	5 mg/ml	PARENTERAL	C08DB01			Hospital use only		1371/07/19
Diltiazem	HCl	CAPSULE, EXTENDED RELEASE	120 mg	ORAL	C08DB01
Diltiazem	HCl	TABLET, EXTENDED RELEASE	120 mg	ORAL	C08DB01					1377/09/01
Diltiazem	HCl	TABLET	60 mg	ORAL	C08DB01					1369/10/16
Diltiazem	HCl	TABLET	30 mg	ORAL	C08DB01					1397/04/31
Diltiazem	HCl	TABLET	90 mg	ORAL	C08DB01					1397/04/31
Dimenhydrinate		TABLET	50 mg	ORAL				OTC medicines		1369/10/30
Dimercaprol		INJECTION	100 mg/ml	INTRAMUSCULAR	V03AB09
Dimethyl Fumarate		CAPSULE, DELAYED RELEASE	120 mg	ORAL	N07XX09					1393/02/07
Dimethyl Fumarate		CAPSULE, DELAYED RELEASE	240 mg	ORAL	N07XX09					1393/02/07
Dimethyl Sulfoxide		SOLUTION	50%	PARENTERAL	G04BX13		Treatment of cutaneous manifestations of scleroderma. Treatment of palmar-plantar erythrodysethesia syndrome.	Orphan medicines		1382/03/04
Diphenhydramine	HCl	SOLUTION	12.5 mg/5ml	ORAL	R06AA02			OTC medicines		1369/10/30
Diphenhydramine	HCl	TABLET	25 mg	ORAL	R06AA02			OTC medicines		1369/10/30
Diphenhydramine	HCl	CAPSULE, LIQUID FILLED	25 mg	ORAL	R06AA02			OTC medicines		1385/09/15
Diphenhydramine	HCl	INJECTION	50 mg/ml	PARENTERAL	R06AA02					1361/11/17
Diphenhydramine+Ammonium chloride		SYRUP		ORAL	R06AA52	(Diphenhydramine HCl 12.5mg + Ammonium chloride 125mg) / 5ml				1369/10/30
Diphenoxylate	HCl	TABLET	2.5 mg	ORAL	A07DA01	Diphenoxylate HCl 2.5mg+Atropine sulfate 25mcg
Diphteria Antitoxin Equine		INJECTION		PARENTERAL/vaccine	J06AA01
Diphteria Toxoid+Tetanus Toxoid+Pertussis		INJECTION		PARENTERAL/vaccine	J07AM02
Diphteria Toxoid+Tetanus Toxoid+Pertussis+Haemophilus Influenza Type B		INJECTION		PARENTERAL/vaccine	J07					1388/10/30
Diphteria Toxoid+Tetanus Toxoid+Pertussis+Haemophilus Influenza Type B+Hepatitis B Vaccine		INJECTION		PARENTERAL/vaccine	J07C					1388/10/30
Diphteria+Tetanus toxoids Adsorbed (Dt)		INJECTION		PARENTERAL/vaccine	J07AM02				for Pediatrics
Diphteria+Tetanus toxoids Adsorbed (Td)		INJECTION		PARENTERAL/vaccine	J07AM02				for adults
Dipyridamole		TABLET	25 mg	ORAL	B01AC07
Dipyridamole		INJECTION	5 mg/ml	PARENTERAL	B01AC07			Hospital use only		1369/01/26
Dipyridamole		TABLET	75 mg	ORAL	B01AC07
Dipyridamole+ASA		CAPSULE, EXTENDED RELEASE		ORAL	B01AC30	Dipyridamole 200 mg+ASA25 mg		Need to be assessed by clinical trial before registration.		1389/10/25
Disopyramide	As Phosphate	CAPSULE	100 mg	ORAL	C01BA03
Distilled Water		BULK			V03			Bulk medicines
Disulfiram		TABLET	200 mg	ORAL	N07BB01					1387/12/21
Disulfiram		TABLET	250 mg	ORAL	N07BB01					1387/12/21
Disulfiram		TABLET	500 mg	ORAL	N07BB01					1387/12/21
Dithranol		CREAM	0.25%	TOPICAL	D05AC01					1361/10/19
Dithranol		BULK			V03			Bulk medicines		1365/10/14
Dobutamine		INJECTION, SOLUTION	12.5 mg/ml	PARENTERAL	C01CA07	As HCL		Hospital use only
Dobutamine		INJECTION, POWDER, LYOPHILIZED	250 mg	PARENTERAL	C01CA07	As HCL		Hospital use only
Docetaxel		INJECTION, SOLUTION	20 mg/ml	PARENTERAL	L01CD02					1392/5/29
Docetaxel		INJECTION, SOLUTION	10 mg/ml	PARENTERAL	L01CD02					1389/11/04
Docetaxel		INJECTION, POWDER	20 mg	PARENTERAL	L01CD02
Docetaxel		INJECTION, POWDER	80 mg	PARENTERAL	L01CD02					1375/12/12
Docusate Na+Sorbitol		ENEMA		RECTAL	A06AA02	Docusate Na 0.01g+Sorbitol 13.4 g				1372/07/11
Dolutegravir	As Sodium	TABLET	50 mg	ORAL	J05AX12			For Health Dept. of MOH only		1396/05/28
Domperidone	As Maleate	TABLET	10 mg	ORAL	A03FA03					1386/04/26
Domperidone		SUSPENSION	1mg/ml	ORAL	A03FA03					1395/12/18
Donepezil	HCl	TABLET	10 mg	ORAL	N06DA02					1383/12/16
Donepezil	HCl	TABLET	5 mg	ORAL	N06DA02					1383/12/16
Donepezil	HCl	TABLET, ORALLY DISINTEGRATING	10 mg	ORAL	N06DA02					1396/01/29
Donepezil	HCl	TABLET, ORALLY DISINTEGRATING	5 mg	ORAL	N06DA02					1396/01/29
Dopamine	HCl	INJECTION	40 mg/ml	PARENTERAL	C01CA04			Hospital use only
Dorzolamide	As HCl	SOLUTION/ DROPS	2%	OPHTHALMIC	S01EC03					1374/10/03
Dorzolamide+Timolol		SOLUTION/ DROPS		OPHTHALMIC	S01ED51	[Dorzolamide(As Hydrochloride) 2% + Timolol(As Maleate) 0.5%]				1386/03/23
Doxapram	HCl	INJECTION	20 mg/ml	PARENTERAL	R07AB01			Hospital use only
Doxepin	As HCl	CAPSULE	10 mg	ORAL	N06AA12					1381/10/08
Doxepin	As HCl	TABLET	10 mg	ORAL	N06AA12					1383/06/29
Doxepin	As HCl	CAPSULE	25 mg	ORAL	N06AA12					1381/10/08
Doxepin	As HCl	TABLET	25 mg	ORAL	N06AA02					1383/06/29
Doxorubicin	HCl	INJECTION, POWDER	10 mg	PARENTERAL	L01DB01
Doxorubicin	HCl	INJECTION, LIPOSOMAL	2 mg/ml	PARENTERAL	L01DB01				Pegylated	1389/06/15
Doxorubicin	HCl	INJECTION, SOLUTION, CONCENTRATE	2 mg/ml	PARENTERAL	L01DB01
Doxorubicin	HCl	INJECTION, POWDER	50 mg	PARENTERAL	L01DB01
Doxycycline	As Monohydrate	CAPSULE	100 mg	ORAL	J01AA02
Doxycycline	As Hyclate or Monohydrate	TABLET	100 mg	ORAL	J01AA02					1387/06/13
Doxycycline	As Hyclate	CAPSULE	100 mg	ORAL	J01AA02					1392/5/29
Doxycycline	As Hyclate	CAPSULE, DELAYED RELEASE	100 mg	ORAL	J01AA02					1396/04/18
Doxycycline		INJECTION	100 mg/ Vial	PARENTERAL	J01AA02			Hospital use only		1387/12/21
Doxycycline	As Monohydrate	CAPSULE	50 mg	ORAL	J01AA02					1386/08/09
Droperidol		INJECTION	1.25 mg/ml	PARENTERAL	N05AD08			Hospital use only		1396/03/21
Droperidol		INJECTION	2.5 mg/ml	PARENTERAL	N05AD08			Hospital use only		1362/08/15
Droperidol Compound		INJECTION		PARENTERAL	N01AH51	(Droperidol 25mg+Fentanyl(as citrate) 0.5mg)/10ml		Hospital use only
Drospirenone+Ethinyl Estradiol		TABLET		ORAL	G03FA17	(Drospirenone 3 mg + Ethinyl Estradiol 0.02 mg)			With obstetricians and General Practitioners prescriptions only	1387/06/13
Drospirenone+Ethinyl Estradiol		TABLET		ORAL	G03FA17	(Drospirenone 3 mg + Ethinyl Estradiol 0.03 mg)			With obstetricians and General Practitioners prescriptions only	1385/08/09
Duloxetine	As HCl	CAPSULE, DELAYED RELEASE	20 mg	ORAL	N06AX21					1390/03/07
Duloxetine	As HCl	CAPSULE, DELAYED RELEASE	30 mg	ORAL	N06AX21					1390/03/07
Duloxetine	As HCl	CAPSULE, DELAYED RELEASE	60 mg	ORAL	N06AX21					1390/03/07
Dutasteride		CAPSULE, LIQUID FILLED	0.5 mg	ORAL	G04CB02					1396/09/12
Dutasteride+Tamsulosin		CAPSULE		ORAL	G04CA52	Dutastride 0.5 mg +Tamsulosin HCl 0.4 mg				1396/12/08
Dutasteride+Tamsulosin		CAPSULE, EXTENDED RELEASE		ORAL	G04CA52	Dutastride 0.5 mg +Tamsulosin HCl 0.4 mg				1397/07/14
Dydrogesterone		TABLET	10 mg	ORAL	G03DB01					1384/04/20
Dydrogesterone		TABLET	5 mg	ORAL	G03DB01
Echothiophate	Iodide	SOLUTION/ DROPS	0.06%	OPHTHALMIC	S01EB03
Echothiophate	Iodide	SOLUTION/ DROPS	0.125%	OPHTHALMIC	S01EB03
Echothiophate	Iodide	SOLUTION/ DROPS	0.25%	OPHTHALMIC	S01EB03
Edaravone		INJECTION, SOLUTION	30 mg/20 ml	PARENTERAL	N07XX14		ESALS			1397/10/04
Edetate Calcium Disodium		INJECTION	50 mg/ml	PARENTERAL	V03AB03			Hospital use only		1362/01/14
Edetate Calcium Disodium		INJECTION	200 mg/ml	PARENTERAL	V03AB03			Hospital use only		1396/12/13
Edetate Dicobalt		INJECTION	15 mg/ml	PARENTERAL	V03AB03			Hospital use only		1362/01/21
Edetate Disodium		INJECTION	150 mg/ml	PARENTERAL	V03AB03			Hospital use only		1361/02/19
Edetate Sodium		SOLUTION/ DROPS		OPHTHALMIC	S01XA05
Edrophonium	Chloride	INJECTION	10 mg/ml	PARENTERAL	V04CX			Hospital use only
Efavirens+Emtricitabine+Tenofovir		TABLET		ORAL	J05AR06	Efavirens 600 mg+Emtricitabine 200 mg+Tenofovir disoproxil (as fumarate) 245 mg	Treatment of AIDS related complex.	For Health Dept. of MOH only		1393/10/14
Efavirenz		CAPSULE	100 mg	ORAL	J05AG03		Treatment of AIDS related complex.	For Health Dept. of MOH only		1386/04/11
Efavirenz		SOLUTION	150 mg/5ml	ORAL	J05AG03		Treatment of AIDS related complex.	For Health Dept. of MOH only
Efavirenz		CAPSULE	200 mg	ORAL	J05AG03		Treatment of AIDS related complex.	For Health Dept. of MOH only		1386/04/11
Efavirenz		TABLET	200 mg	ORAL	J05AG03		Treatment of AIDS related complex.	For Health Dept. of MOH only		1386/06/10
Efavirenz		CAPSULE	50 mg	ORAL	J05AG03		Treatment of AIDS related complex.	For Health Dept. of MOH only		1386/04/11
Efavirenz		TABLET	600 mg	ORAL	J05AG03		Treatment of AIDS related complex.	For Health Dept. of MOH only		1386/04/11
Eflornithine	HCl	CREAM	13.90%	Topical	D11AX16				for local production only	1389/10/25
Elosulfase alfa		INJECTION, SOLUTION, CONCENTRATE	1 mg/ml	PARENTERAL	A16AB12		Morquio A Syndrom	Orphan medicines		1394/07/05
Empagliflozin		TABLET	10 mg	ORAL	A10BX12		Diabetes Mellitus type 2			1396/11/29
Empagliflozin		TABLET	25 mg	ORAL	A10BX12		Diabetes Mellitus type 2			1396/11/29
Empagliflozin+Linagliptin		TABLET		ORAL	A10BD19	Empagliflozin 10 mg+Linagliptin 5mg	Diabetes Mellitus type 2			1396/12/13
Empagliflozin+Linagliptin		TABLET		ORAL	A10BD19	Empagliflozin 25 mg+Linagliptin 5mg	Diabetes Mellitus type 2			1396/12/13
Empagliflozin+Metformin		TABLET		ORAL	A10BD20	Empagliflozin 5 mg+Metformin HCl 500 mg	Diabetes Mellitus type 2			1397/02/11
Empagliflozin+Metformin		TABLET		ORAL	A10BD20	Empagliflozin 12.5 mg+Metformin HCl 500 mg	Diabetes Mellitus type 2			1397/02/11
Empagliflozin+Metformin		TABLET		ORAL	A10BD20	Empagliflozin 5 mg+Metformin HCl 1000 mg	Diabetes Mellitus type 2			1397/02/11
Empagliflozin+Metformin		TABLET		ORAL	A10BD20	Empagliflozin 12.5 mg+Metformin HCl 1000 mg	Diabetes Mellitus type 2			1397/02/11
Empagliflozin+Metformin		TABLET, EXTENDED RELEASE		ORAL	A10BD20	Empagliflozin 10 mg+Metformin HCl 1000 mg	Diabetes Mellitus type 2			1397/09/03
Empagliflozin+Metformin		TABLET, EXTENDED RELEASE		ORAL	A10BD20	Empagliflozin 25 mg+Metformin HCl 1000 mg	Diabetes Mellitus type 2			1397/09/03
Emtricitabine+Tenofovir		TABLET		ORAL	J05AR17	Emtricitabine 200 mg+ Tenofovir Alafenamide (as Fumarate) 25 mg		For Health Dept. of MOH only		1395/12/22
Enalapril		TABLET	10 mg	ORAL	C09AA02					1386/08/09
Enalapril		TABLET	2.5 mg	ORAL	C09AA02					1386/08/09
Enalapril		TABLET	20 mg	ORAL	C09AA02					1369/11/14
Enalapril		TABLET	5 mg	ORAL	C09AA02					1369/11/14
Enflurane		INHALANT		RESPIRATORY	N01AB04			Orphan medicines. Hospital use only
Enoxaparin	Sodium	INJECTION	100 mg/ml	PARENTERAL	B01AB05			volumes of 1ml, 3 ml are for hospital use only
Entecavir		TABLET	0.5 mg	ORAL	J05AF10		Chronic hepatitis B			1396/11/29
Entecavir		TABLET	1 mg	ORAL	J05AF10		Chronic hepatitis B			1396/11/29
Eosin		BULK			V03			Bulk medicines		1376/12/10
Ephedrine	HCl	TABLET	20 mg	ORAL	R03CA02
Ephedrine	HCl	TABLET	15 mg	ORAL	R03CA02					1396/08/07
Ephedrine	HCl	TABLET	30 mg	ORAL	R03CA02					1396/08/07
Ephedrine	HCl	INJECTION	50 mg/ml	PARENTERAL	R03CA02			Hospital use only		1376/05/19
Ephedrine	Sulfate	INJECTION	50 mg/ml	PARENTERAL	R03CA02			Hospital use only
Epinephrine	As Acid Tartrate or As HCl	SOLUTION/ DROPS	1%	OPHTHALMIC	S01EA01					1360/09/15
Epinephrine	As HCl	INJECTION	0.1mg/ml	PARENTERAL	C01CA24
Epinephrine	As Acid Tartrate or As HCl	INJECTION	1 mg/ml	PARENTERAL	C01CA24			Hospital use only		1374/06/26
Epinephrine		INJECTION, SOLUTION	0.15 mg/0.3 ml	PARENTERAL	C01CA24		Allergic emergencies			1395/03/31
Epinephrine		INJECTION, SOLUTION	0.3 mg/0.3 ml	PARENTERAL	C01CA24		Allergic emergencies			1395/03/31
Epirubicin	HCl	INJECTION, POWDER	10 mg	PARENTERAL	L01DB03		Treatment of breast cancer			1365/09/16
Epirubicin	HCl	INJECTION, SOLUTION, CONCENTRATE	2mg/ml	PARENTERAL	L01DB03		Treatment of breast cancer			1388/08/20
Epirubicin	HCl	INJECTION, POWDER	50 mg	PARENTERAL	L01DB03		Treatment of breast cancer			1365/09/16
Eplerenone		TABLET	25 mg	ORAL	C03DA04					1392/12/11
Eplerenone		TABLET	50 mg	ORAL	C03DA04					1392/12/11
Epoetin		INJECTION	1000 U/ ml	PARENTERAL	B03XA01		Treatment of anemia
Epoetin		INJECTION	10000 U/ ml	PARENTERAL	B03XA01		Treatment of anemia
Epoetin		INJECTION	2000 U/ 0. 4 ml	PARENTERAL	B03XA01		Treatment of anemia
Epoetin		INJECTION	2000 U/ ml	PARENTERAL	B03XA01		Treatment of anemia
Epoetin		INJECTION	20000 U/ ml	PARENTERAL	B03XA01		Treatment of anemia
Epoetin		INJECTION	40,000 U/ ml	PARENTERAL	B03XA01		Treatment of anemia			1386/04/13
Epoetin		INJECTION	4000 U/ 0. 3 ml	PARENTERAL	B03XA01		Treatment of anemia
Epoetin		INJECTION	4000 U/ 0. 4 ml	PARENTERAL	B03XA01		Treatment of anemia
Epoetin		INJECTION	4000 U/ ml	PARENTERAL	B03XA01		Treatment of anemia
Epoetin		INJECTION	2000 U/0.3 ml	PARENTERAL	B03XA01		Treatment of anemia			1396/03/13
Epoetin		INJECTION	10000 U/0.6 ml	PARENTERAL	B03XA01		Treatment of anemia			1396/03/13
Epoetin		INJECTION	20000 U/0.6 ml	PARENTERAL	B03XA01		Treatment of anemia			1396/03/13
Epoetin		INJECTION	40000 U/0.6 ml	PARENTERAL	B03XA01		Treatment of anemia			1396/03/13
Epoprostenol	As Sodium	INJECTION, POWDER	0.5 mg	PARENTERAL	B01AC09			Orphan medicines		1396/09/12
Epoprostenol	As Sodium	INJECTION, POWDER	1.5 mg	PARENTERAL	B01AC09			Orphan medicines		1396/09/12
Eprosartan	As Mesylate	TABLET	600 mg	ORAL	C09CA02					1388/02/30
Eprosartan	As Mesylate	TABLET	300 mg	ORAL	C09CA02					1388/02/30
Eptifibatide		INJECTION	0. 75mg/ ml	PARENTERAL	B01AC16					1387/12/21
Eptifibatide		INJECTION	2mg/ ml	PARENTERAL	B01AC16					1387/12/21
Erbium [169Er] Citrate Colloid		INJECTION, COLLOIDAL SOLUTION	(5-10) mCi	INTRA-CAVITY	V10AX04				Radiopharmaceuticals	1389/10/25
Ergotamine	Tartrate	TABLET	2 mg	SUBLINGUAL	N02CA02					1377/07/26
Ergotamine Compound		TABLET		ORAL	N02CA52	Ergotamine tartrate 2 mg + Caffeine 100mg + Cyclizine Hcl 50 mg				1382/04/01
Ergotamine+Caffeine		TABLET		ORAL	N02CA72	Ergotamine tartrate 1mg+Caffeine 100mg
Erlotinib	As HCl	TABLET	100mg	ORAL	L01XE03
Erlotinib	As HCl	TABLET	150mg	ORAL	L01XE03
Erlotinib	As HCl	TABLET	25 mg	ORAL	L01XE03					1396/07/22
Erythromycin		OINTMENT	0.50%	OPHTHALMIC	S01AA17					1362/11/30
Erythromycin		GEL	2%	TOPICAL	D10AF02					1373/05/02
Erythromycin		SWAB	2%	TOPICAL	D10AF02					1397/10/04
Erythromycin		SOLUTION	2%	TOPICAL	D10AF02					1376/04/29
Erythromycin		GEL	4%	TOPICAL	D10AF02					1381/11/20
Erythromycin		SOLUTION	4%	TOPICAL	D10AF02					1381/11/20
Erythromycin	As Lactobionate	INJECTION, POWDER	1 g	PARENTERAL	J01FA01			Hospital use only		1371/09/15
Erythromycin	As Ethylsuccinate	TABLET	200 mg	ORAL	J01FA01					1360/08/24
Erythromycin	As Ethylsuccinate	TABLET, CHEWABLE	200 mg	ORAL	J01FA01					1372/09/21
Erythromycin	As Ethylsuccinate	POWDER, FOR SUSPENSION	200 mg/5ml	ORAL	J01FA01
Erythromycin	As Ethylsuccinate	TABLET	400 mg	ORAL	J01FA01
Erythromycin		BULK			V03			Bulk medicines		1376/12/10
Erythromycin+Azelaic Acid		GEL		TOPICAL	D10AF52	Erythromycin 2% + Azelaic Acid 5%				1389/11/4
Erythromycin+Azelaic Acid		LOTION		TOPICAL	D10AF52	Erythromycin 2% + Azelaic Acid 5%				1389/11/4
Erythromycin+Benzoyl peroxide		GEL		TOPICAL	D10AF52	Erythromycin 3% + Benzoyl Peroxide 5%
Escitalopram	As Oxalate	TABLET	10 mg	ORAL	N06AB10		Antidepressant, Anxiety disorder			1393/02/07
Escitalopram	As Oxalate	TABLET	5 mg	ORAL	N06AB10		Antidepressant, Anxiety disorder			1395/05/02
Escitalopram	As Oxalate	TABLET	20 mg	ORAL	N06AB10		Antidepressant, Anxiety disorder			1395/05/02
Esmolol	HCl	INJECTION	250 mg/ml	PARENTERAL	C07AB09			Hospital use only		1374/10/03
Esmolol	HCl	INJECTION, POWDER	2500 mg	PARENTERAL	C07AB09			Hospital use only		1395/11/06
Esmolol	HCl	INJECTION	10 mg/ml	PARENTERAL	C07AB09			Hospital use only	Preservative Free	1395/10/08
Esomeprazole		CAPSULE, DELAYED RELEASE	20 mg	ORAL	A02BC05			OTC medicines		1387/12/21
Esomeprazole	As Magnesium	CAPSULE, DELAYED RELEASE	20 mg	ORAL	A02BC05			OTC medicines		1397/03/01
Esomeprazole		TABLET, DELAYED RELEASE	20 mg	ORAL	A02BC05			OTC medicines		1387/12/18
Esomeprazole		CAPSULE, DELAYED RELEASE	40 mg	ORAL	A02BC05					1387/12/21
Esomeprazole	As Magnesium	CAPSULE, DELAYED RELEASE	40 mg	ORAL	A02BC05					1396/03/21
Esomeprazole		TABLET, DELAYED RELEASE	40 mg	ORAL	A02BC05					1387/12/18
Esomeprazole	As Magnesium	GRANULE FOR SUSPENSION, DELAYED RELEASE	2.5 mg	ORAL	A02BC05					1397/06/24
Esomeprazole	As Magnesium	GRANULE FOR SUSPENSION, DELAYED RELEASE	5 mg	ORAL	A02BC05					1395/10/08
Esomeprazole	As Magnesium	GRANULE FOR SUSPENSION, DELAYED RELEASE	10 mg	ORAL	A02BC05					1395/10/08
Estradiol		GEL	0.06%	VAGINAL	G03CA03
Estradiol		GEL	0.06%	TOPICAL	G03CA03
Estradiol	Valerate	TABLET	1 mg	ORAL	G03CA03
Estradiol	As Hemihydrate	TABLET	10 mcg	VAGINAL	G03CA03					1391/07/25
Estradiol	Valerate	INJECTION	10 mg/ml	PARENTERAL	G03CA03
Estradiol	Hemihydrate	PATCH, EXTENDED RELEASE	100 mcg/24h	TRANSDERMAL	G03CA03					1382/02/21
Estradiol		PATCH, EXTENDED RELEASE	100 mcg/24h	TRANSDERMAL	G03CA03					1382/02/21
Estradiol	Valerate	TABLET	2 mg	ORAL	G03CA03
Estradiol		PATCH, EXTENDED RELEASE	25 mcg/24h	TRANSDERMAL	G03CA03					1382/02/21
Estradiol	Hemihydrate	PATCH, EXTENDED RELEASE	25 mcg/24h	TRANSDERMAL	G03CA03					1382/02/21
Estradiol		PATCH, EXTENDED RELEASE	50 mcg/24h	TRANSDERMAL	G03CA03					1382/02/21
Estradiol	Hemihydrate	PATCH, EXTENDED RELEASE	50 mcg/24h	TRANSDERMAL	G03CA03					1382/02/21
Estradiol		GEL	500 mcg	TOPICAL	G03CA03		Estrogen replacement therapywith Turner syndrome			1382/10/28
Estramustine	Sodium Phosphate	CAPSULE	140 mg	ORAL	L01XX11
Etanercept		INJECTION	25 mg	PARENTERAL	L04AB01		Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs.			1386/12/06
Etanercept		INJECTION, POWDER	25 mg	PARENTERAL	L04AB01		Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs.
Etanercept		INJECTION	50 mg/ml	PARENTERAL	L04AB01		Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs.			1389/08/24
Ethacridine Lactate		BULK			V03			Bulk medicines	Rivanol	1376/12/10
Ethacrynic Acid		TABLET	50 mg	ORAL	C03CC01
Ethambutol	HCl	TABLET	400 mg	ORAL	J04AK02
Ethambutol+Isoniazid+Pirazinamide+Rifampin		TABLET		ORAL	J04AM06	Ethambutol 275mg+Isoniazid 75mg+Pirazinamide 400mg +Rifampin 150mg		For Health Dept. of MOH only
Ethambutol+Isoniazid+Rifampin		TABLET		ORAL	J04AM06	Ethambutol 275mg+Isoniazid 75mg+Rifampin 150mg		For Health Dept. of MOH only
Ethanol		BULK			V03			Denaturated for Medical Use; Bulk medicines		1375/08/28
Ethanol		BULK			V03			Denaturated for Medical Use; Bulk medicines
Ether		INHALANT		RESPIRATORY	N01AA			Hospital use only
Etherified Starch		INJECTION, SOLUTION		PARENTERAL	B05AA07
Ethinylestradiol		TABLET	0.05 mg	ORAL	G03CA01		Treatment of Turner's syndrome
Ethinylestradiol		TABLET	0.5 mg	ORAL	L02AA03		Treatment of Turner's syndrome
Ethiodized Oil		INJECTION	10ml	PARENTERAL	V08AD01					1369/07/15
Ethionamide		TABLET	250 mg	ORAL	J04AD03					1380/04/17
Ethosuximide		CAPSULE, LIQUID FILLED	250 mg	ORAL	N03AD01					1386/11/08
Ethosuximide		CAPSULE	250 mg	ORAL	N03AD01
Ethosuximide		SYRUP	250 mg/5ml	ORAL	N03AD01
Etidronate	Disodium	TABLET	200 mg	ORAL	M05BA01		Treatment of hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration.			1373/04/12
Etomidate		INJECTION	2 mg/ml	PARENTERAL	N01AX07			Hospital use only		1370/12/18
Etoposide		CAPSULE	100 mg	ORAL	L01CB01					1365/09/16
Etoposide		INJECTION, SOLUTION	20 mg/ml	INTRAVENOUS DRIP	L01CB01					1365/09/16
Etoposide		CAPSULE	50 mg	ORAL	L01CB01					1366/07/26
Everolimus		TABLET	0.25 mg	ORAL	L04AA18		Kidney, Liver, Heart transpalantation			1390/07/05
Everolimus		TABLET	0.5 mg	ORAL	L04AA18		Kidney, Liver, Heart transpalantation			1390/07/05
Everolimus		TABLET	0.75 mg	ORAL	L04AA18		Kidney, Liver, Heart transpalantation			1390/07/05
Everolimus		TABLET	5 mg	ORAL	L01XE10		Antineoplastic drugs			1390/07/05
Everolimus		TABLET	10 mg	ORAL	L01XE10		Antineoplastic drugs			1395/05/02
Exemestane		TABLET	25 mg	ORAL	L02BG06		Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.			1382/04/01
Exenatide		INJECTION, POWDER, EXTENDED RELEASE	2 mg	PARENTERAL	A10BX04		Type 2 Diabetes Mellitus			1394/11/13
Exenatide		INJECTION,	250 mcg/ml	PARENTERAL	A10BX04		Type 2 Diabetes Mellitus			1396/04/18
Expectorant		SYRUP		ORAL	R05CA10	(Guaifenesin 100mg + Chlorpheniramine maleate 2mg + Pseudoephedrine HCl 30 mg ) / 5ml		OTC medicines		1369/10/30
Expectorant+Codeine		SYRUP		ORAL	R05CA10	(Guaifenesin 100mg + Pseudoephedrine HCl 30 mg + Codeine phosphate 10mg)/5ml				1383/09/02
Ezetimibe		TABLET	10 mg	ORAL	C10AX09					1384/04/12
Factor IX		INJECTION, POWDER, LYOPHILIZED	500 IU	PARENTERAL	B02BD09					1388/10/30
Factor IX		INJECTION, POWDER, LYOPHILIZED	600 IU	PARENTERAL	B02BD09					1394/09/03
Factor IX		INJECTION, POWDER, LYOPHILIZED	1000 IU	PARENTERAL	B02BD09					1394/07/18
Factor IX		INJECTION, POWDER, LYOPHILIZED	1200 IU	PARENTERAL	B02BD09					1397/06/24
Factor VII		INJECTION, POWDER, For SOLUTION	600 U	PARENTERAL	B02BD05			Orphan medicines	Human Coagulation factor VII (IV Injection)	1389/11/18
Factor VIIa		INJECTION	1 mg	PARENTERAL	B02BD05			Orphan medicines	Room Temperature
Factor VIIa		INJECTION, POWDER, LYOPHILIZED	1.2 mg	PARENTERAL	B02BD05			Orphan medicines
Factor VIIa		INJECTION	2 mg	PARENTERAL	B02BD05			Orphan medicines	Room Temperature
Factor VIIa		INJECTION, POWDER, LYOPHILIZED	2.4 mg	PARENTERAL	B02BD05			Orphan medicines
Factor VIIa		INJECTION, POWDER, LYOPHILIZED	4.8 mg	PARENTERAL	B02BD05			Orphan medicines
Factor VIIa		INJECTION, POWDER, LYOPHILIZED	5 mg	PARENTERAL	B02BD05			Orphan medicines		1395/12/18
Factor VIIa		INJECTION, POWDER, LYOPHILIZED	8 mg	PARENTERAL	B02BD05			Orphan medicines		1395/12/18
Factor VIII		INJECTION, POWDER, LYOPHILIZED	250 IU	PARENTERAL	B02BD02
Factor VIII		INJECTION, POWDER, LYOPHILIZED	500 U	PARENTERAL	B02BD02
Factor VIII		INJECTION, POWDER, LYOPHILIZED	1000 U	PARENTERAL	B02BD02					1395/07/28
Factor VIII		INJECTION, POWDER, LYOPHILIZED	2000 U	PARENTERAL	B02BD02					1395/09/13
Factor VIII+Von Willbrand		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	B02BD06	Factor VIII 1000 U +Von Willbrand factor 1000 U	Treatment of patients with von Willebrand's disease			1391/10/03
Factor VIII+Von Willbrand		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	B02BD06	Factor VIII 500 U +Von Willbrand factor 500 U	Treatment of patients with von Willebrand's disease			1391/10/03
Factor VIII+Von Willbrand		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	B02BD06	Factor VIII 250 U +Von Willbrand factor 600 U	Treatment of patients with von Willebrand's disease			1394/11/13
Factor VIII+Von Willbrand		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	B02BD06	Factor VIII 500 U +Von Willbrand factor 1200 U	Treatment of patients with von Willebrand's disease			1394/11/13
Factor VIII+Von Willbrand		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	B02BD06	Factor VIII 1000U +Von Willbrand factor 750 U	Treatment of patients with von Willebrand's disease			1395/10/07
Factor XIII		INJECTION, POWDER		PARENTERAL	B02BD07		Human Fibrin-stabilising Factor	Orphan medicines		1388/03/03
Famotidine		TABLET	20 mg	ORAL	A02BA03			OTC medicines
Famotidine		INJECTION , SOLUTION	20 mg/50ml	INTRAVENOUS DRIP	A02BA03			OTC medicines		1391/05/02
Famotidine		TABLET	40 mg	ORAL	A02BA03
Famotidine+Calcium Carbonate+Magnesium Hydroxide		TABLET, CHEWABLE		ORAL	A02BA53	Famotidine 10mg+Calcium Carbonate 800 mg+Magnesium Hydroxide 165 mg		OTC medicines		1389/10/25
Fampridine		TABLET, EXTENDED RELEASE	10 mg	ORAL	N07XX07					1391/12/23
Febuxostat		TABLET	40 mg	ORAL	M04AA03		Hyperuricaemia in gout			1393/05/12
Febuxostat		TABLET	80 mg	ORAL	M04AA03		Hyperuricaemia in gout			1393/05/12
Febuxostat		TABLET	120 mg	ORAL	M04AA03		Hyperuricaemia in gout			1395/03/19
Fenofibrate		CAPSULE	100 mg	ORAL	C10AB05					1382/10/07
Fenofibrate		CAPSULE	200 mg	ORAL	C10AB05					1382/10/07
Fenofibrate		CAPSULE	145 mg	ORAL	C10AB05					1395/08/15
Fenofibrate		TABLET	145 mg	ORAL	C10AB05					1395/09/01
Fentanyl		PATCH	100 mcg/h	TOPICAL	N02AB03					1385/02/12
Fentanyl		PATCH	25 mcg/h	TRANSDERMAL	N02AB03
Fentanyl		PATCH	50 mcg/h	TRANSDERMAL	N02AB03
Fentanyl	As Citrate	INJECTION	50 mcg/ml	PARENTERAL	N01AH01			Hospital use only		1362/08/15
Fentanyl		PATCH	75 mcg/h	TOPICAL	N02AB03					1385/02/12
Ferric Carboxy Maltose		INJECTION	50 mg ferric/ml	PARENTERAL	B03AC					1391/02/25
Ferric Oxide Saccharated		INJECTION	20 mg/ml	PARENTERAL	B03AC					1380/09/04
Ferrous	sulfate	SYRUP	200mg/5ml	ORAL	B03AA01				40 mg Fe 2+(Elemental)/5ml	1363/05/21
Ferrous-glycine-sulfate		CAPSULE, DELAYED RELEASE	567.66 mg	ORAL	B03AA01				100 mg Fe 2+(base)	1384/11/18
Ferrous-glycine-sulfate+Folic Acid		CAPSULE		ORAL	B03AA02	Ferrous-glycine-sulfate 454.13 mg + Folic Acid 1 mg; ( 80 mg Fe 2+ elemental )				1384/11/18
Fexofenadine	HCl	TABLET	120 mg	ORAL	R06AX26			OTC medicines	for local production only	1390/03/23
Fexofenadine	HCl	TABLET	180 mg	ORAL	R06AX26			OTC medicines	for local production only	1390/03/23
Fexofenadine	HCl	TABLET	30 mg	ORAL	R06AX26			OTC medicines		1392/10/23
Fexofenadine	HCl	SUSPENSION	30 mg/5 ml	ORAL	R06AX26				for local production only	1390/09/21
Fexofenadine	HCl	TABLET	60 mg	ORAL	R06AX26			OTC medicines	for local production only	1390/03/23
Fibrinogen		INJECTION, POWDER	1 g	PARENTERAL	B02BB01		For the control of bleeding and prophylactic treatment of patients deficient in fibrinogen.	Hospital use only; Orphan medicines		1360/02/02
Fibrinolysin+ Desoxyribonuclease		OINTMENT		TOPICAL	B06AA02	(Fibrinolysin 1U+Desoxyribonuclease 666U)/g Human				1390/03/23
Filgrastim		INJECTION	300 mcg/ml	PARENTERAL	L03AA02		Reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia. Treatment of patients with AIDS who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir.			1374/02/09
Filgrastim		INJECTION	600 mcg/ml	PARENTERAL	L03AA02		Reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia. Treatment of patients with AIDS who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir.
Finasteride		GEL	1%	TOPICAL	D11AX10					1392/03/11
Finasteride		TABLET	1 mg	ORAL	G04CB01
Finasteride		TABLET	5 mg	ORAL	G04CB01					1374/07/09
Fingolimod	As HCl	CAPSULE	0.5 mg	ORAL	L04AA27				for local production only	1390/03/07
Flecainide	Acetate	TABLET	100 mg	ORAL	C01BC04					1378/01/22
Flecainide	Acetate	CAPSULE, EXTENDED RELEASE	100 mg	ORAL	C01BC04					1396/05/28
Flecainide	Acetate	CAPSULE, EXTENDED RELEASE	200 mg	ORAL	C01BC04					1396/05/28
Fluconazole		CAPSULE	100 mg	ORAL	J02AC01
Fluconazole		TABLET	100mg	ORAL	J02AC01					1371/10/27
Fluconazole		CAPSULE	150 mg	ORAL	J02AC01
Fluconazole		TABLET	150 mg	ORAL	J02AC01
Fluconazole		INJECTION	2 mg/ml	PARENTERAL	J02AC01			Hospital use only.		1390/03/09
Fluconazole		CAPSULE	200 mg	ORAL	J02AC01
Fluconazole		TABLET	200 mg	ORAL	J02AC01
Fluconazole		SUSPENSION	200 mg/5ml	ORAL	J02AC01					1386/09/07
Fluconazole		TABLET	50 mg	ORAL	J02AC01					1371/10/27
Fluconazole		CAPSULE	50 mg	ORAL	J02AC01
Flucytosine		TABLET	500 mg	ORAL	J02AX01					1368/04/18
Fludarabine	Phosphate	TABLET	10 mg	ORAL	L01BB05					1391/11/02
Fludarabine	Phosphate	INJECTION, SOLUTION	25mg/ml	PARENTERAL	L01BB05		(Chronic lymphocytic leukemia (CLL) , including refractory CLLa, treat and manage non- Hodykin lyxphome)
Fludarabine	Phosphate	INJECTION, POWDER	50 mg	INTRAVENOUS DRIP	L01BB05		Treatment of chronic lymphocytic leukemia (CLL), including refractory CLL. Treatment and management of patients with non-Hodgkins lymphoma.
Fluorodeoxyglucose [18F-FDG]		INJECTION, SOLUTION	10 mCi	PARENTERAL	V09IX04				Radiopharmaceuticals	1389/10/25
Fludrocortisone	Acetate	TABLET	0.1 mg	ORAL	H02AA02
Flumazenil		INJECTION	0.1 mg/ml	PARENTERAL	V03AB25			Hospital use only
Fluocinolone	Acetonide	CREAM	0.03%	TOPICAL	D07AC04
Fluocinolone	Acetonide	OINTMENT	0.03%	TOPICAL	D07AC04
Fluocinolone+ Hydroquinone+ Tretinoin		CREAM		TOPICAL	D10AD51	Fluocinolone Acetonide 0.01%+ Hydroquinone 4%+ Tretinoin 0.05%	Hyperpigmented skin			1395/03/09
Fluorescein	As Sodium	INJECTION	10%	PARENTERAL	S01JA01			Hospital use only
Fluorescein	Sodium	STRIP	1 mg/strip	OPHTHALMIC	S01JA01					1361/12/23
Fluoride	Sodium	MOUTHWASH	0.20%	DENTAL	A01AA01			OTC medicines		1373/03/22
Fluoride		GEL	1.23%	DENTAL	A01AA01			OTC medicines		1376/11/05
Fluoride	As Sodium	TABLET	0.25 mg	ORAL	A12CD01			OTC medicines		1369/07/15
Fluoride	As Acidulated Phosphate	TABLET	1 mg	ORAL	A12CD01			OTC medicines		1369/07/15
Fluoride	Sodium	SOLUTION/ DROPS	1.1 mg/ml	ORAL	A12CD01					1379/08/29
Fluoride	Sodium	TABLET	20 mg	ORAL	A12CD01					1373/04/12
Fluoride	Sodium	SOLUTION/ DROPS	550 mcg/0.15ml	ORAL	A12CD01
Fluorometholone		SUSPENSION/ DROPS	0.10%	OPHTHALMIC	S01BA07
Fluorouracil		CREAM	5%	TOPICAL	L01BC02
Fluorouracil		OINTMENT	5%	TOPICAL	L01BC02					1386/01/22
Fluorouracil		INJECTION	50 mg/ml	PARENTERAL	L01BC02		For use in combination with interferon alpha-2a, recombinant, for the treatment of esophageal carcinoma. For use in combination with interferon alpha-2a, recombinant, for the treatment of advanced colorectal carcinoma.
Fluoxetine	As HCl	CAPSULE	10 mg	ORAL	N06AB03					1376/04/08
Fluoxetine	As HCl	CAPSULE	20 mg	ORAL	N06AB03					1371/06/08
Fluoxetine	As HCl	CAPSULE, DELAYED RELEASE	90 mg	ORAL	N06AB03					1396/04/31
Fluoxetine	As HCl	SYRUP	20 mg/5ml	ORAL	N06AB03		Treatment of body dysmorphic disorder in children
Flupenthixol	As DiHCl	TABLET	0.5 mg	ORAL	N05AF01
Flupenthixol	Decanoate	INJECTION	20 mg/ml	PARENTERAL	N05AF01					1362/05/02
Flupenthixol	As DiHCl	TABLET	3 mg	ORAL	N05AF01
Fluphenazine	As DiHCl	TABLET	1 mg	ORAL	N05AB02
Fluphenazine	As DiHCl	TABLET	2.5 mg	ORAL	N05AB02					1362/02/04
Fluphenazine	Decanoate	INJECTION	25 mg/ml	PARENTERAL	N05AB02
Flurazepam	As HCl	CAPSULE	15 mg	ORAL	N05CD01					1375/07/01
Flutamide		TABLET	250 mg	ORAL	L02BB01					1375/09/25
Fluticasone	Propionate	INHALER	125 mcg/dose	RESPIRATORY	R03BA05					1378/05/10
Fluticasone	Propionate	INHALER	250 mcg/dose	RESPIRATORY	R03BA05					1380/05/31
Fluticasone	Furoate	INHALER	27.5 mcg/dose	INTRANASAL	R01AD08
Fluticasone	Propionate	INHALER	50 mcg/ dose	NASAL	R01AD08					1380/05/31
Fluticasone	Propionate	INHALER	50 mcg/dose	RESPIRATORY	R03BA05					1380/05/31
Fluvoxamine	Maleate	TABLET	100 mg	ORAL	N06AB08					1383/09/16
Fluvoxamine	Maleate	TABLET	50 mg	ORAL	N06AB08
Folic Acid		TABLET	1 mg	ORAL	B03BB01
Folic Acid		TABLET	5 mg	ORAL	B03BB01					1378/05/10
Folic Acid		INJECTION	5 mg/ml	PARENTERAL	B03BB01			Hospital use only		1372/01/29
Follitropin Alfa		INJECTION	600 IU/ml	PARENTERAL	G03GA05		For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism. AMENDED indication 6/27/00: For the induction of spermatogenesis in men with primary testicular failure			1385/10/20
Follitropin Alfa		INJECTION, POWDER	75 IU	PARENTERAL	G03GA05					1384/05/16
Follitropin Alfa+Lutropin Alfa		INJECTION, POWDER		PARENTERAL	G03GA30	Follitropin Alfa 150U+Lutropin Alfa 75 U			Recombinant	1392/08/20
Follitropin Beta		INJECTION, SOLUTION	50 IU/0.5 ml	PARENTERAL	G03GA06				Recombinant	1397/07/28
Follitropin Beta		INJECTION, SOLUTION	100 IU/0.5 ml	PARENTERAL	G03GA06				Recombinant	1397/07/28
Follitropin Beta		INJECTION, SOLUTION	200 IU/0.5 ml	PARENTERAL	G03GA06				Recombinant	1397/07/28
Follitropin Beta		INJECTION	75 IU	PARENTERAL	G03GA06				Recombinant
Follitropin Beta		INJECTION	833 IU/ml	PARENTERAL	G03GA06				Recombinant	1390/1/29
Fomepizole		INJECTION	1 g/ml	PARENTERAL	V03AB34		Treatment of methanol or ethylene glycol poisoning.	Hospital use only; Orphan medicines		1385/02/12
Formaldehyde		BULK			V03			Bulk medicines
Formoterol	Fumarate	INHALER	12 mcg	RESPIRATORY	R03AC13					1385/08/17
Formoterol	Fumarate	INHALER	12 mcg/capsule	RESPIRATORY	R03AC13					1384/02/11
Formoterol	Fumarate	INHALER	9 mcg	RESPIRATORY	R03AC13					1384/12/09
Formoterol	Fumarate	INHALER	4.5 mcg	RESPIRATORY	R03AC13					1384/12/09
Formoterol	Fumarate	POWDER, INHALATION	6 mcg/metered inhalation	RESPIRATORY	R03AC13					1396/01/29
Fosfestrol	As Tetra Sodium	TABLET	120 mg	ORAL	L02AA04
Fosfestrol	As Tetra Sodium	INJECTION	50 mg/ml	PARENTERAL	L02AA04
Fosfomycin	As Trometamol	GRANULE, FOR SUSPENSION	3 g	ORAL	J01XX01					1393/06/02
Furazolidone		TABLET	100 mg	ORAL	G01AX06					1359/11/08
Furazolidone		SUSPENSION	50 mg/15ml	ORAL	G01AX06
Furosemide		INJECTION, SOLUTION	10 mg/ml	INTRAVENOUS DRIP	C03CA01			volume of 25 ml is for Hospital use only		1366/10/20
Furosemide		TABLET	40 mg	ORAL	C03CA01
Furosemide		SOLUTION	40 mg/5ml	ORAL	C03CA01					1395/09/01
Fusidate Sodium		OINTMENT	2%	TOPICAL	D06AX01		Topical Antibiotics			1395/08/02
Fusidic Acid		CREAM	2%	TOPICAL	D06AX01		Topical Antibiotics			1395/08/02
Fusidic Acid+Hydrocortisone		CREAM		TOPICAL	D07CA01	Fusidic Acid 2%+Hydrocortisone 1%	Topical Antibiotics and Antiinflamatory			1396/04/31
Gabapentin		CAPSULE	100 mg	ORAL	N03AX12		Treatment of amyotrophic lateral sclerosis.			1382/05/05
Gabapentin		CAPSULE	300 mg	ORAL	N03AX12		Treatment of amyotrophic lateral sclerosis.			1382/05/05
Gabapentin		CAPSULE	400 mg	ORAL	N03AX12		Treatment of amyotrophic lateral sclerosis.			1382/05/05
Gabapentin		TABLET	600 mg	ORAL	N03AX12		Treatment of amyotrophic lateral sclerosis.			1387/05/06
Gabapentin		CAPSULE	800 mg	ORAL	N03AX12		Treatment of amyotrophic lateral sclerosis.
Gabapentin		TABLET	800 mg	ORAL	N03AX12		Treatment of amyotrophic lateral sclerosis.			1387/05/06
Gadobutrol		INJECTION	604.72 mg/ml (1mmol/ml)	PARENTERAL	V08CA09					1387/09/09
Gadodiamide		INJECTION	287 mg/ml	PARENTERAL	V08CA03					1379/12/21
Gadopentetate	Dimeglumine	INJECTION	469 mg/ml	PARENTERAL	V08CA01					137103/03
Galantamine	As HBr	TABLET	12 mg	ORAL	N06DA04					1383/07/12
Galantamine	As HBr	CAPSULE, EXTENDED RELEASE	16 mg	ORAL	N06DA04					1386/12/26
Galantamine	As HBr	SOLUTION	20 mg/5ml	ORAL	N06DA04					1383/07/12
Galantamine	As HBr	CAPSULE, EXTENDED RELEASE	24 mg	ORAL	N06DA04					1386/12/26
Galantamine	As HBr	TABLET	4 mg	ORAL	N06DA04					1383/07/12
Galantamine	As HBr	TABLET	8 mg	ORAL	N06DA04					1383/07/12
Galantamine	As HBr	CAPSULE, EXTENDED RELEASE	8 mg	ORAL	N06DA04					1386/12/26
Gallium [68 Ga]-DOTATATE, DOTATOC or DOTANOC		INJECTION, SOLUTION	5.5 mCi	PARENTERAL	V09X				Radiopharmaceuticals	1391/09/01
Gallium [67Ga] Citrate		INJECTION, SOLUTION	5-10 mCi	PARENTERAL	V09HX01				Radiopharmaceuticals	1383/09/22
Gallium [68Ga]-prostate specific membrane antigen, (68Ga-PSMA)		INJECTION, SOLUTION	10 mCi	PARENTERAL	V09IX09				Radiopharmaceuticals	1397/02/18
Galsulfase		INJECTION	1mg/ml	PARENTERAL	A16AB08			Orphan medicines		1391/02/07
Ganciclovir		GEL	0.15%	OPHTHALMIC	S01AD09					1390/09/21
Ganciclovir		INJECTION, POWDER, LYOPHILIZED	500 mg	PARENTERAL	J05AB06		Treatment of acute herpetic keratitis (dendritic and geographic ulcers)	Hospital use only		1378/08/23
Ganirelix	As Acetate	INJECTION	500 mcg/ml	PARENTERAL	H01CC01
Gaseous Gangrene Antitoxin		INJECTION		PARENTERAL	J06AA05			Hospital use only
Gefitinib		TABLET	250mg	ORAL	L01XE02					1391/12/23
Gelatin Modified		INJECTION	4%	PARENTERAL	B05AA06	(Gelatin Succinylated 40g (4%) + Na+ 154 mmol + Cl- 120 mmol )/lit		Hospital use only		1380/09/04
Gelatin Modified		INJECTION	4%	PARENTERAL	B05AA06	(Gelatin Succinylated 40g (4%) + Na+ 151 mmol + Cl- 103 mmol )/lit		Hospital use only		1396/11/29
Gelatin Modified		INJECTION, SOLUTION		INTRAVENOUS DRIP	B05AA06	(Gelatin Succinylate 30g + NaCl 4.51g + CaCl2,2H20 0.21g) / 1000 ml		Hospital use only		1377/06/22
Gemcitabine	As HCl	INJECTION, POWDER, LYOPHILIZED	1 g	PARENTERAL	L01BC05					1380/03/27
Gemcitabine	As HCl	INJECTION, SOLUTION, CONCENTRATE	38 mg/ml	PARENTERAL	L01BC05					1390/03/23
Gemcitabine	As HCl	INJECTION, POWDER, LYOPHILIZED	200 mg	PARENTERAL	L01BC05					1380/03/27
Gemcitabine	As HCl	INJECTION, SOLUTION, CONCENTRATE	100mg/ml	PARENTERAL	L01BC05					1390/03/23	1394/06/10
Gemfibrozil		CAPSULE	300 mg	ORAL	C10AB04					1369/10/16
Gemfibrozil		TABLET	450 mg	ORAL	C10AB04
Gemifloxacin	As Mesilate	TABLET	320 mg	ORAL	J01MA15				for local production only	1389/05/30
Gentamicin	As Sulfate	INJECTION	0.8 mg/ml	PARENTERAL	J01GB03			Hospital use only	for local production only ; in sodium chloride 0.9% (premixed)	1390/03/09
Gentamicin	As Sulfate	INJECTION	10 mg/ml	PARENTERAL	J01GB03					1390/12/22
Gentamicin	As Sulfate	OINTMENT	3 mg/g	OPHTHALMIC	S01AA11
Gentamicin	As Sulfate	SOLUTION/ DROPS	3 mg/ml	OPHTHALMIC	S03AA06
Gentamicin	As Sulfate	INJECTION	40 mg/ml	PARENTERAL	J01GB03					1390/12/22
Gentian Violet		SOLUTION	1%	TOPICAL	D01AE02	Crystal Violet 1 g + Ethanol 96% (8-10)ml + water qs to 100 ml
Gentian Violet		BULK			V03			Bulk medicines		1361/09/28
Germanium [68Ge]/Gallium [68Ga]		GENERATOR	(10-100) mCi	Not for direct patient administration, only for preparation of radiopharmaceuticals	V09X				Radiopharmaceuticals	1391/09/01
Gestonorone	Caproate	INJECTION	100 mg/ml	PARENTERAL	L02AB03					1368/04/18
Glatiramer	Acetate	INJECTION	20 mg/ml	PARENTERAL	L03AX13					1389/03/29
Glatiramer	Acetate	INJECTION	40 mg/ml	PARENTERAL	L03AX13					1393/02/07
Glibenclamide		TABLET	5 mg	ORAL	A10BB01		Type 2 Diabetes Mellitus
Gliclazide		TABLET, EXTENDED RELEASE	30 mg	ORAL	A10BB09		Type 2 Diabetes Mellitus			1383/07/12
Gliclazide		TABLET, EXTENDED RELEASE	60 mg	ORAL	A10BB09		Type 2 Diabetes Mellitus			1394/03/31
Gliclazide		TABLET	80 mg	ORAL	A10BB09		Type 2 Diabetes Mellitus			1372/07/11
Glimepiride		TABLET	1 mg	ORAL	A10BB12		Type 2 Diabetes Mellitus			1395/12/22
Glimepiride		TABLET	2 mg	ORAL	A10BB12		Type 2 Diabetes Mellitus			1395/12/22
Glimepiride		TABLET	3 mg	ORAL	A10BB12		Type 2 Diabetes Mellitus			1395/12/22
Glimepiride		TABLET	4 mg	ORAL	A10BB12		Type 2 Diabetes Mellitus			1395/12/22
Glucagon	As HCl	INJECTION, POWDER	1 mg	PARENTERAL	H04AA01			Hospital use only
Glycerin		SUPPOSITORY	1 g	RECTAL	A06AX01			OTC medicines	Equal to 700 mg Glycerin
Glycerin		SUPPOSITORY	1.2 mg	RECTAL	A06AX01			OTC medicines
Glycerin		SUPPOSITORY	2 g	RECTAL	A06AX01			OTC medicines	Equal to 1.4 g Glycerin
Glycerin		SUPPOSITORY	4 g	RECTAL	A06AX01			OTC medicines		1395/11/12
Glycerin		SUPPOSITORY	3.4 mg	RECTAL	A06AX01			OTC medicines
Glycerin		BULK			V03			Bulk medicines		1376/12/10
Glycine		SOLUTION	1.50%	IRRIGATION	B05CX03				Aminoacetic Acid
Glycine		POWDER	1 g	ORAL	B05CX03		for treatment of pateints with Isovaleric Acidemia			1387/11/06
Glycolic Acid		SOLUTION	70%	TOPICAL	D					1387/06/13
Glycolic Acid		BULK			V03			Bulk medicines
Glycopyrronium	Bromide	INJECTION	200 mcg/ml	PARENTERAL	A03AB02					1385/06/14
Gold Sodium Thiomalate		INJECTION	100 mg/ml	PARENTERAL	M01CB01
Gold Sodium Thiomalate		INJECTION	20 mg/ml	PARENTERAL	M01CB01					1368/02/10
Gold Sodium Thiomalate		INJECTION	40 mg/ml	PARENTERAL	M01CB01
Gold Sodium Thiomalate		INJECTION	50 mg/ml	PARENTERAL	M01CB01					1368/02/10
Gonadorelin		INJECTION, POWDER	100 mcg	PARENTERAL	V04CM01					1372/06/07
Gonadorelin	Acetate	INJECTION, POWDER	0.8 mg	PARENTERAL	H01CA01		For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion.			1371/03/03
Gonadorelin	Acetate	INJECTION, POWDER	3.2 mg	PARENTERAL	H01CA01		For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion.			1371/03/03
Goserelin	As Acetate	IMPLANT	10.8mg	PARENTERAL	L02AE03					1391/12/23
Goserelin	As Acetate	IMPLANT	3.6mg	PARENTERAL	L02AE03					1391/12/23
Granisetron	As HCl	TABLET	1 mg	ORAL	A04AA02					1372/07/11
Granisetron	As HCl	INJECTION, SOLUTION	1 mg/ml	INTRAVENOUS DRIP	A04AA02					1372/07/11
Granisetron		PATCH, EXTENDED RELEASE	3.1mg/24h (34.3 mg/52 cm2	TRANSDERMAL	A04AA02					1390/09/21
Guaifenesin		CAPSULE, LIQUID FILLED	100 mg	ORAL	R05CA03			OTC medicines	for local production only	1390/09/21
Guaifenesin		SYRUP	100 mg/5ml	ORAL	R05CA03			OTC medicines		1369/10/30
Guaifenesin		CAPSULE, LIQUID FILLED	200 mg	ORAL	R05CA03			OTC medicines	for local production only	1390/09/21
Haemophilus Influenza Type B		INJECTION, POWDER		PARENTERAL	J07AG01				vaccine	1387/05/01
Haemophilus Influenza Type B		INJECTION, SOLUTION		PARENTERAL	J07AG01				vaccine	1388/09/17
Haloperidol		TABLET	0.5 mg	ORAL	N05AD01
Haloperidol		TABLET	2 mg	ORAL	N05AD01					1378/01/22
Haloperidol	As Lacate	SOLUTION	2 mg/ml	ORAL	N05AD01
Haloperidol		TABLET	5 mg	ORAL	N05AD01					1360/10/27
Haloperidol	As Lacate	INJECTION	5 mg/ml	PARENTERAL	N05AD01
Haloperidol	As Decanoate	INJECTION	50 mg/ml	PARENTERAL	N05AD01					1368/04/18
Halothane		INHALANT	250 ml/bottle	RESPIRATORY	N01AB01			Hospital use only
Hematinic		CAPSULE, LIQUID FILLED		ORAL	B03AE02	VIT. B12 15mcg+Ferrous Fumarate 350 mg+VIT.C 150mg+Folic Acid 1mg		OTC medicines		1385/09/15
Hematinic		CAPSULE		ORAL	B03AE02	VIT. B12 15mcg+Ferrous Fumarate 350 mg+VIT.C 150mg+Folic Acid 1mg		OTC medicines
Hemodialysis Concentrated I		SOLUTION, CONCENTRATE		UNASSIGNED	B05ZA	(Na+4725mEq + Mg2+35mEq + K+ 35mEq + Ca2+ 87.5mEq + Cl- 3657.5mEq + Acetate 1225 mEq + Dextrose 70 g)/ L; Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml				1360/02/02
Hemodialysis Concentrated I ,Acidic		SOLUTION, CONCENTRATE		UNASSIGNED	B05ZA	(Na+3710mEq + Mg++35mEq + K+ 35mEq + Ca++ 87.5mEq + Cl- 3902.5 mEq + CH3Coo- 122.5 mEq + Dextrose 70 g)/ L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml				1393/10/14
Hemodialysis Concentrated I,without Dextrose		SOLUTION, CONCENTRATE		UNASSIGNED	B05ZA	(Na+ 4725 mEq + Mg2+35 mEq + K+ 35mEq + Ca2+ 87.5 mEq + Cl- 3657.5 mEq + Acetate 1225mEq )/ L				1362/11/09
Hemodialysis Concentrated II		SOLUTION, CONCENTRATE		UNASSIGNED	B05ZA	(Na+ 4725 mEq+MG2+ 35mEq + K+ 70mEq+Ca2+ 87.5mEq+ Cl- 3692.5 mEq + Acetate 1225mEq + Dextrose 70 g) / L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml				1360/02/02
Hemodialysis Concentrated II ,Acidic		SOLUTION, CONCENTRATE		UNASSIGNED	B05ZA	(Na+3710mEq + Mg2+35mEq + K+ 70mEq + Ca2+ 87.5mEq + Cl- 3902.5 mEq + CH3Coo- 122.5 mEq + Dextrose 70 g)/ L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml				1381/09/24
Hemodialysis Concentrated III		SOLUTION, CONCENTRATE		UNASSIGNED	B05ZA	(Na+4725mEq + Mg2+35mEq + K+ 105mEq + Ca2+ 87.5mEq + Cl- 3745 mEq + Acetate 1225 mEq + Dextrose 70 g)/ L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml
Hemodialysis Concentrated III ,Acidic		SOLUTION, CONCENTRATE		UNASSIGNED	B05ZA	(Na+3710mEq + Mg++35mEq + K+ 105mEq + Ca++ 87.5mEq + Cl- 3902.5 mEq + CH3Coo- 122.5 mEq + Dextrose 70 g)/ L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml				1393/10/14
Hemofiltration+Haemodiafiltration		SOLUTION		UNASSIGNED	B05ZB	(Na+125-150mEq + Mg2+0.5-3 mEq + K+0- 4.5 mEq + Ca2+ 2-5 mEq + Cl- 90-120 mEq + Acetate and or lactate and or Hydrogen Carbonate 30-60 mEq + Glucose 0-25 mmol)/ L				1392/06/12
Heparin	Sodium	INJECTION	10,000 U/ml	PARENTERAL	B01AB01			Hospital use only
Heparin	Sodium	INJECTION	5000 U/ml	PARENTERAL	B01AB01			Hospital use only
Heparin	Sodium	INJECTION	1000 U/ml	PARENTERAL	B01AB01			Hospital use only	without preservative	1396/08/07
Hepatitis B immune globulin		INJECTION	At least 200 IU/ml	PARENTERAL	J06BB04		Prophylaxis against hepatitis B virus reinfection in liver transplant patients.
Hepatitis B Immune Globulin(humam		INJECTION	50 IU/ml	PARENTERAL	J06BB04
Hepatitis B Virus		INJECTION		PARENTERAL	J07BC01				vaccine	1372/08/23
Hexamethylmelamine		CAPSULE	100 mg	ORAL	L01XX03
Homatropine	HBr	SOLUTION/ DROPS	2%	OPHTHALMIC	S01FA05
Human Papiloma Virus		INJECTION		PARENTERAL	J07BM01				2 Valents	1390/07/05
Human Papiloma Virus		INJECTION		PARENTERAL	J07BM01				4 Valents	1390/07/05
Human Papiloma Virus		INJECTION		PARENTERAL	J07BM01				9 Valents	1395/12/18
Hydralazine	HCl	TABLET	10 mg	ORAL	C02DB02
Hydralazine	HCl	INJECTION, POWDER	20 mg	PARENTERAL	C02DB02			Hospital use only
Hydralazine	HCl	INJECTION, SOLUTION, CONCENTRATE	20 mg	PARENTERAL	C02DB02			Hospital use only
Hydralazine	HCl	TABLET	25 mg	ORAL	C02DB02
Hydralazine	HCl	TABLET	50 mg	ORAL	C02DB02					1359/09/12
Hydrochloric Acid		BULK			V03			Bulk medicines
Hydrochlorothiazide		TABLET	50 mg	ORAL	C03AA03		Oedema, Hypertension
Hydrochlorothiazide		TABLET	25 mg	ORAL	C03AA03		Oedema, Hypertension			1394/07/05
Hydrochlorothiazide		TABLET	12.5 mg	ORAL	C03AA03		Oedema, Hypertension			1394/07/05
Hydrocortisone		CREAM	1%	TOPICAL	D07AA02
Hydrocortisone	Acetate	CREAM	1%	TOPICAL	D07AA02					1388/10/30
Hydrocortisone	Acetate	OINTMENT	1%	OPHTHALMIC	S01BA02
Hydrocortisone	Acetate	OINTMENT	1%	TOPICAL	D07AA02
Hydrocortisone		TABLET	10 mg	ORAL	H02AB09					1371/08/24
Hydrocortisone	As Sodium Phosphate	INJECTION, POWDER	100 mg	PARENTERAL	H02AB09
Hydrocortisone	As Sodium succinate	INJECTION, POWDER	100 mg	PARENTERAL	H02AB09					1368/12/13
Hydrocortisone		ENEMA	100 mg/60ml	RECTAL	A07EA02					1364/04/30
Hydrocortisone	As Sodium Phosphate	INJECTION	50 mg/ml	PARENTERAL	H02AB09
Hydrocortisone	As Sodium succinate	INJECTION	50 mg/ml	PARENTERAL	H02AB09					1380/07/18
Hydrocortisone+Acetic Acid		SOLUTION/ DROPS		OTIC	S02CA03	Hydrocortisone 1% + Acetic Acid 2%				1386/12/06
Hydrogen Peroxide Concentrate		BULK	30% w/w		V03			Bulk medicines
Hydromorphone		TABLET	2 mg	ORAL	N02AA03					1387/10/15
Hydromorphone		TABLET	4 mg	ORAL	N02AA03					1387/10/15
Hydrophilic Petrolatum		BULK			V03	White Petrolatum86%+White Wax8%+Strearyl Alcohol3%+Cholestrol3%		Bulk medicines
Hydroquinone		CREAM	2%	TOPICAL	D11AX11					1369/10/30
Hydroquinone		CREAM	4%	TOPICAL	D11AX11					1378/02/19
Hydroquinone		BULK			V03			Bulk medicines
Hydroxychloroquine	Sulfate	TABLET	200 mg	ORAL	P01BA02					1371/08/03
Hydroxyprogesteron	Caproate	INJECTION	250 mg/ml	PARENTERAL	G03DA03					1382/03/04
Hydroxyurea		CAPSULE	250 mg	ORAL	L01XX05		Treatment of pediatric patients with sickle cell anemia. Treatment of patients with sickle cell anemia as shown by the presence of hemoglobin S.			1385/03/23
Hydroxyurea		CAPSULE	500 mg	ORAL	L01XX05		Treatment of pediatric patients with sickle cell anemia. Treatment of patients with sickle cell anemia as shown by the presence of hemoglobin S.
Hydroxyzine	HCl	TABLET	10 mg	ORAL	N05BB01
Hydroxyzine	HCl	SYRUP	10 mg/5ml	ORAL	N05BB01
Hydroxyzine	HCl	TABLET	25 mg/ml	ORAL	N05BB01
Hyoscine-n-butyl	Bromide	SUPPOSITORY	10 mg	RECTAL	A03BB01
Hyoscine-n-butyl	Bromide	TABLET	10 mg	ORAL	A03BB01
Hyoscine-n-butyl	Bromide	INJECTION	20 mg/ml	PARENTERAL	A03BB01
Hyoscine-n-butyl	Bromide	SUPPOSITORY	7.5 mg	RECTAL	A03BB01
Ibuprofen		GEL	5%	TOPICAL	M02AA13			OTC medicines		1389/06/15
Ibuprofen	As Lysine	INJECTION	10 mg/ml	PARENTERAL	C01EB16			Hospital use only		1390/09/21
Ibuprofen		SUSPENSION	100 mg/5ml	ORAL	M01AE01					1373/05/30
Ibuprofen		SUSPENSION	40 mgml	ORAL	M01AE01					1396/04/18
Ibuprofen		INJECTION	100mg/ml	PARENTERAL	M01AE01			Hospital use only		1390/06/14
Ibuprofen		CAPSULE, LIQUID FILLED	200 mg	ORAL	M01AE01			OTC medicines		1383/04/29
Ibuprofen		TABLET	200 mg	ORAL	M01AE01			OTC medicines		1369/10/30
Ibuprofen		TABLET, EXTENDED RELEASE	800 mg	ORAL	M01AE01					1397/02/11
Ibuprofen		TABLET, ORALLY DISINTEGRATING	200 mg	ORAL	M01AE01			OTC medicines		1396/11/29
Ibuprofen		CAPSULE, LIQUID FILLED	400 mg	ORAL	M01AE01					1383/04/29
Ibuprofen		TABLET	400 mg	ORAL	M01AE01
Ibuprofen		GRANULE, EFFERVESCENT	600 mg	ORAL	M01AE01					1397/07/14
Ibuprofen	As Lysine	TABLET	200 mg	ORAL	M01AE01					1392/07/22
Ibuprofen	As Lysine	TABLET	400 mg	ORAL	M01AE01					1392/07/22
Ibuprofen	As Lysine	INJECTION , SOLUTION	400 mg/3ml	PARENTERAL	M01AE01			Hospital use only		1392/05/29
Ibuprofen		INJECTION	5mg/ml	INTRAVENOUS	C01EB16		For diagnosis of PDA (Patent ductus arterious)	Hospital use only		1386/11/03
Ichthammol		OINTMENT	10%	TOPICAL	D10BX				Ichthyol	1369/10/30
Ichthammol		OINTMENT	20%	TOPICAL	D10BX				Ichthyol	1397/03/01
Ichthammol		BULK			V03			Bulk medicines	Ichthyol
Idarubicin	HCl	INJECTION, POWDER, LYOPHILIZED	10 mg	PARENTERAL	L01DB06		Treatment of acute lymphoblastic leukemia in pediatric patients. Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.	Orphan medicines		1371/04/14
Idarubicin	HCl	INJECTION, POWDER, LYOPHILIZED	5 mg	PARENTERAL	L01DB06		Treatment of acute lymphoblastic leukemia in pediatric patients. Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.	Orphan medicines		1371/04/14
Idarubicin	HCl	INJECTION, SOLUTION	1mg/ml	PARENTERAL	L01DB06		Treatment of acute lymphoblastic leukemia in pediatric patients. Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.	Orphan medicines		1395/09/01
Idarucizumab		INJECTION, SOLUTION	2.5 g/50 ml	PARENTERAL	V03AB37				Antidote for Dabigatran	1397/05/10
Idoxuridine		SOLUTION/ DROPS	0.10%	OPHTHALMIC	S01AD01
Ifosfamide		INJECTION, POWDER	1 g	PARENTERAL	L01AA06		Treatment of testicular cancer. Treatment of bone sarcomas Treatment of soft tissue sarcomas			1365/01/24
Ifosfamide		INJECTION, POWDER	2 g	PARENTERAL	L01AA06		Treatment of testicular cancer. Treatment of bone sarcomas Treatment of soft tissue sarcomas			1365/01/24
Ifosfamide		INJECTION, SOLUTION	40mg/ml	PARENTERAL	L01AA06		Treatment of testicular cancer. Treatment of bone sarcomas Treatment of soft tissue sarcomas		In 25 ml final dose reach to 1 gr	1391/10/03
Ifosfamide		INJECTION, SOLUTION	50mg/ml	PARENTERAL	L01AA06		Treatment of testicular cancer. Treatment of bone sarcomas Treatment of soft tissue sarcomas		In 20 ml final dose reach to 1 gr
Igm-enriched Human (Immune globulin)		INJECTION		PARENTERAL	J06BA02			Hospital use only
Imatinib		TABLET	100 mg	ORAL	L01XE01		Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia Treatment of Philadelphia-positive ALL Treatment of dermatofibrosarcoma protuberans Treatment of gastrointestinal stromal tumors			1384/02/12
Imatinib	As Mesylate	CAPSULE	100 mg	ORAL	L01XE01		Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia Treatment of Philadelphia-positive ALL Treatment of dermatofibrosarcoma protuberans Treatment of gastrointestinal stromal tumors			1380/08/27
Imatinib	As Mesylate	CAPSULE	400 mg	ORAL	L01XE01		Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia Treatment of Philadelphia-positive ALL Treatment of dermatofibrosarcoma protuberans Treatment of gastrointestinal stromal tumors			1395/07/17
Imatinib	As Mesylate	TABLET	400 mg	ORAL	L01XE01		Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia; treatment of Philadelphia-positive ALL Treatment of dermatofibrosarcoma protuberans Treatment of gastrointestinal stromal tumors			1392/09/25
Imatinib		CAPSULE	50 mg	ORAL	L01XE01		Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemia Treatment of Philadelphia-positive ALL Treatment of dermatofibrosarcoma protuberans Treatment of gastrointestinal stromal tumors			1380/08/27
Imiglucerase		INJECTION, POWDER	200 U	PARENTERAL	A16AB02		Replacement therapy in patients with types I, II, and III Gaucher's disease.	Orphan medicines		1382/03/04
Imiglucerase		INJECTION, POWDER	400 U	PARENTERAL	A16AB02		Replacement therapy in patients with types I, II, and III Gaucher's disease.	Orphan medicines		1385/03/23
Imipenem+Cilastatin		INJECTION, POWDER		PARENTERAL	J01DH51	Imipenem(as Monohydrate) 250 mg + Cilastatin(as Sodium) 250 mg		Hospital use only		1383/07/12
Imipenem+Cilastatin		INJECTION, POWDER		PARENTERAL	J01DH51	Imipenem(as Monohydrate) 500 mg + Cilastatin(as Sodium) 500 mg		Hospital use only		1383/07/12
Imipenem+Cilastatin		INJECTION, POWDER		PARENTERAL	J01DH51	Imipenem(as Monohydrate) 750 mg + Cilastatin(as Sodium) 750 mg		Hospital use only		1383/07/12
Imipramine	HCl	TABLET	10 mg	ORAL	N06AA02
Imipramine	HCl	INJECTION	12.5 mg/ml	PARENTERAL	N06AA02			Hospital use only
Imipramine	HCl	TABLET	25 mg	ORAL	N06AA02
Imipramine	HCl	TABLET	50 mg	ORAL	N06AA02					1372/04/27
Imiquimod		CREAM	5%	TOPICAL	D06BB10					1385/02/12
Immune Globulin		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	J06BA02	Treatment of multifocal motor neuropathy, Guillain Barre Syndrome, polymyositis/dermatomyositis		Hospital use only		1361/08/20
Immune Globulin		INJECTION	100 mg/ml	PARENTERAL	J06BA02	Treatment of multifocal motor neuropathy, Guillain Barre Syndrome, polymyositis/dermatomyositis		Hospital use only
Immune Globulin		INJECTION	200 mg/ml	PARENTERAL	J06BA01	Treatment of multifocal motor neuropathy, Guillain Barre Syndrome, polymyositis/dermatomyositis		Hospital use only	Subcutaneous	1395/03/19
Immune Globulin		INJECTION	120 mg/ml	INTRAVENOUS	J06BA02	Treatment of multifocal motor neuropathy, Guillain Barre Syndrome, polymyositis/dermatomyositis		Hospital use only
Immune Globulin		INJECTION	50 mg/ml	INTRAVENOUS	J06BA02	Treatment of multifocal motor neuropathy, Guillain Barre Syndrome, polymyositis/dermatomyositis		Hospital use only
Indapamide		TABLET, EXTENDED RELEASE	1.5 mg	ORAL	C03BA11					1383/08/10
Indapamide		TABLET	2.5 mg	ORAL	C03BA11					1395/12/22
Indium [111In] Ibritumomab Tiuxetan		INJECTION, SOLUTION	5 mCi	PARENTERAL	V09				Radiopharmaceuticals	1389/10/25
Indium [111In]-Oxyquinoline, (111In-Oxine)		INJECTION, SOLUTION	1 mCi/ml	Not for direct patient administration, only for preparation of radiolabeled cells	V09				Radiopharmaceuticals	1389/10/25
Indium [111In]-Pentetate, (111In-DTPA)		INJECTION, SOLUTION	1 mCi/ml	PARENTERAL	V09AX01				Radiopharmaceuticals	1389/10/25
Indocyanine Green		INJECTION, POWDER	25 mg	PARENTERAL	V04CX			Orphan medicines		1385/06/14
Indometacin		SUPPOSITORY	100 mg	RECTAL	M01AB01
Indometacin		CAPSULE	25 mg	ORAL	M01AB01
Indometacin		INJECTION, SOLUTION	25 mg/ml	PARENTERAL	M01AB01		For diagnosis of PDA (Patent ductus arterious)	Hospital use only		1390/03/07
Indometacin		SUPPOSITORY	50 mg	RECTAL	M01AB01					1368/03/07
Indometacin		CAPSULE, EXTENDED RELEASE	75 mg	ORAL	M01AB01
Indometacin		TABLET, EXTENDED RELEASE	75 mg	ORAL	M01AB01
Indometacin		TABLET, EXTENDED RELEASE	80 mg	ORAL	M01AB01
Infliximab		INJECTION, POWDER	100 mg	PARENTERAL	L04AB02		Treatment of moderately to severely active Crohn's disease for the reduction of the signs and symptoms, in patients who have an inadequate response to conventional therapy; and treatment of patients with fistulizing Crohn's disease. Treatment of chronic sarcoidosis Treatment of giant cell arteritis	Orphan medicines		1384/08/08
Influenza Virus		INJECTION		PARENTERAL	J07BB01				vaccine
Insulin (Regular)		INJECTION	100 IU/ml	PARENTERAL	A10AB01					1385/08/17
Insulin Aspart		INJECTION, SUSPENSION	100 IU/ml	PARENTERAL	A10AB05	30% soluble Insulin Aspart + 70% Insulin Aspart crystallised with Protamine				1384/12/09
Insulin Aspart		INJECTION, SOLUTION	100 IU/ml	PARENTERAL	A10AB05					1384/12/09
Insulin Biphasic Isophane		INJECTION, SUSPENSION	100 IU/ml	PARENTERAL	A10AB30	( Isophane Insulin 75% + Insulin Regular 25%)				1385/12/02
Insulin Biphasic Isophane		INJECTION	100 IU/ml	PARENTERAL	A10AB30	Isophane Insulin 70% + Insulin Reg 30%
Insulin Detemir		INJECTION, SOLUTION	100 IU/ml	PARENTERAL	A10AE05					1392/12/11
Insulin Glargine		INJECTION	100 IU/ml	PARENTERAL	A10AE01		Diabetes Mellitus		Recombinant	1385/10/05
Insulin Glargine		INJECTION	300 IU/ml	PARENTERAL	A10AE04		Diabetes Mellitus		Recombinant	1394/11/13
Insulin Glulisin		INJECTION, SOLUTION	100 IU/ml	PARENTERAL	A10AB06					1392/12/11
Insulin Isophane		INJECTION	100 IU/ml	PARENTERAL	A10AE01				NPH	1385/08/17
Insulin Lispro		INJECTION, SOLUTION	100 IU/ml	PARENTERAL	A10AB04		Diabetes Mellitus		Human Recombinant	1396/12/08
Insulin Biphasic Lispro		INJECTION, SUSPENSION	100 IU/ml	PARENTERAL	A10AD04	Insulin Lispro 25% + Insulin Lispro Protamine 75%	Diabetes Mellitus		Human Recombinant	1396/12/08
Insulin Biphasic Lispro		INJECTION, SUSPENSION	100 IU/ml	PARENTERAL	A10AD04	Insulin Lispro 50% + Insulin Lispro Protamine 50%	Diabetes Mellitus		Human Recombinant	1396/12/08
Insulin Zinc		INJECTION	100 IU/ml	PARENTERAL	A10AE01
Interferon Alfa-2a		INJECTION	6 Million U/ml	PARENTERAL	L03AB04		For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer. Treatment of AIDS related Kaposi's sarcoma. For the treatment of metastatic malignant melanoma in combination with Teceleukin.
Interferon Alfa-2a		INJECTION	9 Million U/ml	PARENTERAL	L03AB04		For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer. Treatment of AIDS related Kaposi's sarcoma. For the treatment of metastatic malignant melanoma in combination with Teceleukin.
Interferon Alfa-2b		INJECTION, POWDER	10 Million U	PARENTERAL	L03AB05		Treatment of AIDS-related Kaposi's sarcoma. Treatment of acute hepatitis B. Treatment of primary malignant brain tumors. Treatment of carcinoma in situ of the urinary bladder. Treatment of chronic delta hepatitis.
Interferon Alfa-2b		INJECTION	10MillionU/ml	PARENTERAL	L03AB05		Treatment of AIDS-related Kaposi's sarcoma. Treatment of acute hepatitis B. Treatment of primary malignant brain tumors. Treatment of carcinoma in situ of the urinary bladder. Treatment of chronic delta hepatitis.
Interferon Alfa-2b		INJECTION	3 Million U	PARENTERAL	L03AB05		Treatment of AIDS-related Kaposi's sarcoma. Treatment of acute hepatitis B. Treatment of primary malignant brain tumors. Treatment of carcinoma in situ of the urinary bladder. Treatment of chronic delta hepatitis.			1391/02/25
Interferon Alfa-2b		INJECTION	5 Million U	PARENTERAL	L03AB05		Treatment of AIDS-related Kaposi's sarcoma. Treatment of acute hepatitis B. Treatment of primary malignant brain tumors. Treatment of carcinoma in situ of the urinary bladder. Treatment of chronic delta hepatitis.			1391/02/25
Interferon Beta-1a		INJECTION	12 Million U, 44 mcg	PARENTERAL	L03AB07		For the systemic treatment of cutaneous malignant melanoma. Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3. Treatment of acute non-A, non-B hepatitis.
Interferon Beta-1a		INJECTION	12 MillionU/ml, 30 mcg	PARENTERAL	L03AB07		For the systemic treatment of cutaneous M Melanoma Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells Treatment of acute non-A, non-B hepatitis.
Interferon Beta-1a		INJECTION, POWDER	6 Million U, 30 mcg	PARENTERAL	L03AB07		For the systemic treatment of cutaneous M Melanoma Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells Treatment of acute non-A, non-B hepatitis.
Interferon Beta-1b		INJECTION, POWDER	250 mcg	PARENTERAL	L03AB07		For the systemic treatment of cutaneous M Melanoma Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells Treatment of acute non-A, non-B hepatitis.
Interferon Beta-1b		INJECTION, POWDER	9.6 Million U, 300 mcg	PARENTERAL	L03AB08		For the systemic treatment of cutaneous M Melanoma Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells Treatment of acute non-A, non-B hepatitis.
Interferon Gamma-1b		INJECTION	100 mcg	PARENTERAL	L03AB03		renal cell carcinoma/chronic granuloma+ous diseasea/delaying time to dieseas progressin in patients with severe, malignant osteoperosisa, diopathic pulomonary fibrosis
Iobenguane [123I], (123I-MIBG)		INJECTION, SOLUTION	10 mCi	PARENTERAL	V09				Radiopharmaceuticals	1389/10/25
Iobenguane [131I], (131I-MIBG)		INJECTION, SOLUTION	(50-300) mCi	PARENTERAL	V10XA02				Radiopharmaceuticals	1389/10/25
Iobenguane [131I], (131I-MIBG)		INJECTION, SOLUTION	1 mCi	PARENTERAL	V09IX02				Radiopharmaceuticals	1389/10/25
Iodide [131I] Sodium		SOLUTION	(50-200) mCi	ORAL	V09FX03				Radiopharmaceuticals	1383/09/22
Iodide [131I] Sodium		CAPSULE	(5-100) micCi	ORAL	V09FX03				Radiopharmaceuticals	1383/09/22
Iodide [131I] Sodium		CAPSULE	(5-200) mCi	ORAL	V09FX03				Radiopharmaceuticals	1383/09/22
Iodixanol		INJECTION	150 mgI/ml	PARENTERAL	V08AB09					1379/12/21
Iodixanol		INJECTION	270 mgI/ml	PARENTERAL	V08AB09					1379/12/21
Iodixanol		INJECTION	320 mgI/ml	PARENTERAL	V08AB09					1379/12/21
Iodoquinol		TABLET	210 mg	ORAL	G01AC01				Diiodohydroxyquinoline	1367/12/14
Iohexol		INJECTION	240 mgI/ml	PARENTERAL	V08AB02				518 mg/ml	1367/09/20
Iohexol		INJECTION	300 mgI/ml	PARENTERAL	V08AB02				647 mg/ml	1371/04/14
Iohexol		INJECTION	350 mgI/ml	PARENTERAL	V08AB02				755 mg/ml	1371/07/19
Iopamidol		INJECTION	300 mgI/ml	PARENTERAL	V08AB04				612mg/ml	1383/11/04
Iopamidol		SOLUTION	300mgI/ml	ORAL	V08AB04					1382/04/01
Iopamidol		INJECTION	370 mgI/ml	PARENTERAL	V08AB04				755 mg/ml	1383/11/04
Iopanoic Acid		TABLET	500 mg	ORAL	V08AC06
Iopromide		INJECTION	240 mgI/ml	PARENTERAL	V08AB05					1372/08/23
Iopromide		INJECTION	300 mgI/ml	PARENTERAL	V08AB05					1386/11/08
Iopromide		INJECTION	300 mgI/ml	PARENTERAL	V08AB05					1372/08/23
Iopromide		INJECTION	370 mgI/ml	PARENTERAL	V08AB05					1372/08/23
Iotroxate	Meglumine	INJECTION	50 mgI/ml	PARENTERAL	V08AC02
Ipecac		SYRUP	0.14%	ORAL	V03AB01				0.14%Total Alkaloids	1369/10/30
Ipratropium	Bromide	INHALER	20 mcg/dose	RESPIRATORY	R03BB01
Ipratropium	Bromide	NEBULISATION	250 mcg/ml	RESPIRATORY	R03BB01				Nebulisation
Ipratropium	Bromide	INHALER	40 mcg/dose	RESPIRATORY	R03BB01					1376/06/09
Ipratropium	Bromide	SPRAY, METERED	21 mcg/spray	NASAL	R03BB01					1396/03/13
Ipratropium	Bromide	SPRAY, METERED	42 mcg/spray	NASAL	R03BB01					1396/03/13
Ipratropium+Fenoterol		AEROSOL, METERED		RESPIRATORY	R03AL01	(Ipratropium bromide 20 mcg + Fenoterol hydrobromide 50 mcg)/dose			HFA only	1389/08/24
Ipratropium+Salbutamol		AEROSOL, METERED		RESPIRATORY	R03AL02	(Ipratropium bromide 20 mcg + Salbutamol ( As sulfate ) 100 mcg)/dose
Ipratropium+Salbutamol		NEBULISATION		RESPIRATORY	R03AL02	(Ipratropium bromide 200 mcg + Salbutamol ( As sulfate ) 1 mg)/ml				1387/03/08
Irinotecan	HCl	INJECTION, POWDER	100mg	INTRAVENOUS DRIP	L01XX19
Irinotecan	HCl	INJECTION	20 mg/ml	PARENTERAL	L01XX19					1390/01/29
Irinotecan	HCl	INJECTION, POWDER	40mg	INTRAVENOUS DRIP	L01XX19
Iron	as isomaltoside	INJECTION	100mg/ml	PARENTERAL	B03AC			Hospital use only	for local production only	1391/05/02
Iron	As Sucrose	INJECTION	20 mg/ml	INTRAVENOUS	B03AC03			Hospital use only
Iron		SOLUTION/ DROPS	25 mg/ml	ORAL	B03AA02			OTC medicines
Iron	As Sorbitol	INJECTION	50 mg/ml	INTRAMUSCULAR	B03AC03			Hospital use only		1364/03/12
Isocarboxazid		TABLET	10 mg	ORAL	N06AF01					1371/06/08
Isoflurane		INHALANT		RESPIRATORY	N01AB06			Hospital use only		1363/05/28
Isoniazid		TABLET	100 mg	ORAL	J04AC01
Isoniazid		INJECTION	100 mg/ml	PARENTERAL	J04AC01			Hospital use only
Isoniazid		TABLET	300 mg	ORAL	J04AC01
Isoniazid+Prazinamide+Rifampin		TABLET		ORAL	J04AM05	Isoniazid 50 mg + Pyrazinamide 300 mg + Rifampin 120 mg		For Health Dept. of MOH only		1378/05/10
Isoniazid+Rifampin		TABLET		ORAL	J04AM02	Isoniazid 75 mg + Rifampin 150 mg		For Health Dept. of MOH only
Isopropyl Alcohol		BULK			V03			Bulk medicines
Isoproterenol	HCl	INJECTION	0.2 mg/ml	PARENTERAL	R03CB01			Hospital use only
Isoproterenol	HCl	INJECTION	1 mg/ml	PARENTERAL	R03CB01			Hospital use only
Isosorbide	Dinitrate	SPRAY	1.25mg/Dose	TOPICAL	C01DA08					1387/05/16
Isosorbide	Dinitrate	TABLET	10 mg	ORAL	C01DA08
Isosorbide	Dinitrate	TABLET, EXTENDED RELEASE	40 mg	ORAL	C01DA08					1364/11/06
Isosorbide	Dinitrate	TABLET	5 mg	SUBLINGUAL	C01DA08
Isosorbide	Mononitrate	CAPSULE, EXTENDED RELEASE	50 mg	ORAL	C01DA08				Modified(30/70)	1386/07/18
Isosorbide	Mononitrate	TABLET, EXTENDED RELEASE	60 mg	ORAL	C01DA08
Isotretinoin		GEL	0.05%	TOPICAL	D10AD04					1384/04/20
Isotretinoin		CAPSULE	10 mg	ORAL	D10BA01					1385/11/04
Isotretinoin		CAPSULE, LIQUID FILLED	16 mg	ORAL	D10BA01					1389/09/22
Isotretinoin		CAPSULE, LIQUID FILLED	20 mg	ORAL	D10BA01
Isotretinoin		CAPSULE, LIQUID FILLED	8 mg	ORAL	D10BA01					1389/09/22
Isoxsuprine	HCl	TABLET	10 mg	ORAL	C04AA01
Itraconazole		CAPSULE	100 mg	ORAL	J02AC02					1374/04/18
Itraconazole		SOLUTION	10 mg/ml	ORAL	J02AC02					1395/10/08
Ivabradine	As HCl	TABLET	5 mg	ORAL	C01EB17		Chronic heart failure, Angina pectoris			1396/11/29
Ivabradine	As HCl	TABLET	7.5 mg	ORAL	C01EB17		Chronic heart failure, Angina pectoris			1396/11/29
Ivermectin		TABLET	3 mg	ORAL	P02CF01		Anthelmintic			1394/11/13
Ivermectin		TABLET	6 mg	ORAL	P02CF01		Anthelmintic			1394/11/13
Ivermectin		LOTION	0.50%	TOPICAL	P02CF01				W/W	1396/09/12
Ivermectin		CREAM	1.00%	TOPICAL	D11AX22		Inflammatory lesions of rosacea		W/W	1397/02/02
Ketamine	As HCl	INJECTION	50 mg/ml	PARENTERAL	N01AX03			Hospital use only		1372/11/17
Ketoconazole		CREAM	2%	TOPICAL	D01AC08					1368/11/15
Ketoconazole		LOTION	2%	TOPICAL	D01AC08					1387/02/18
Ketoconazole		SHAMPOO	2%	TOPICAL	D01AC08					1372/11/17
Ketoconazole		TABLET	200 mg	ORAL	J02AB02					1368/11/15
Ketoconazole		BULK			V03			Bulk medicines		1376/12/10
Ketorolac	Trometamol	SOLUTION/ DROPS	0.50%	OPHTHALMIC	S01BC05					1386/11/03
Ketorolac	Trometamol	SOLUTION/ DROPS	0.45%	OPHTHALMIC	S01BC05					1396/03/13
Ketorolac	Trometamol	TABLET	10 mg	ORAL	M01AB15				for local production only	1389/05/30
Ketorolac	Trometamol	INJECTION	15 mg/ml	PARENTERAL	M01AB15					1392/05/29
Ketorolac	Trometamol	INJECTION, SOLUTION	30 mg/ml	PARENTERAL	M01AB15			Hospital use only		1389/05/30
Ketotifen	As Fumarate	SOLUTION/ DROPS	0.03%	OPHTHALMIC	S01GX08					1386/03/23
Ketotifen	As Fumarate	TABLET	1 mg	ORAL	R06AX17					1373/12/21
Ketotifen	As Fumarate	SOLUTION/ DROPS	1 mg/ ml	ORAL	R06AX17					1388/08/20
Ketotifen	As Fumarate	SYRUP	1 mg/5 ml	ORAL	R06AX17					1373/12/21
Kojic Acid		BULK			V03			Bulk medicines
Labetalol	HCl	INJECTION	5 mg/ml	PARENTERAL	C07AG01			Hospital use only		1386/12/07
Lacosamide		TABLET	50 mg	ORAL	N03AX18		Control of epilepsies			1397/07/28
Lacosamide		TABLET	100 mg	ORAL	N03AX18		Control of epilepsies			1397/07/28
Lacosamide		TABLET	150 mg	ORAL	N03AX18		Control of epilepsies			1397/07/28
Lacosamide		TABLET	200 mg	ORAL	N03AX18		Control of epilepsies			1397/07/28
Lactic Acid		BULK			V03			Bulk medicines
Lactose		BULK			V03			Bulk medicines
Lactulose		POWDER, FOR SOLUTION	10 g	ORAL	A06AD11
Lactulose		SYRUP	10 g/15 ml	ORAL	A06AD11
Lamivudine		SOLUTION	10 mg/ml	ORAL	J05AF05
Lamivudine		TABLET	100 mg	ORAL	J05AF05					1379/06/20
Lamivudine		TABLET	150 mg	ORAL	J05AF05
Lamivudine+Zidovudine		TABLET		ORAL	J05AR01	Lamivudine 150 mg+Zidovudine300 mg		For Health Dept. of MOH only		1393/10/14
Lamotrigine		SOLUTION	10 mg/ml	ORAL	N03AX09
Lamotrigine		TABLET	100 mg	ORAL	N03AX09
Lamotrigine		TABLET	25 mg	ORAL	N03AX09
Lamotrigine		TABLET	50 mg	ORAL	N03AX09
Lanolin		BULK			V03			Bulk medicines
Lanreotide	As Acetate	INJECTION, SOLUTION, EXTENDED RELEASE	120 mg	PARENTERAL	H01CB03					1393/06/02
Lanreotide	As Acetate	INJECTION, SOLUTION, EXTENDED RELEASE	60 mg	PARENTERAL	H01CB03					1393/06/02
Lanreotide	As Acetate	INJECTION, SOLUTION, EXTENDED RELEASE	90 mg	PARENTERAL	H01CB03					1393/06/02
Lansoprazole		CAPSULE, DELAYED RELEASE	15 mg	ORAL	A02BC03					1387/12/21
Lansoprazole		CAPSULE, DELAYED RELEASE	30 mg	ORAL	A02BC03					1387/12/21
Laronidase		INJECTION	2.9mg/ml	PARENTERAL	A16AB05		for treatment of mocopolysacoidosis	Orphan medicines		1387/11/06
Latanoprost		SOLUTION	50 mcg/ml	OPHTHALMIC	S01EE01					1379/11/09
Latanoprost+Timolol		SOLUTION/ DROPS		OPHTHALMIC	S01ED51	Latanoprost 50 mcg + Timolol (As Maleate) 5 mg				1387/05/06
L-Carnitine		TABLET, CHEWABLE	1 g	ORAL	A16AA01
L-Carnitine	As L-Tartrate	TABLET, CHEWABLE	1 g	ORAL	A16AA01					1388/08/20
L-Carnitine		SOLUTION	100 mg/ml	ORAL	A16AA01
L-Carnitine		INJECTION	200 mg/ml	PARENTERAL	A16AA01			Hospital use only
L-Carnitine		TABLET	250 mg	ORAL	A16AA01
L-Carnitine	As L-Tartrate	TABLET	250 mg	ORAL	A16AA01					1388/08/20
L-Carnitine		TABLET	330 mg	ORAL	A16AA01					1388/10/30
Ledipasvir+Sofosbuvir		TABLET		ORAL	J05AX	Ledipasvir 90 mg+Sofosbuvir 400 mg	Hepatitis C infection			1394/03/31
Leflunomide		TABLET	10 mg	ORAL	L04AA13		Arthritis rheumatoid			1395/12/22
Leflunomide		TABLET	20 mg	ORAL	L04AA13		Arthritis rheumatoid			1395/12/22
Leishmanin		SUSPENSION		INTRADERMAL	V04CX					1386/11/08
Lenalidomide		CAPSULE	10 mg	ORAL	L04AX04		for multiple myolema; and myeloma depylastic			1393/02/07
Lenalidomide		CAPSULE	15 mg	ORAL	L04AX04		for multiple myolema; and myeloma depylastic			1393/02/07
Lenalidomide		CAPSULE	25 mg	ORAL	L04AX04		for multiple myolema; and myeloma depylastic			1393/02/07
Lenalidomide		CAPSULE	5 mg	ORAL	L04AX04		for multiple myolema; and myeloma depylastic			1393/02/07
Letrozole		TABLET	2.5 mg	ORAL	L02BG04					1381/06/18
Leucovorin		INJECTION	125mg/ml	PARENTERAL	V03AF03		For rescue use after high dose methotrexate therapy in the treatment of osteosarcoma.
Leucovorin		INJECTION	3 mg/ml	PARENTERAL	V03AF03		For rescue use after high dose methotrexate therapy in the treatment of osteosarcoma.
Leucovorin		INJECTION, POWDER	30 mg	PARENTERAL	V03AF03		For rescue use after high dose methotrexate therapy in the treatment of osteosarcoma.
Leuprorelin	Acetate	INJECTION, POWDER	3.75 mg	PARENTERAL	L02AE02		Treatment of central precocious puberty.
Leuprorelin	Acetate	INJECTION, POWDER, EXTENDED RELEASE	3.75 mg	PARENTERAL	L02AE02		Prostate Cancer			1396/12/23
Leuprorelin	Acetate	INJECTION, POWDER, EXTENDED RELEASE	7.5 mg	PARENTERAL	L02AE02		Prostate Cancer			1387/02/04
Leuprorelin	Acetate	INJECTION, POWDER, EXTENDED RELEASE	11.25 mg	PARENTERAL	L02AE02		Prostate Cancer			1396/12/23
Leuprorelin	Acetate	INJECTION, POWDER, EXTENDED RELEASE	22.5 mg	PARENTERAL	L02AE02		Prostate Cancer			1394/07/05
Leuprorelin	Acetate	INJECTION, POWDER, EXTENDED RELEASE	45 mg	PARENTERAL	L02AE02		Prostate Cancer			1395/05/02
Levamisole	As HCl	SYRUP	40 mg/5ml	ORAL	P02CE01
Levamisole	As HCl	TABLET	50 mg	ORAL	P02CE01
Levetiracetam		INJECTION, SOLUTION, CONCENTRATE	100 mg/ml	PARENTERAL	N03AX14					1392/09/25
Levetiracetam		INJECTION, SOLUTION	500 mg/100 ml	PARENTERAL	N03AX14				In Sodium Chloride	1395/04/09
Levetiracetam		INJECTION, SOLUTION	1500 mg/100 ml	PARENTERAL	N03AX14				In Sodium Chloride	1395/12/22
Levetiracetam		TABLET	1000 mg	ORAL	N03AX14					1391/06/13
Levetiracetam		TABLET	250 mg	ORAL	N03AX14					1387/12/21
Levetiracetam		TABLET	500 mg	ORAL	N03AX14					1387/12/21
Levetiracetam		SOLUTION	100 mg/ml	ORAL	N03AX14					1388/02/30
Levetiracetam		TABLET	750 mg	ORAL	N03AX14					1388/08/20
Levocetirizine	DiHCl	TABLET	5 mg	ORAL	R06AE09					1386/09/07
Levodopa		TABLET	500 mg	ORAL	N04BA01
Levodopa+ Carbidopa+ Entacapon		TABLET		ORAL	N04BA03	Levodopa 100mg+ Carbidopa 25 mg+ Entacapon 200 mg				1387/12/21
Levodopa+ Carbidopa+ Entacapon		TABLET		ORAL	N04BA03	Levodopa 125mg+ Carbidopa31.25 mg+ Entacapon 200 mg				1389/8/24
Levodopa+ Carbidopa+ Entacapon		TABLET		ORAL	N04BA03	Levodopa 150mg+ Carbidopa 37.5 mg+ Entacapon 200 mg				1387/12/21
Levodopa+ Carbidopa+ Entacapon		TABLET		ORAL	N04BA03	Levodopa 200mg+ Carbidopa 50 mg+ Entacapon 200 mg				1389/08/24
Levodopa+ Carbidopa+ Entacapon		TABLET		ORAL	N04BA03	Levodopa 50mg+ Carbidopa 12.5mg+ Entacapon 200 mg				1387/12/21
Levodopa+ Carbidopa+ Entacapon		TABLET		ORAL	N04BA03	Levodopa 75mg+ Carbidopa 18.75 mg+ Entacapon 200 mg				1389/08/24
Levodopa+Benserazide		TABLET		ORAL	N04BA02	Levodopa 100 mg+Benserazide (as Hydrochloride) 25				1365/11/05
Levodopa+Benserazide		TABLET		ORAL	N04BA02	Levodopa 200 mg+Benserazide (as Hydrochloride) 50
Levodopa+Benserazide		TABLET		ORAL	N04BA02	Levodopa 50 mg+Benserazide (as Hydrochloride) 12.5				1365/11/05
Levodopa+Carbidopa		TABLET		ORAL	N04BA02	Levodopa 100 mg+Carbidopa (as Monohydrate) 10 mg
Levodopa+Carbidopa		TABLET		ORAL	N04BA02	Levodopa 100 mg+Carbidopa (as Monohydrate) 25 mg
Levodopa+Carbidopa		TABLET, EXTENDED RELEASE		ORAL	N04BA02	Levodopa 100 mg+Carbidopa (as Monohydrate) 25 mg				1392/05/29
Levodopa+Carbidopa		TABLET, EXTENDED RELEASE		ORAL	N04BA02	Levodopa 200 mg+Carbidopa (as Monohydrate) 50 mg				1392/05/29
Levodopa+Carbidopa Forte		TABLET		ORAL	N04BA02	Levodopa 250 mg+Carbidopa (as Monohydrate) 25 mg
Levofloxacin	Hemihydrate	SOLUTION/ DROPS	0.50%	OPHTHALMIC	S01AX19					1390/01/29
Levofloxacin		TABLET	250 mg	ORAL	J01MA12				for local production only	1389/10/25
Levofloxacin		INJECTION, SOLUTION CONCENTRATE	25mg/ml	PARENTRAL	J01MA12			Hospital use only.		1392/04/04
Levofloxacin		TABLET	500 mg	ORAL	J01MA12				for local production only	1389/10/25
Levofloxacin		INJECTION , SOLUTION	5 mg/ml	INTRAVENOUS DRIP	J01MA12			Hospital use only		1391/05/02
Levofloxacin		TABLET	750 mg	ORAL	J01MA12				for local production only	1389/10/25
Levonorgestrel		TABLET	1.5 mg	ORAL	G03AC03			OTC medicines		1388/09/04
Levonorgestrel		IMPLANT	2 X 75 mg	TRANSDERMAL	G03AC03				for local production only	1390/01/29
Levonorgestrel		TABLET	30 mcg	ORAL	G03AC03
Levonorgestrel		IMPLANT	6 X 36 mg	TRANSDERMAL	G03AC03					1371/08/24
Levonorgestrel		TABLET	750 mcg	ORAL	G03AC03			OTC medicines		1381/06/31
Levothyroxine	Sodium	CAPSULE, LIQUID FILLED	100 mcg	ORAL	H03AA01					1386/07/18
Levothyroxine	Sodium	TABLET	100 mcg	ORAL	H03AA01
Levothyroxine	Sodium	SOLUTION	20 mcg/ml	ORAL	H03AA01					1396/02/02
Levothyroxine	Sodium	CAPSULE, LIQUID FILLED	50 mcg	ORAL	H03AA01					1386/07/18
Levothyroxine	Sodium	TABLET	50 mcg	ORAL	H03AA01					1378/08/23
Levothyroxine	Sodium	TABLET	75 mcg	ORAL	H03AA01					1386/04/27
Levothyroxine	Sodium	TABLET	25 mcg	ORAL	H03AA01					1395/06/24
Levothyroxine	Sodium	TABLET	150 mcg	ORAL	H03AA01					1395/06/24
Lidocaine	HCl	INJECTION	1%	PARENTERAL	C01BB01			Hospital use only
Lidocaine	HCl	INJECTION	2%	PARENTERAL	C01BB01				Cartridge (carpool)
Lidocaine	HCl	INJECTION	2%	PARENTERAL	C01BB01			Hospital use only
Lidocaine	HCl	GEL	2%	TOPICAL	D04AB01			OTC medicines
Lidocaine		CREAM	4%	TOPICAL	D04AB01			OTC medicines		1396/09/19
Lidocaine	HCl	INJECTION, SOLUTION	4%	PARENTERAL	N01BB52			Hospital use only		1368/07/16
Lidocaine	HCl	SOLUTION	4%	TOPICAL	D04AB01
Lidocaine	HCl	INJECTION	5%	INTRASPINAL	N01BB52	Lidocaine HCl 5%+Dextrose 7.5%		Hospital use only		1362/09/27
Lidocaine	HCl	SPRAY	6.50%	TOPICAL	D04AB01					1384/12/09
Lidocaine	HCl	INJECTION, SOLUTION	20%	PARENTERAL	C01BB01			Hospital use only
Lidocaine		SPRAY	10 mg/dose	TOPICAL	D04AB01				10%	1386/11/08
Lidocaine		PATCH	5%	TOPICAL	D04AB01					1395/11/06
Lidocaine+Epinephrine		INJECTION		PARENTERAL	N01BB52	(Lidocaine HCl 20mg+Epinephrine (As Bitartrate) 12.5 mcg)/ ml		Hospital use only
Lidocaine+Epinephrine		INJECTION		PARENTERAL	N01BB52	Lidocaine HCl 10mg+Epinephrine (As Bitartrate) 5mcg/ml		Hospital use only
Lidocaine+Chlorhexidine		GEL		TOPICAL	N01BB52	Lidocaine Hydrochloride 2%+Chlorhexidine Dihydrochloride 0.05%				1384/12/09
Lidocaine+Hydrocortisone		OINTMENT		RECTAL	N01BB52	Lidocaine 5%+Hydrocortisone Acetate 0.5%				1368/08/07
Lidocaine+Prilocaine		CREAM		TOPICAL	N01BB52	Lidocaine 2.5% + Prilocaine 2.5%				1379/01/29
Lidocaine+Tetracaine		CREAM		TOPICAL	N01BB52	Lidocaine7% + Tetracaine 7%				1396/06/25
Linagliptin		TABLET	5 mg	ORAL	A10BH05		Type 2 Diabetes Mellitus			1395/08/02
Lindane		LOTION	1%	TOPICAL	P03AB02
Lindane		SHAMPOO	1%	TOPICAL	P03AB02
Linezolid		POWDER, FOR SUSPENSION	100 mg/5ml	ORAL	J01XX08					1391/12/23
Linezolid		TABLET	400 mg	ORAL	J01XX08					1391/12/23
Linezolid		TABLET	600 mg	ORAL	J01XX08					1391/12/23
Linezolid		INJECTION, SOLUTION	2 mg/ml	PARENTERAL	J01XX08			Hospital use only		1391/12/23
Liothyronine	Sodium	TABLET	25 mcg	ORAL	H03AA02
Lipid Infusion		INJECTION, SOLUTION	10%	INTRAVENOUS DRIP	B05BA02
Lipid Infusion		INJECTION, SOLUTION	20%	INTRAVENOUS DRIP	B05BA02			Hospital use only		1381/02/09
Liraglutide		INJECTION, SOLUTION	6 mg/ml	PARENTERAL	A10BX07				Disposable pen	1391/02/07
Lisdexamfetamine	Mesilate	CAPSULE	10 mg	ORAL	N06BA12		ADHD			1396/11/29
Lisdexamfetamine	Mesilate	CAPSULE	20 mg	ORAL	N06BA12		ADHD			1396/11/29
Lisdexamfetamine	Mesilate	CAPSULE	30 mg	ORAL	N06BA12		ADHD			1396/11/29
Lisdexamfetamine	Mesilate	CAPSULE	40 mg	ORAL	N06BA12		ADHD			1396/11/29
Lisdexamfetamine	Mesilate	CAPSULE	50 mg	ORAL	N06BA12		ADHD			1396/11/29
Lisdexamfetamine	Mesilate	CAPSULE	60 mg	ORAL	N06BA12		ADHD			1396/11/29
Lisdexamfetamine	Mesilate	CAPSULE	70 mg	ORAL	N06BA12		ADHD			1396/11/29
Lisinopril		TABLET	10 mg	ORAL	C09AA03					1382/03/04
Lisinopril		TABLET	20 mg	ORAL	C09AA03					1382/03/04
Lisinopril		TABLET	5 mg	ORAL	C09AA03					1382/03/04
Lisinopril+Hydrochlorothiazide		TABLET		ORAL	C09BA03	Lisinopril 10mg + Hydrochlorothiazide 12.5mg				1387/07/07
Lisinopril+Hydrochlorothiazide		TABLET		ORAL	C09BA03	Lisinopril 20mg + Hydrochlorothiazide 12.5mg				1387/07/07
Lisinopril+Hydrochlorothiazide		TABLET		ORAL	C09BA03	Lisinopril 20mg + Hydrochlorothiazide 25mg				1387/07/07
Lithium	Carbonate	TABLET	300 mg	ORAL	N05AN01
Lithium	Carbonate	CAPSULE, EXTENDED RELEASE	400 mg	ORAL	N05AN01
Lithium	Carbonate	TABLET, EXTENDED RELEASE	400 mg	ORAL	N05AN01
Lithium	Carbonate	TABLET, EXTENDED RELEASE	450 mg	ORAL	N05AN01					1397/09/27
Lomustine		CAPSULE	40 mg	ORAL	L01AD02
Loperamide	HCl	SOLUTION	1 mg/5ml	ORAL	A07DA03			OTC medicines		1383/10/28
Loperamide	HCl	CAPSULE	2 mg	ORAL	A07DA03			OTC medicines
Loperamide	HCl	TABLET	2 mg	ORAL	A07DA03			OTC medicines
Lopinavir+Ritonavir		SOLUTION		ORAL	J05AE	(Lopinavir 400mg+Ritonavir 100mg)/5ml		for Health Dept. of MOH only		1386/04/11
Lopinavir+Ritonavir		SOLUTION		ORAL	J05AR10	(Lopinavir80 mg+Ritonavir 20 mg)/ml		for Health Dept. of MOH only		1393/10/14
Lopinavir+Ritonavir		TABLET		ORAL	J05AR10	Lopinavir 100 mg+Ritonavir 25 mg		for Health Dept. of MOH only		1393/10/14
Lopinavir+Ritonavir		CAPSULE, LIQUID FILLED		ORAL	J05AR10	Lopinavir 133.3mg+Ritonavir 33.3mg		for Health Dept. of MOH only		1386/04/11
Lopinavir+Ritonavir		TABLET		ORAL	J05AR10	Lopinavir 200mg+Ritonavir 50mg		for Health Dept. of MOH only		1386/04/11
Loratadine		CAPSULE, LIQUID FILLED	10 mg	ORAL	R06AX13				for local production only	1390/03/23
Loratadine		TABLET	10 mg	ORAL	R06AX13
Loratadine		TABLET, ORALLY DISINTEGRATING	10 mg	ORAL	R06AX13					1385/02/12
Loratadine		SYRUP	5 mg/5ml	ORAL	R06AX13
Loratadine+Pseudoephedrine		TABLET, EXTENDED RELEASE		ORAL	R01BA52	Loratadine 5 mg + Pseudoephedrine Sulfate 120 mg			for local production only	1389/07/17
Lorazepam		TABLET	1 mg	ORAL	N05BA06					1366/07/19
Lorazepam		TABLET	2 mg	ORAL	N05BA06					1366/07/19
Lorazepam		INJECTION	2 mg/ml	PARENTERAL	N05BA06			Hospital use only		1374/12/20
Lorazepam		INJECTION	4 mg/ml	PARENTERAL	N05BA06			Hospital use only		1382/09/03
Lorenzos Oil		OIL	500 ml	ORAL			Treatment of early stages of Adrenoleucodystrophy			1387/11/06
Losartan	Potassium	TABLET	12.5 mg	ORAL	C09CA01					1397/04/30
Losartan	Potassium	TABLET	25 mg	ORAL	C09CA01					1377/11/18
Losartan	Potassium	TABLET	50 mg	ORAL	C09CA01
Losartan	Potassium	TABLET	100 mg	ORAL	C09CA01					1397/04/30
Losartan+Hydrochlorothiazide		TABLET		ORAL	C03AX01	Losartan Potassium 50mg + Hydrochlorothiazide 12.5mg				1387/08/01
Loteprednol	Etabonate	SUSPENSION/ DROPS	0.50%	OPHTHALMIC	S01BA14					1388/05/11
Loteprednol	Etabonate	OINTMENT	0.50%	OPHTHALMIC	S01BA14					1395/12/22
Lovastatin		TABLET	20 mg	ORAL	C10AA02					1369/10/16
Low Sodium Salt		POWDER	5 g	ORAL	A12CA	[Kcl(670 mg-700 mg) + Nacl(300 mg-330 mg) + Mgco3 (4 mg-5 mg)] / g sachet
Lutetium [177Lu]-DOTATATE		INJECTION, SOLUTION	200 mCi	PARENTERAL	V10XX04				Radiopharmaceuticals	1397/02/18
Lutetium [177Lu]-prostate specific membrane antigen, (177Lu-PSMA)		INJECTION, SOLUTION	200 mCi	PARENTERAL	V10XX04				Radiopharmaceuticals	1397/02/18
Lutetium [177Lu]-Ethylenediamine tetramethylene phosphonate, (177Lu-EDTMP)		INJECTION, SOLUTION	1 mCi/kg	PARENTERAL	V10B				Radiopharmaceuticals	1391/09/01
Lutropin Alfa		INJECTION, POWDER	75 IU	PARENTERAL	G03GA07					1385/12/02
Lynestrenol		TABLET	0.5 mg	ORAL	G03AC02				With obstetricians and General Practitioners prescriptions only	1371/03/03
Macitentan		TABLET	10 mg	ORAL	C02KX04		PAH		Pulmonologist prescription only, Local production only	1397/10/04
Mafenide	Acetate	CREAM	112 mg/g	TOPICAL	D06BA03				eq to 85 mg ( Base )/g	1381/04/23
Magnesium Hydroxide		SUSPENSION	8%	ORAL	A02AA04			OTC medicines		1369/10/30
Magnesium Oxide		TABLET	400 mg	ORAL	A02AA04				250 mg elemental
Magnesium Sulfate		INJECTION	10%	PARENTERAL	A12CC02					1385/11/18
Magnesium Sulfate		INJECTION	20%	PARENTERAL	A12CC02					1385/11/18
Magnesium Sulfate		INJECTION	50%	PARENTERAL	A12CC02			Hospital use only		1385/11/18
Mannitol		INJECTION, SOLUTION	10%	INTRAVENOUS DRIP	B05BC01
Mannitol		INJECTION, SOLUTION	20%	INTRAVENOUS DRIP	B05BC01			Hospital use only
Maprotiline	HCl	TABLET	25 mg	ORAL	N06AA21					1371/06/08
Maprotiline	HCl	TABLET	75 mg	ORAL	N06AA21					1371/06/08
Measles Vaccine		INJECTION		PARENTERAL	J07BD01				(Rubeola) Virus live Attenuated vaccine
Measles Immune globulin		INJECTION	200 IU/ml	PARENTERAL	J06BB14
Measles+Mumps+Rubella Vaccine		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	J07BD52				MMR vaccine
Measles+Rubella Vaccine		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	J07BD53				MR vaccine; Virus alive
Mebendazole		TABLET, CHEWABLE	100 mg	ORAL	P02CA01			OTC medicines
Mebeverine	HCl	TABLET	135 mg	ORAL	A03AA04
Mebeverine	HCl	CAPSULE, EXTENDED RELEASE	200 mg	ORAL	A03AA04					1385/08/17
Medroxyprogesterone	Acetate	INJECTION	100 mg/ml	PARENTERAL	L02AB02		Treatment of immune thrombocytopenic purpura.
Medroxyprogesterone	Acetate	INJECTION	150 mg/ml	PARENTERAL	G03AC06		Treatment of immune thrombocytopenic purpura.			1371/03/03
Medroxyprogesterone	Acetate	INJECTION	160 mg/ml	PARENTERAL	G03AC06		Endometriosis, Contraception			1396/05/28
Medroxyprogesterone	Acetate	TABLET	250 mg	ORAL	G03AC06				With obstetricians and General Practitioners prescriptions only	1363/06/11
Medroxyprogesterone	Acetate	TABLET	5 mg	ORAL	G03DA02				With obstetricians and General Practitioners prescriptions only
Medroxyprogestrone+Estradiol		INJECTION		PARENTERAL	G03AA08	Depot Medroxyprogesterone Acetate 25mg + Estradiol Cypionate 5mg/0.5ml
Mefenamic Acid		CAPSULE	250 mg	ORAL	M01AG01					1368/09/19
Mefloquine		TABLET	250 mg	ORAL	P01BC02					1383/04/07
Megestrol	Acetate	TABLET	15 mg	ORAL	L02AB01		Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome.
Megestrol	Acetate	TABLET	20 mg	ORAL	L02AB01		Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome.
Megestrol	Acetate	TABLET	40 mg	ORAL	L02AB01		Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome.
Megestrol	Acetate	SUSPENSION	40 mg/ml	ORAL	L02AB01		Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome.
Meglumine	Antimonate	INJECTION	300 mg/ml	PARENTERAL	P01CB01
Meglumine	Gadoterate	INJECTION	377 mg/ml	PARENTERAL	V08CA01
Meglumine Compound		INJECTION		PARENTERAL	V08AA01	Meglumine Diatrizoate 52.1%+Sodium Diatrizoate 7.9%
Meglumine Compound		SOLUTION		ORAL	V08AA01	Meglumine Diatrizoate 66%+Sodium Diatrizoate 10%
Meglumine+Ioxaglate		INJECTION		PARENTERAL	V08AB03	Meglumine Ioxaglate 393 mg/ml + Sodium Ioxaglate 196.5 mg/ml
Meloxicam		TABLET	15 mg	ORAL	M01AC06					1387/09/09
Meloxicam		TABLET	7.5 mg	ORAL	M01AC06					1387/09/09
Meloxicam		TABLET, ORALLY DISINTEGRATING	15 mg	ORAL	M01AC06					1396/02/02
Meloxicam		TABLET, ORALLY DISINTEGRATING	7.5 mg	ORAL	M01AC06					1396/02/02
Melphalan		TABLET	2 mg	ORAL	L01AA03
Melphalan		INJECTION, POWDER	50 mg	PARENTERAL	L01AA03		Treatment of patients with multiple myeloma for whom ORAL therapy is inappropriate. For use in hyperthermic regional limb perfusion to treat metastatic melanoma of the extremity.			1373/08/01
Memantine	HCl	TABLET	10 mg	ORAL	N06DX01					1385/04/13
Memantine	HCl	SOLUTION	10mg/g	ORAL	N06DX01				for local production only	1390/09/21
Memantine	HCl	CAPSULE,EXTENDED RELEASE	14 mg	ORAL	N06DX01					1390/01/29
Memantine	HCl	SOLUTION	2 mg/ml	ORAL	N06DX01					1390/01/29
Memantine	HCl	TABLET	20 mg	ORAL	N06DX01					1390/01/29
Memantine	HCl	CAPSULE,EXTENDED RELEASE	21 mg	ORAL	N06DX01					1390/01/29
Memantine	HCl	TABLET	5 mg	ORAL	N06DX01					1385/04/13
Meningococcal Vaccine		INJECTION		PARENTERAL	J07AH05				Meningococcal AC conjugate (2 Valents)	1391/02/25
Meningococcal Vaccine		INJECTION		PARENTERAL	J07AH05				Meningococcal AC polysaccharide (2 Valents)	1391/02/25
Meningococcal Vaccine		INJECTION		PARENTERAL	J07AH05				Meningococcal ACWY polysaccharide (4 Valents)	1391/02/25
Meningococcal Vaccine		INJECTION		PARENTERAL	J07AH05				Meningococcal ACWY conjugate (4 Valents)	1391/02/25
Menotropins		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	G03GA02	150 IU FSH+150 IU LH				1393/06/02
Menotropins		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	G03GA02	75 IU FSH+75 IU LH				1359/07/13
Menotropins		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	G03GA02	600 IU FSH+600 IU LH				1396/08/29
Menotropins		INJECTION, POWDER, LYOPHILIZED		PARENTERAL	G03GA02	1200 IU FSH+1200 IU LH				1396/08/29
Menthol		BULK			V03			Bulk medicines
Menthol Salicylate		OINTMENT		TOPICAL	M02AC	Methyl Salicylate 15%+Menthol 10%		OTC medicines		1369/10/30
Menthol+Zinc oxide+Calamine		OINTMENT		TOPICAL	D02AB	(Menthol 0.44 g + Zinc oxide 20.625 g + Calamine 10 g)/100g		OTC medicines	for local production only	1389/07/17
Mepivacaine	HCl	INJECTION	2%	PARENTERAL	N01BB03			Hospital use only
Mepivacaine	HCl	INJECTION	3%	PARENTERAL	N01BB03		Dentistry applications only			3/23/1990
Mequinol		OINTMENT	10%	TOPICAL	D11AX06					1380/03/27
Mequinol+Tretinoin		SOLUTION		TOPICAL	D10AD51	Mequinol 2% + Tretinoin 0. 01%				1380/06/03
Mercaptopurine		TABLET	50 mg	ORAL	L01BB02			Orphan medicines
Meropenem	As Trihydrate	INJECTION, POWDER	1 g	PARENTERAL	J01DH02		Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms.	Hospital use only
Meropenem	As Trihydrate	INJECTION, POWDER	500 mg	PARENTERAL	J01DH02		Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms.	Hospital use only.		1383/07/12
Mesalazine		GRANULE, EXTENDED RELEASE	1 g	ORAL	A07EC02				sachet	1380/12/05
Mesalazine		TABLET, EXTENDED RELEASE	1 g	ORAL	A07EC02					1393/03/04
Mesalazine		ENEMA	1 g/100ml	RECTAL	A07EC02					1393/03/04
Mesalazine		ENEMA, FOAM	1 g/application aerosol can	RECTAL	A07EC02					1395/11/06
Mesalazine		ENEMA	4 g/100ml	RECTAL	A07EC02
Mesalazine		SUPPOSITORY, EXTENDED RELEASE	1000 mg	RECTAL	A07EC02					1386/01/22
Mesalazine		GRANULE, EXTENDED RELEASE	2 g	ORAL	A07EC02				sachet	1393/03/04
Mesalazine		GRANULE, EXTENDED RELEASE	4 g	ORAL	A07EC02				sachet	1396/11/29
Mesalazine		TABLET, DELAYED RELEASE	250 mg	ORAL	A07EC02
Mesalazine		TABLET, EXTENDED RELEASE	250 mg	ORAL	A07EC02
Mesalazine		TABLET, DELAYED RELEASE	400 mg	ORAL	A07EC02					1380/09/04
Mesalazine		SUPPOSITORY	500 mg	RECTAL	A07EC02
Mesalazine		TABLET, DELAYED RELEASE	500 mg	ORAL	A07EC02
Mesalazine		TABLET, EXTENDED RELEASE	500 mg	ORAL	A07EC02
Mesalazine		CAPSULE, EXTENDED RELEASE	500 mg	ORAL	A07EC02					1392/05/01
Mesalazine		TABLET, EXTENDED RELEAS	1200 mg	ORAL	A07EC02					1397/04/30
Mesalazine		TABLET, DELAYED RELEASE	800 mg	ORAL	A07EC02					1385/05/10
Mesna		INJECTION	100 mg/ml	PARENTERAL	V03AF01		For use as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. Inhibition of the urotoxic effects induced by oxazaphosphorine compounds such as cyclophosphamide.			1365/01/24
Metaproterenol	Sulfate	INJECTION	0.5 mg/ml	PARENTERAL	R03CB03			Hospital use only
Metaproterenol	Sulfate	TABLET	20 mg	ORAL	R03CB03
Metformin	HCl	TABLET	1000 mg	ORAL	A10BA02					1385/08/17
Metformin	HCl	TABLET, EXTENDED RELEASE	1000 mg	ORAL	A10BA02					1391/07/25
Metformin	HCl	TABLET, EXTENDED RELEASE	750 mg	ORAL	A10BA02					1395/03/19
Metformin	HCl	TABLET, EXTENDED RELEASE	500 mg	ORAL	A10BA02					1391/07/25
Metformin	HCl	TABLET	500 mg	ORAL	A10BA02					1361/05/31
Metformin	HCl	TABLET	850 mg	ORAL	A10BA02					1396/08/29
Metformin	HCl	SOLUTION	500 mg/5ml	ORAL	A10BA02					1395/09/01
Metformin+Glibenclamide		TABLET		ORAL	A10BD02	Metformin HCl 500 mg+ Glibenclamide 2.5 mg				1389/06/29
Metformin+Glibenclamide		TABLET		ORAL	A10BD02	Metformin HCl 500 mg+ Glibenclamide 5 mg				1389/06/29
Metformin+Glibenclamide		TABLET		ORAL	A10BD02	Metformin HCl 1000 mg+ Glibenclamide 5 mg				1396/03/13
Metformin+Pioglitazone		TABLET		ORAL	A10BD05	Metformin HCL 500 mg + Pioglitazone 15 mg				1389/08/24
Metformin+Linagliptin		TABLET		ORAL	A10BD11	Metformin HCL 500 mg + Linagliptin2.5 mg				1396/04/31
Metformin+Linagliptin		TABLET		ORAL	A10BD11	Metformin HCL 1000 mg + Linagliptin2.5 mg				1396/04/31
Metformin+Linagliptin		TABLET, EXTENDED RELEASE		ORAL	A10BD11	Metformin HCL 1000 mg + Linagliptin 5 mg				1396/08/29
Metformin+Linagliptin		TABLET, EXTENDED RELEASE		ORAL	A10BD11	Metformin HCL 1000 mg + Linagliptin 2.5 mg				1396/08/29
Methacholine	Chloride	INHALER	100 mg/20ml	RESPIRATORY	V04CX					1386/11/03
Methadone	HCl	POWDER	1 g	ORAL	N07BC02				Sachet	1384/11/18
Methadone	HCl	INJECTION	10 mg/ml	PARENTERAL	N07BC02			Hospital use only
Methadone	HCl	TABLET	20 mg	ORAL	N07BC02					1382/12/25
Methadone	HCl	TABLET, DISPERSIBLE	20 mg	ORAL	N07BC02					1386/12/06
Methadone	HCl	SOLUTION	25 mg/5ml	ORAL	N07BC02					1384/02/12
Methadone	HCl	TABLET, DISPERSIBLE	40 mg	ORAL	N07BC02					1386/12/06
Methadone	HCl	TABLET	40 mg	ORAL	N07BC02					1382/12/25
Methadone	HCl	TABLET	5 mg	ORAL	N07BC02
Methadone	HCl	INJECTION	5 mg/ml	PARENTERAL	N07BC02			Hospital use only		1369/01/26
Methadone	HCl	SOLUTION	5mg/5ml	ORAL	N07BC02
Methimazole		TABLET	5 mg	ORAL	H03BB02
Methocarbamol		INJECTION	100 mg/ml	PARENTERAL	M03EA03
Methocarbamol		TABLET	500 mg	ORAL	M03EA03
Methocarbamol		TABLET	750 mg	ORAL	M03EA03					1396/02/02
Methotrexate	As Sodium	INJECTION, POWDER, LYOPHILIZED	1 g	PARENTERAL	L01BA01				with and without preservative	1375/07/29
Methotrexate	As Sodium	INJECTION, SOLUTION	10 mg/ml	PARENTERAL	L01BA01				with and without preservative
Methotrexate	As Sodium	INJECTION, SOLUTION	20 mg/ml	PARENTERAL	L01BA01				without preservative	1396/06/25
Methotrexate	As Sodium	INJECTION, SOLUTION	100 mg/ml	PARENTERAL	L01BA01				with and without preservative
Methotrexate	As Sodium	INJECTION, SOLUTION	50 mg/ml	PARENTERAL	L01BA01				without preservative	1395/09/01
Methotrexate	As Sodium	INJECTION, SOLUTION	2.5 mg/ml	PARENTERAL	L01BA01				with and without preservative	1375/07/29
Methotrexate	As Sodium	TABLET	2.5 mg	ORAL	L01BA01					1389/6/29
Methotrexate		TABLET	2.5 mg	ORAL	L01BA01
Methotrexate	As Sodium	INJECTION, SOLUTION	25 mg/ml	PARENTERAL	L01BA01				with and without preservative	1375/07/29
Methotrexate		INJECTION, SOLUTION	25 mg/ml	PARENTERAL	L01BA01				without preservative	1397/04/03
Methotrexate	As Sodium	INJECTION, POWDER, LYOPHILIZED	5 mg	PARENTERAL	L01BA01				with and without preservative
Methotrexate	As Sodium	INJECTION, SOLUTION	5 mg/ml	PARENTERAL	L01BA01				with and without preservative	1375/07/29
Methotrexate	As Sodium	INJECTION, POWDER, LYOPHILIZED	50 mg	PARENTERAL	L01BA01				with and without preservative	1369/09/18
Methotrexate		TABLET	5mg	ORAL	L01BA01					1385/05/10
Methoxsalen		SOLUTION	1%	TOPICAL	D05AD02					1373/09/20
Methoxsalen		TABLET	10 mg	ORAL	D05AD02		For use in conjunction with the UVAR photopheresis system to treat graft versus host disease.
Methoxy Polyethylen Glycol-Epoetin Beta		INJECTION, SOLUTION	50 mcg/0.3 ml	PARENTERAL	B03XA03		Hypoplastic, Haemolytic, Renal Anaemia			1394/11/13
Methoxy Polyethylen Glycol-Epoetin Beta		INJECTION, SOLUTION	100 mcg/0.3 ml	PARENTERAL	B03XA03		Hypoplastic, Haemolytic, Renal Anaemia			1394/11/13
Methoxy Polyethylen Glycol-Epoetin Beta		INJECTION, SOLUTION	200 mcg/0.3 ml	PARENTERAL	B03XA03		Hypoplastic, Haemolytic, Renal Anaemia			1394/11/13
Methyl Salicylate		OINTMENT	30%	TOPICAL	M02AC			OTC medicines		1369/10/30
Methylcellulose		GRANULE		ORAL	A06AC06					1376/11/02
Methyldopa		TABLET	250 mg	ORAL	C02AB02
Methylene Blue		INJECTION	10 mg/ml	PARENTERAL	V03AB17
Methylergonovine	Maleate	TABLET	0.125 mg	ORAL	G02AB01
Methylergonovine	Maleate	INJECTION	0.2 mg/ml	PARENTERAL	G02AB01
Methylphenidate	HCl	TABLET	10 mg	ORAL	N06BA04
Methylphenidate	HCl	TABLET, EXTENDED RELEASE	20 mg	ORAL	N06BA04					1385/03/23
Methylphenidate	HCl	TABLET, EXTENDED RELEASE	18 mg	ORAL	N06BA04					1395/05/03
Methylphenidate	HCl	TABLET, EXTENDED RELEASE	27 mg	ORAL	N06BA04					1395/05/03
Methylphenidate	HCl	TABLET, EXTENDED RELEASE	36 mg	ORAL	N06BA04					1395/05/03
Methylphenidate	HCl	TABLET, EXTENDED RELEASE	54 mg	ORAL	N06BA04					1395/05/03
Methylphenidate	HCl	CAPSULE, EXTENDED RELEASE	30 mg	ORAL	N06BA04					1395/05/03
Methylprednisolone	As Sodium Succinate	INJECTION, POWDER	1000 mg	PARENTERAL	H02AB04			Hospital use only		1382/08/12
Methylprednisolone	As Sodium Succinate	INJECTION, POWDER	250 mg	PARENTERAL	H02AB04			Hospital use only		1382/08/12
Methylprednisolone	As Sodium Succinate	INJECTION, POWDER	40 mg	PARENTERAL	H02AB04					1384/05/16
Methylprednisolone	Acetate	INJECTION	40 mg/ml	PARENTERAL	H02AB04					1383/10/06
Methylprednisolone	As Sodium succinate	INJECTION, POWDER	500 mg	PARENTERAL	H02AB04			Hospital use only		1364/11/13
Methyltestosterone		TABLET	25 mg	ORAL	G03BA02
Metoclopramide	HCl	CAPSULE, LIQUID FILLED	10 mg	ORAL	A03FA01					1385/11/18
Metoclopramide	HCl	TABLET	10 mg	ORAL	A03FA01
Metoclopramide	HCl	SOLUTION/ DROPS	4 mg/ml, 15ml	ORAL	A03FA01
Metoclopramide	HCl	INJECTION	5 mg/ml	PARENTERAL	A03FA01
Metoprolol	Tartrate	TABLET	100 mg	ORAL	C07AB02					1380/06/25
Metoprolol	Succinate	TABLET, EXTENDED RELEASE	190 mg	ORAL	C07AB02					1385/11/24
Metoprolol	Tartrate	INJECTION	1mg/ml	PARENTERAL	C07AB02			Hospital use only		1379/04/06
Metoprolol	Succinate	TABLET, EXTENDED RELEASE	23.75 mg	ORAL	C07AB02					1385/11/24
Metoprolol	Succinate	TABLET, EXTENDED RELEASE	47.5 mg	ORAL	C07AB02					1385/11/24
Metoprolol	Tartrate	TABLET	50 mg	ORAL	C07AB02					1377/11/18
Metoprolol	Succinate	TABLET, EXTENDED RELEASE	95 mg	ORAL	C07AB02					1385/11/24
Metronidazole		GEL	0.75%	TOPICAL	D06BX01		Treatment of grade III and IV, anaerobically infected, decubitus ulcers. Treatment of acne rosacea.			1376/03/25
Metronidazole		GEL	0.75%	VAGINAL	G01AF01
Metronidazole	As Benzoate	SUSPENSION	125 mg/5ml	ORAL	P01AB01
Metronidazole		TABLET	250 mg	ORAL	P01AB01
Metronidazole		TABLET	500 mg	ORAL	P01AB01					1395/05/03
Metronidazole		INJECTION, SOLUTION	5 mg/ml	INTRAVENOUS DRIP	J01XD01			Hospital use only		1363/03/06
Metronidazole		SUPPOSITORY	500 mg	VAGINAL	G01AF01
Metronidazole		TABLET	500 mg	VAGINAL	G01AF01					1363/04/31
Metyrapone		TABLET	250 mg	ORAL	V04CD01
Mexiletine		CAPSULE	100 mg	ORAL	C01BB02					1377/02/09
Mexiletine		CAPSULE	200 mg	ORAL	C01BB02
Miconazole	Nitrate	CREAM	2%	TOPICAL	D01AC02
Miconazole	Nitrate	CREAM	2%	VAGINAL	G01AF04
Miconazole	Nitrate	SUPPOSITORY	100 mg	VAGINAL	G01AF04					1382/07/13
Microfibrillar Collagen Hemostat		TAMPON	14.8 mg/cm3	TOPICAL	B02BC07				0.15 cm thikness - Registered as ANTEMA
Microfibrillar Collagen Hemostat		TAMPON	15.5 mg/cm3	TOPICAL	B02BC07				Cillender 8 cm x 3 cm diameter - Registered as ANTEMA
Microfibrillar Collagen Hemostat		TAMPON	22.3mg/cm3	TOPICAL	B02BC07				0.5 cm thickness - Registered as ANTEMA
Midazolam	As HCl	INJECTION	1 mg/ml	PARENTERAL	N05CD08		Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam	Hospital use only		1391/02/25
Midazolam	As HCl	SOLUTION	10 mg/ml, 5ml	BUCCAL	N05CD08			Hospital use only		1391/02/25
Midazolam	As HCl	SYRUP	2 mg/ml	ORAL	N05CD08			Hospital use only		1391/02/25
Midazolam	As HCl	INJECTION	5 mg/ml	PARENTERAL	N05CD08		Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam	Hospital use only		1391/02/25
Midodrine	HCl	TABLET	2. 5 mg	ORAL	C01CA17			Hospital use only; Orphan medicines		1387/12/21
Midodrine	HCl	TABLET	5 mg	ORAL	C01CA17			Hospital use only; Orphan medicines		1387/12/21
Miglustat		CAPSULE	100 mg	ORAL	A16AX06		Mild to moderate type I Gaucher's disease	Hospital use only; Orphan medicines		1395/08/16
Milrinone	As Lactate	INJECTION, SOLUTION	1 mg/ml	PARENTERAL	C01CE02			Hospital use only		1379/02/04
Miltefosine		CAPSULE	50 mg	ORAL	L01XX09		Antileishmania	for Health Dept. of MOH only		1394/11/13
Mineral Oil		BULK			V03			Bulk medicines	liquid Paraffin
Minoxidil		AEROSOL ,FOAM	2%	TOPICAL	D11AX01		Androgenetic Alopecia	OTC medicines		1391/05/02
Minoxidil		AEROSOL, FOAM	5%	TOPICAL	D11AX01		Androgenetic Alopecia	OTC medicines		1391/05/02
Minoxidil		TABLET	10 mg	ORAL	C02DC01
Minoxidil		SOLUTION	20 mg/ml	TOPICAL	D11AX01		Androgenetic Alopecia	OTC medicines		1371/08/03
Minoxidil		SOLUTION	50 mg/ml	TOPICAL	D11AX01		Androgenetic Alopecia	OTC medicines
Minoxidil		BULK			V03			Bulk medicines		1376/12/10
Minoxidil+Azelaic Acid+Betamethasone		SOLUTION		TOPICAL	D11AX	Minoxidil 5% + Azelaic Acid 5% + Betamethasone Valerate 0.025%				1389/11/04
Minoxidil+Azelaic Acid+Betamethasone+Tretinoin		SOLUTION		TOPICAL	D11AX	Minoxidil 5% + Azelaic Acid 5% + Tretinoin 0.025% + Betamethasone Valerate 0.025%				1389/11/04
Mirtazapine		TABLET	7.5 mg	ORAL	N06AX11					1396/05/09
Mirtazapine		TABLET	15 mg	ORAL	N06AX11					1396/05/09
Mirtazapine		TABLET	30 mg	ORAL	N06AX11					1396/05/09
Mirtazapine		TABLET	45 mg	ORAL	N06AX11					1396/05/09
Mirtazapine		TABLET, ORALLY DISINTEGRATING	15 mg	ORAL	N06AX11					1396/05/09
Mirtazapine		TABLET, ORALLY DISINTEGRATING	30 mg	ORAL	N06AX11					1396/05/09
Mirtazapine		TABLET, ORALLY DISINTEGRATING	45 mg	ORAL	N06AX11					1396/05/09
Misoprostol		TABLET	200 mcg	ORAL	G02AD06		Treatment of intrauterine fetal death not accompanied by complete expulsion of the products of conception in the second and third trimesters of pregnancy.	Hospital use only	With obstetricians prescriptions only	1387/03/28
Mitomycin		INJECTION, POWDER	10 mg	PARENTERAL	L01DC03
Mitomycin		INJECTION, POWDER	2 mg	PARENTERAL	L01DC03
Mitomycin		INJECTION, POWDER	40 mg	INTRACAVITARY	L01DC03					1386/11/08
Mitomycin		INJECTION, POWDER	20 mg	INTRACAVITARY	L01DC03					1396/04/27
Mitomycin		INJECTION, POWDER	5 mg	PARENTERAL	L01DC03
Mitotane		TABLET	500 mg	ORAL	L01XX23					1361/09/14
Mitoxantrone	As HCl	INJECTION	2 mg/ml	PARENTERAL	L01DB07		Treatment of hormone refractory prostate cancer. Treatment of progressive-relapsing multiple sclerosis.			1365/09/16
Mivacurium	Chloride	INJECTION, POWDER	2 mg/ml	PARENTERAL	M03AC10			Hospital use only		1382/03/04
Moclobemide		TABLET	150 mg	ORAL	N06AG02					1376/02/28
Modafinil		TABLET	100 mg	ORAL	N06BA07				should be labelled as under control medicine	1387/12/21
Modafinil		TABLET	200 mg	ORAL	N06BA07				should be labelled as under control medicine	1388/08/20
Molgramostim (GMCSF)		INJECTION, POWDER	0.15 mg	PARENTERAL	L03AA03		Treatment of AIDS patients with neutropenia due to the disease, AZTor ganciclovir. Treatment of aplastic anemia.
Molgramostim (GMCSF)		INJECTION, POWDER	0.4 mg	PARENTERAL	L03AA03		Treatment of AIDS patients with neutropenia due to the disease, AZTor ganciclovir. Treatment of aplastic anemia.
Molybdenum (99Mo)/Technetium [99mTc]		GENERATOR	100-3000 mCi	INTRAVENOUS BOLUS	V09FX01			Hospital use only	Radiopharmaceuticals
Mometasone	Furoate	SPRAY, SUSPENSION	0.05%	NASAL	R01AD09					1386/12/07
Mometasone	Furoate	OINTMENT	0. 1%	TOPICAL	D07AC13					1388/02/02
Mometasone	Furoate	CREAM	0. 1%	TOPICAL	D07AC13					1388/02/02
Mometasone	Furoate	LOTION	0. 1%	TOPICAL	D07AC13					1388/02/02
Mometasone	Furoate	POWDER, INHALATION	100 mcg	RESPIRATORY	R03BA07					1392/05/29
Mometasone	Furoate	POWDER, INHALATION	200 mcg	RESPIRATORY	R03BA07					1392/05/29
Mometasone	Furoate	POWDER, INHALATION	400 mcg	RESPIRATORY	R03BA07					1392/05/29
Mometasone+Formoterol		AEROSOL, INHALATION		RESPIRATORY	R03AK07	Mometasone Furoate100 mcg+Formoterol Fumarate 5mcg				1392/05/29
Mometasone+Formoterol		AEROSOL, INHALATION		RESPIRATORY	R03AK07	Mometasone Furoate200 mcg+Formoterol Fumarate 5mcg				1392/05/29
Mometasone+Formoterol		AEROSOL, INHALATION		RESPIRATORY	R03AK07	Mometasone Furoate50 mcg+Formoterol Fumarate 5mcg				1392/05/29
Monobenzone		CREAM	20%	TOPICAL	D11AX13
Montelukast	As Sodium	TABLET	10 mg	ORAL	R03DC03					1384/02/26
Montelukast	As Sodium	GRANULE	4 mg	ORAL	R03DC03				Sachet
Montelukast	As Sodium	TABLET, CHEWABLE	5 mg	ORAL	R03DC03					1379/06/20
Morphine	Sulfate	SUPPOSITORY	10 mg	RECTAL	N02AA01					1385/10/05
Morphine	Sulfate	TABLET	10 mg	ORAL	N02AA01
Morphine	HCl	INJECTION	10 mg/ml	PARENTERAL	N02AA01			Hospital use only	for local production only; Without preservative	1389/8/24
Morphine	Sulfate	INJECTION	10 mg/ml	PARENTERAL	N02AA01			Hospital use only		1389/08/24
Morphine	Sulfate	INJECTION	25mg/ml	PARENTERAL	N02AA01			Hospital use only		1387/10/15
Morphine	Sulfate	INJECTION	50mg/ml	PARENTERAL	N02AA01			Hospital use only		1387/10/15
Moxifloxacin	As HCl	SOLUTION	0.50%	OPHTHALMIC	S01AE07					1390/07/04
Moxifloxacin	As HCl	TABLET	400 mg	ORAL	J01MA14			Hospital use only	for local production only; With infectious diseases specialists and pulmonologists prescriptions only	1390/003/07
Multivitamin Pediatric		INJECTION		INTRAVENOUS	A11AE	(Vit.B1 2.5mg + Vit.B2 3.6mg + Vit. B6 4mg + Vit. B12 5mcg + Niacin 40mg + Pantothenic Acid 15mg + Biotin 60mcg + Vit.C 100mg+Folic Acid 400mcg)/10ml INTERAVENOUS		Hospital use only	With pediatricians prescriptions only	1386/06/28
Multivitamin Infant Oily		INJECTION, EMULSION		INTRAVENOUS	B05XC		Nutrient	Hospital use only	With pediatricians prescriptions only, Should be reconstitute in intralipid	1396/11/29
Multivitamin Adult Oily		INJECTION, EMULSION		INTRAVENOUS	B05XC		Nutrient	Hospital use only	Should be reconstitute in intralipid	1396/11/29
Multivitamin Therapeutic		CAPSULE		ORAL	A11AA	Vit.A 25000 IU+Vit.B1 20 mg+Vit.B2 5mg+Nicotinamide50 mg+Vit.B6 10mg+Vit.B12 5mcg+Vit.C 150mg+Biotin 0.25mg+Vit.D 1000IU+ Vit.E 10mg(IU)+Folic Acid 1mg+Calcium Pantothenate 11.6mg+Ca 100mg +Mg(As MgO) 5mg +Mn 0.5mg+Mo 0.1mg+Iron 10mg+Zn 0.5mg+P 77.27mg+Cu
Multivitamin Therapeutic		TABLET		ORAL	A11AA	Vit.A25000 IU+Vit.B1 20mg+Vit.B2 5mg+Nicotinamide 50mg+Vit. B6 10mg+Vit. B12 5mcg+ Vit.C 150mg+Biotin 0.25mg+Vit.D 500IU+Vit.E 10mg(IU)+Folic Acid 1mg+Calcium Pantothenate 11.6mg +Ca HPO4,2H2O129mg +MnSO4,4H2O 2.05mg+MgO 30mg+CuSO4,5H2O 3.9mg+Sodium molib
Mumps Mirus Vaccine		INJECTION, POWDER		PARENTERAL	J07BX				Live
Mupirocin	As Calcium	OINTMENT	2%	NASAL	R01AX06					1378/02/19
Mupirocin		OINTMENT	2%	TOPICAL	D06AX09					1372/10/19
Mycophenolate Mofetil		CAPSULE	250 mg	ORAL	L04AA06
Mycophenolate Mofetil		TABLET	500 mg	ORAL	L04AA06
Mycophenolate Mofetil		POWDER FOR SUSPENSION	200 mg/ml	ORAL	L04AA06					1396/05/28
Mycophenolic acid		TABLET, DELAYED RELEASE	360 mg	ORAL	L04AA06		Treatment of pemphigus vulgaris Treatment of myasthenia gravis			1384/08/22
Mycophenolic acid		TABLET, DELAYED RELEASE	180 mg	ORAL	L04AA06		Treatment of pemphigus vulgaris Treatment of myasthenia gravis
Nafcillin	Sodium	INJECTION, POWDER	500 mg	PARENTERAL	J01CF06			Hospital use only		1364/12/04
Nalidixic Acid		TABLET	500 mg	ORAL	J01MB02
Nalidixic Acid		SUSPENSION	60 mg/ml	ORAL	J01MB02					1366/07/26
Naloxone	HCl	INJECTION	0.4 mg/ml	PARENTERAL	V03AB15			Hospital use only
Naltrexone	HCl	CAPSULE	25 mg	ORAL	N07BB04
Naltrexone		INJECTION, POWDER	380 mg/vial	PARENTRAL	N07BB04			Hospital use only		1392/05/01
Naltrexone	HCl	CAPSULE	50 mg	ORAL	N07BB04
Nandrolone	Decanoate	INJECTION	25 mg/ml	PARENTERAL	A14AB01
Nandrolone	Phenpropionate	INJECTION	25 mg/ml	PARENTERAL	A14AB01
Naphazoline	HCl	SOLUTION/ DROPS	0.05%	NASAL	R01AA08
Naphazoline	HCl	SPRAY	0.05%	NASAL	R01AA08					1384/03/09
Naphazoline	Nitrate	SOLUTION/ DROPS	0.05%	NASAL	R01AA08
Naphazoline	HCl	SOLUTION/ DROPS	0.1%	OPHTHALMIC	S01GA01
Naphazoline	Nitrate	SOLUTION/ DROPS	0.1%	OPHTHALMIC	S01GA01
Naphazoline+Antazoline		SOLUTION/ DROPS		OPHTHALMIC	S01GA51	Naphazoline HCl 0.05%+Antazoline Phosphate 0.5%				1360/09/22
Naproxen		CAPSULE, LIQUID FILLED	200 mg	ORAL	M01AE02					1389/03/31
Naproxen		TABLET	250 mg	ORAL	M01AE02					1373/05/30
Naproxen		TABLET	375 mg	ORAL	M01AE02					1386/07/18
Naproxen		SUPPOSITORY	500 mg	RECTAL	M01AE02					1379/09/27
Naproxen		TABLET, DELAYED RELEASE	500 mg	ORAL	M01AE02					1374/02/09
Natalizumab		INJECTION, SOLUTION,CONCENTRATE	20 mg/ ml	PARENTERAL	L04AA23					1390/07/05
Natamycin		SOLUTION/ DROPS	5%	OPHTHALMIC	S01AA10					1368/07/16
Nelfinavir	As Mesylate	TABLET	250 mg	ORAL	J05AE04					1379/05/02
Nelfinavir	As Mesylate	POWDER	50 mg/g	ORAL	J05AE04			for Health Dept. of MOH only		1385/09/07
Nelfinavir	As Mesylate	TABLET	625 mg	ORAL	J05AE04			for Health Dept. of MOH only		1383/08/04
Neomycin	Sulfate	SOLUTION	125 mg/5ml	ORAL	J01GB05					1368/05/09
Neomycin	Sulfate	TABLET	500 mg	ORAL	J01GB05
Neostigmine	Methylsulfate	INJECTION	0.5 mg/ml	PARENTERAL	N07AA01			Hospital use only
Neostigmine	Bromide	TABLET	15 mg	ORAL	N07AA01					1379/04/06
Neostigmine	Methylsulfate	INJECTION	2.5 mg/ml	PARENTERAL	N07AA01			Hospital use only		1362/11/23
Nevirapine		TABLET	200 mg	ORAL	J05AG01		Treatment of AIDS related complex.	for Health Dept. of MOH only
Nevirapine		SUSPENSION	50 mg/5ml	ORAL	J05AG01		Treatment of AIDS related complex.	for Health Dept. of MOH only
Niacinamide		TABLET	500 mg	ORAL	A11HA01					1369/10/30
Niclosamide		TABLET, CHEWABLE	500 mg	ORAL	P02DA01
Nicorandil		TABLET	10 mg	ORAL	C01DX16					1387/12/21
Nicorandil		TABLET	20 mg	ORAL	C01DX16					1387/12/21
Nicotine		LOZENGE	1 mg/ml	ORAL	N07BA01				For local production only	1391/06/13
Nicotine		SPRAY	10 mg/ml	NASAL	N07BA01			OTC medicines		1385/09/15
Nicotine		PATCH, EXTENDED RELEASE	14mg/24h	TRANSDERMAL	N07BA01			OTC medicines		1386/04/13
Nicotine		PATCH, EXTENDED RELEASE	15 mg/16h	TRANSDERMAL	N07BA01			OTC medicines
Nicotine		LOZENGE	2 mg	ORAL	N07BA01			OTC medicines		1391/06/13
Nicotine		GUM	2 mg	ORAL	N07BA01			OTC medicines		1372/04/27
Nicotine		TABLET	2 mg	SUBLINGUAL	N07BA01			OTC medicines		1378/08/23
Nicotine		PATCH, EXTENDED RELEASE	21mg/24h	TRANSDERMAL	N07BA01			OTC medicines		1386/04/13
Nicotine		LOZENGE	4 mg	ORAL	N07BA01			OTC medicines		1391/06/13
Nicotine		PATCH, EXTENDED RELEASE	7mg/24h	TRANSDERMAL	N07BA01			OTC medicines		1386/04/13
Nicotinic Acid		TABLET	100 mg	ORAL	C10AD02					1363/04/03
Nicotinic Acid		TABLET	25 mg	ORAL	C04AC01					1369/10/30
Nicotinic Acid		TABLET	500 mg	ORAL	C10AD02					1376/06/30
Nifedipine		CAPSULE	10 mg	ORAL	C08CA05
Nifedipine		TABLET	10 mg	ORAL	C08CA05					1365/02/21
Nifedipine		CAPSULE, EXTENDED RELEASE	20 mg	ORAL	C08CA05					1383/08/18
Nifedipine		TABLET, EXTENDED RELEASE	20 mg	ORAL	C08CA05					1382/01/24
Nifedipine		TABLET, EXTENDED RELEASE	60 mg	ORAL	C08CA05					1396/11/29
Nifedipine		CAPSULE	30 mg	ORAL	C08CA05
Nifedipine		TABLET	30 mg	ORAL	C08CA05					1377/11/18
Nilotinib	As HCl	CAPSULE	150 mg	ORAL	L01XE08				For local production only	1390/03/23
Nilotinib	As HCl	CAPSULE	200 mg	ORAL	L01XE08					1388/05/11
Nimodipine		INJECTION, SOLUTION	0.2 mg/ml	INTRAVENOUS DRIP	C08CA06			Hospital use only
Nimodipine		TABLET	30 mg	ORAL	C08CA06
Nitisinone		CAPSULE	10 mg	ORAL	A16AX04			Orphan medicines; for treatment of Tyrosinemia type I patients		1387/11/06
Nitisinone		TABLET	10 mg	ORAL	A16AX04			Orphan medicines; for treatment of Tyrosinemia type I patients		1387/11/06
Nitisinone		TABLET	2 mg	ORAL	A16AX04			Orphan medicines; for treatment of Tyrosinemia type I patients		1387/11/06
Nitisinone		CAPSULE	2 mg	ORAL	A16AX04			Orphan medicines; for treatment of Tyrosinemia type I patients		1387/11/06
Nitisinone		CAPSULE	5 mg	ORAL	A16AX04			Orphan medicines; for treatment of Tyrosinemia type I patients		1387/11/06
Nitisinone		TABLET	5 mg	ORAL	A16AX04			Orphan medicines; for treatment of Tyrosinemia type I patients		1387/11/06
Nitrazepam		TABLET	5 mg	ORAL	N05CD02					1382/04/01
Nitrofurantoin		TABLET	100 mg	ORAL	J01XB01
Nitrofurantoin		SUSPENSION	25 mg/5ml	ORAL	J01XE01
Nitrofurazone		CREAM	0.20%	TOPICAL	D09AA03
Nitroglycerin		OINTMENT	2%	TOPICAL	C01DA02
Nitroglycerin		CAPSULE, LIQUID FILLED	0.4 mg	SUBLINGUAL	C01DA02
Nitroglycerin		TABLET	0.4 mg	ORAL	C01DA02
Nitroglycerin		INJECTION	1 mg/ml	PARENTERAL	C01DA02			Hospital use only
Nitroglycerin		PLASTER	10 mg/24h	TRANSDERMAL	C01DA02					1368/07/16
Nitroglycerin		PATCH, EXTENDED RELEASE	10 mg/24h	TRANSDERMAL	C01DA02					1387/07/07
Nitroglycerin		CAPSULE, EXTENDED RELEASE	2.5 mg	ORAL	C01DA02
Nitroglycerin		TABLET, EXTENDED RELEASE	2.5 mg	ORAL	C01DA02
Nitroglycerin		CAPSULE, EXTENDED RELEASE	2.6 mg	ORAL	C01DA02
Nitroglycerin		TABLET, EXTENDED RELEASE	2.6 mg	ORAL	C01DA02					1370/02/29
Nitroglycerin		SPRAY	400 mcg/dose	RESPIRATORY	C01DA02					1377/11/18
Nitroglycerin		PLASTER	5 mg/24h	TRANSDERMAL	C01DA02					1368/07/16
Nitroglycerin		PATCH, EXTENDED RELEASE	5 mg/24h	TRANSDERMAL	C01DA02					1387/07/07
Nitroglycerin		OINTMENT	0.40%	TOPICAL	C01DA02					1395/10/07
Nitroglycerin		INJECTION	5 mg/ml	PARENTERAL	C01DA02			Hospital use only		1382/02/28
Nitroglycerin		CAPSULE, EXTENDED RELEASE	6.4 mg	ORAL	C01DA02
Nitroglycerin		TABLET, EXTENDED RELEASE	6.4 mg	ORAL	C01DA02					1361/06/07
Nitroglycerin		CAPSULE, EXTENDED RELEASE	6.5 mg	ORAL	C01DA02
Nitroglycerin		TABLET, EXTENDED RELEASE	6.5 mg	ORAL	C01DA02
Nitroprusside	Sodium	INJECTION, POWDER	50 mg	PARENTERAL	C02DD01		Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage.
Nitrous Oxide		INHALER	1000 PPM	RESPIRATORY	N01AX13
Nitrous Oxide		INHALANT		RESPIRATORY	N01AX13
Nitrous oxide+Oxygen		GAS, MEDICINAL		INHALATION	N01AX63	Nitrous oxide 50%v/v+Oxygen 50%V/V		Hospital use only	for local production only	1389/05/30
Nonoxynol-9		CREAM	5%	VAGINAL	G02BB					1369/10/30
Norepinephrine	As Bitartrate	INJECTION	0.10%	PARENTERAL	C01CA03			Hospital use only
Nortriptyline	As HCl	TABLET	10 mg	ORAL	N06AA10					1362/03/08
Nortriptyline	As HCl	TABLET	25 mg	ORAL	N06AA10					1362/03/08
Nystatin		TABLET	500,000 U	ORAL	A03AA03
Nystatin		TABLET	100,000 U	VAGINAL	G01AA01					1359/06/08
Nystatin		OINTMENT	100,000 U/g	TOPICAL	D01AA01
Nystatin		POWDER, FOR SUSPENSION	100,000 U/ml	LOCAL ORAL	A07AA03
Obidoxime	Chloride	INJECTION	250 mg/ml	PARENTERAL	V03AB13			Hospital use only		1365/11/19
Obidoxime	Chloride	INJECTION	275 mg/ml	PARENTERAL	V03AB13			Hospital use only
Ocrelizumab		INJECTION, SOLUTION, CONCENTRATE	30 mg/ml	PARENTERAL	L04AA36		Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis			1397/06/24
Octreotide	As Acetate	INJECTION	100 mcg/ml	PARENTERAL	H01CB02		Treatment of acromegaly. Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma). Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.	Hospital use only
Octreotide	As Acetate	INJECTION,POWDER,EXTENDED RELEASE	20 mg	PARENTERAL	H01CB02		Treatment of acromegaly. Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma). Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.	Hospital use only
Octreotide	As Acetate	INJECTION	200 mcg/ml	PARENTERAL	H01CB02		Treatment of acromegaly. Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma). Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.	Hospital use only
Octreotide	As Acetate	INJECTION,POWDER,EXTENDED RELEASE	30 mg	PARENTERAL	H01CB02		Treatment of acromegaly. Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma). Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.	Hospital use only		1389/03/31
Octreotide	As Acetate	INJECTION	50 mcg/ml	PARENTERAL	H01CB02		Treatment of acromegaly. Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma). Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.	Hospital use only		1382/04/29
Ofloxacin		SOLUTION/ DROPS	0.3%	OTIC	S02AA16					1381/10/08
Ofloxacin		TABLET	200 mg	ORAL	J01MA01
Ofloxacin		TABLET	300 mg	ORAL	J01MA01					1380/02/30
Ofloxacin		SOLUTION/ DROPS	3mg/ml	OPHTALMIC	S01AE01					1391/06/13
Ofloxacin		TABLET	400 mg	PARENTERAL	J01MA01					1386/09/07
Olanzapine		INJECTION, POWDER, FOR SOLUTION	10 mg	PARENTERAL	N05AH03					1392/03/21
Olanzapine		TABLET	10 mg	ORAL	N05AH03
Olanzapine		TABLET	15 mg	ORAL	N05AH03					1382/09/03
Olanzapine		TABLET	2.5 mg	ORAL	N05AH03					1382/09/03
Olanzapine		TABLET	5 mg	ORAL	N05AH03					1379/06/20
Olopatadine	HCl	SPRAY	0.6%(665 mcg/puff)	INTRANASAL	R01AC08					1390/06/14
Olopatadine	As HCl	SOLUTION/ DROPS	5 mg/ 5 ml	OPHTALMIC	S01GX09					1388/04/21
Omalizumab		INJECTION, POWDER	150 mg	PARENTERAL	R03DX05					1391/12/23
Omalizumab		INJECTION, POWDER	75mg	PARENTERAL	R03DX05					1391/12/23
Omeprazole		POWDER, FOR SUSPENSION	20 mg	ORAL	A02BC01				sachet	1386/09/07
Omeprazole	As Magnesium	POWDER, FOR SUSPENSION, DELAYED RELEASE	10 mg	ORAL	A02BC01				sachet	1395/06/24
Omeprazole	As Magnesium	POWDER, FOR SUSPENSION, DELAYED RELEASE	2.5 mg	ORAL	A02BC01				sachet	1395/06/24
Omeprazole		CAPSULE, DELAYED RELEASE PELLETS	20 mg	ORAL	A02BC01
Omeprazole	As Magnesium	CAPSULE, DELAYED RELEASE PELLETS	20 mg	ORAL	A02BC01					1396/03/21
Omeprazole	As Magnesium	TABLET, DELAYED RELEASE	20 mg	ORAL	A02BC01					1396/08/29
Omeprazole	As Sodium	INJECTION, POWDER	40 mg	PARENTERAL	A02BC01		PPI			1396/11/29
Ondansetron	As HCl	INJECTION, SOLUTION	32 mg/50ml	INTRAVENOUS DRIP	A04AA01					1391/10/03
Ondansetron	As HCl	TABLET	4 mg	ORAL	A04AA01					1377/06/22
Ondansetron	As HCl	TABLET	8 mg	ORAL	A04AA01					1396/12/08
Ondansetron		TABLET, ORALLY DISINTEGRATING	4 mg	ORAL	A04AA01				ODT	1395/12/18
Ondansetron		TABLET, ORALLY DISINTEGRATING	8 mg	ORAL	A04AA01				ODT	1395/12/18
Ondansetron	As HCl	FILM	4 mg	ORAL	A04AA01				ORALLY DISINTEGRATING	1396/03/21
Ondansetron	As HCl	FILM	8 mg	ORAL	A04AA01				ORALLY DISINTEGRATING	1396/03/21
Ondansetron	As HCl	SOLUTION	4 mg/5ml	ORAL	A04AA01					1382/02/21
Ondansetron	As HCl	INJECTION	2 mg/ml	PARENTERAL	A04AA01					1377/06/22
Ophthalmic Bath Solution 1		SOLUTION		OPHTHALMIC	S01AX07	Boric Acid 1610 mg/100 ml		OTC medicines		1369/10/30
Ophthalmic Bath Solution 2		SOLUTION		OPHTHALMIC	S01X	NaCl 0.49% or 0.64% + KCl 0.075% + MgCl2, 6H2O 0.03% + CaCl2, 2 H2O 0.048% +Sodium Citrate, 2 H2O 0.17% + Sodium Acetate, 3H2O 0.39%		OTC medicines	Balanced Salt Solution	1360/09/22
Ophthalmic Bath Solution 3		SOLUTION		OPHTHALMIC	S01X	Part 1:480ml (NaCl 7.44mg+KCl 0.395mg + Na2HPO4 0.433mg+ NaHCO3 2.19mg)/ml, Part 2:20ml (Glutathion Disulfide 4.6mg + Dextrose 23 mg +Calcium Chloride,2H2O 3.85mg + Magnesium Chloride,6H2O 5mg)/ml		OTC medicines	Balanced Salt Solution+Glutathion	1361/12/23
Opium		TINCTURE	10 mg/ml	ORAL	N02AA02				For abuse and addiction treatment centers	1389/03/29
Orlistat		CAPSULE	120 mg	ORAL	A08AB01					1381/06/10
Orlistat		CAPSULE	60 mg	ORAL	A08AB01			OTC medicines		1387/03/28
Oseltamivir		CAPSULE	30 mg	ORAL	J05AH02			For Health Dept. of MOH only		1388/08/20
Oseltamivir		CAPSULE	45 mg	ORAL	J05AH02			For Health Dept. of MOH only		1388/08/20
Oseltamivir	As phosphate	POWDER, FOR SOLUTION	30 mg/5ml	ORAL	J05AH02			For Health Dept. of MOH only		1395/05/03
Oseltamivir	As phosphate	POWDER, FOR SOLUTION	60 mg/5ml	ORAL	J05AH02			For Health Dept. of MOH only
Oseltamivir	As phosphate	POWDER, FOR SUSPENSION	60 mg/5ml	ORAL	J05AH02			For Health Dept. of MOH only		1391/06/13
Oseltamivir	As phosphate	CAPSULE	75 mg	ORAL	J05AH02			For Health Dept. of MOH only		1384/04/12
Oxaliplatin		INJECTION, POWDER, LYOPHILIZED	100 mg	PARENTERAL	L01XA03					1380/02/09
Oxaliplatin		INJECTION, SOLUTION, CONCENTRATE	5 mg/ml	PARENTERAL	L01XA03
Oxaliplatin		INJECTION, POWDER, LYOPHILIZED	50 mg	PARENTERAL	L01XA03					1380/02/09
Oxandrolone		TABLET	2.5 mg	ORAL	A14AA08					1378/08/23
Oxandrolone		TABLET	10 mg	ORAL	A14AA08					1397/06/24
Oxazepam		TABLET	10 mg	ORAL	N05BA04
Oxcarbazepine		TABLET	150 mg	ORAL	N03AF02					1380/11/28
Oxcarbazepine		TABLET	300 mg	ORAL	N03AF02					1380/11/28
Oxcarbazepine		TABLET	600 mg	ORAL	N03AF02					1380/11/28
Oxybutynin	HCl	TABLET, EXTENDED RELEASE	10 mg	ORAL	G04BD04					1392/07/22
Oxybutynin	HCl	TABLET, EXTENDED RELEASE	15 mg	ORAL	G04BD04					1392/07/22
Oxybutynin	HCl	TABLET	5 mg	ORAL	G04BD04
Oxycodone	HCl	TABLET, EXTENDED RELEASE	10 mg	ORAL	N02AA05			Narcotic medicines; Should be labelled as under control medicines		1388/08/20
Oxycodone	HCl	TABLET	15 mg	ORAL	N02AA05			Narcotic medicines; Should be labelled as under control medicines		1383/11/04
Oxycodone	HCl	TABLET, EXTENDED RELEASE	20 mg	ORAL	N02AA05			Narcotic medicines; Should be labelled as under control medicines		1388/08/20
Oxycodone	HCl	TABLET	30 mg	ORAL	N02AA05			Narcotic medicines; Should be labelled as under control medicines		1383/11/04
Oxycodone	HCl	TABLET, EXTENDED RELEASE	40 mg	ORAL	N02AA05			Narcotic medicines; Should be labelled as under control medicines		1388/08/20
Oxycodone	HCl	TABLET	5 mg	ORAL	N02AA05			Narcotic medicines; Should be labelled as under control medicines		1383/11/04
Oxycodone	HCl	TABLET, EXTENDED RELEASE	80 mg	ORAL	N02AA05			Narcotic medicines; Should be labelled as under control medicines		1388/08/20
Oxygen		GAS, MEDICINAL		INHALATION						1396/03/21
Oxymetazoline	HCl	SPRAY	0.05%	NASAL	S01GA04				for local production only	1389/06/29
Oxymetazoline	HCl	SPRAY	0.10%	NASAL	S01GA04				for local production only	1389/06/29
Oxymetholone		TABLET	50 mg	ORAL	A14AA05
Oxytocin		INJECTION	10 U/ml	PARENTERAL	H01BB02			Hospital use only
Oxytocin		INJECTION	5 U/ml	PARENTERAL	H01BB02			Hospital use only
Paclitaxel		INJECTION, POWDER FOR SUSPENSION	100 mg	PARENTERAL	L01CD01				Albumin band (Nano)	1392/06/12
Paclitaxel		INJECTION	6 mg/ml	PARENTERAL	L01CD01		Treatment of AIDS-related Kaposi's sarcoma. Treatment of non-superficial urothelial cancer			1381/05/20
Pamidronate	Disodium	INJECTION	15 mg/ml	PARENTERAL	M05BA03					1385/08/17
Pamidronate	Disodium	INJECTION	3 mg/ml	PARENTERAL	M05BA03
Pamidronate	Disodium	INJECTION, POWDER, LYOPHILIZED	30 mg	PARENTERAL	M05BA03					1382/03/04
Pamidronate	Disodium	INJECTION, POWDER, LYOPHILIZED	90 mg	PARENTERAL	M05BA03					1382/03/04
Pamidronate	Disodium	INJECTION, SOLUTION, CONCENTRATE	9mg/ml	PARENTERAL	M05BA03
Pancreatin		TABLET, DELAYED RELEASE		ORAL	A09AA02			OTC medicines		1369/10/30
Pancreatin		CAPSULE		ORAL	A09AA02
Pancuronium	Bromide	INJECTION	2 mg/ml	PARENTERAL	M03AC01			Hospital use only		1371/08/03
Panitumumab		INJECTION, SOLUTION, CONCENTRATE	20mg/ml	PARENTERAL	L01XC08			Metastatic colorectal cancer		1395/12/22
Pantoprazole	As Sodium sesquihydrate	CAPSULE, DELAYED RELEASE	15 mg	ORAL	A02BC02					1385/08/17
Pantoprazole	As Sodium sesquihydrate	TABLET, DELAYED RELEASE	20 mg	ORAL	A02BC02					1382/04/15
Pantoprazole	As Sodium sesquihydrate	CAPSULE, DELAYED RELEASE	20 mg	ORAL	A02BC02					1386/06/28
Pantoprazole	As Sodium	INJECTION, POWDER, LYOPHILIZED	40 mg	INTRAVENOUS DRIP	A02BC02					1382/03/04
Pantoprazole	As Sodium sesquihydrate	TABLET, DELAYED RELEASE	40 mg	ORAL	A02BC02					1382/04/15
Pantoprazole	As Sodium sesquihydrate	CAPSULE, DELAYED RELEASE	40 mg	ORAL	A02BC02					1386/06/28
Papaverine	HCl	INJECTION	40 mg/ml	PARENTERAL	G04BE02			Hospital use only		1375/12/12
Para aminosalicylic acid		GRANULE	4 g	ORAL	J04AA01		Treatment of tuberculosis infections
Para-Aminobenzoic Acid		BULK			V03			Bulk medicines
Parathormon		INJECTION	100 uspU/ml	PARENTERAL	H05AA01			Hospital use only		1361/09/14
Paromomycin	As Sulfate	SYRUP	125 mg/ 5ml	ORAL	A07AA06					1359/07/13
Paromomycin	As Sulfate	CAPSULE	250 mg	ORAL	A07AA06					1359/07/13
Paromomycin+Urea		OINTMENT		TOPICAL	D06AX	(Paromomycin 15 g + Urea 10 g ) / 100 g
Paroxetine	As HCl	TABLET	20 mg	ORAL	N06AB05					1393/02/07
Paroxetine	As HCl	TABLET	40 mg	ORAL	N06AB05					1393/02/07
Paroxetine	As Mesilate	TABLET	20 mg	ORAL	N06AB05					1395/12/22
Patent Blue V		INJECTION		PARENTERAL	V04CX					1363/05/21
Pediatric Grippe		SYRUP		ORAL	R06AB54	(Chlorpheniramine Maleate 0.67mg + Pseudoephedrine HCl 10 mg)/5ml		OTC medicines
Pegaspargase		INJECTION, POWDER	3750 IU	PARENTERAL	L01XX24			Orphan medicines
Pegaspargase		INJECTION	750 IU/ml	PARENTERAL	L01XX24		treatment of Acute lymphocytic leukemia	Orphan medicines		1383/06/01
Pegfilgrastim		INJECTION, SOLUTION	10 mg/ml	PARENTERAL	L03AA13					1393/03/25
Peginterferon Alfa-2a		INJECTION	180 mcg/ml	PARENTERAL	L03AB11		Treatment of chronic myelogenous leukemia. Treatment of renal cell carcinoma.			1383/02/13
Peginterferon Alfa-2a		INJECTION	270 mcg/ml	PARENTERAL	L03AB11		Treatment of chronic myelogenous leukemia. Treatment of renal cell carcinoma.			1386/03/23
Peginterferon Alfa-2a		INJECTION	360 mcg/ml	PARENTERAL	L03AB11		Treatment of chronic myelogenous leukemia. Treatment of renal cell carcinoma.
Peginterferon Alfa-2b		INJECTION, POWDER, LYOPHILIZED	100 mcg	PARENTERAL	L03AB10		Treatment of chronic myelogenous leukemia. Treatment of renal cell carcinoma.			1384/05/16
Peginterferon Alfa-2b		INJECTION, POWDER, LYOPHILIZED	120 mcg	PARENTERAL	L03AB10		Treatment of chronic myelogenous leukemia. Treatment of renal cell carcinoma.			1384/05/16
Peginterferon Alfa-2b		INJECTION, POWDER, LYOPHILIZED	150 mcg	PARENTERAL	L03AB10		Treatment of chronic myelogenous leukemia. Treatment of renal cell carcinoma.			1384/05/16
Peginterferon Alfa-2b		INJECTION, POWDER, LYOPHILIZED	50 mcg	PARENTERAL	L03AB10		Treatment of chronic myelogenous leukemia. Treatment of renal cell carcinoma.			1384/05/16
Peginterferon Alfa-2b		INJECTION, POWDER, LYOPHILIZED	80 mcg	PARENTERAL	L03AB10		Treatment of chronic myelogenous leukemia. Treatment of renal cell carcinoma.			1384/05/16
Peginterferon Beta-1a		INJECTION	125 mcg/ 0.5 ml	PARENTERAL	L03AB13		Treatment of relapsing-remitting multiple sclerosis			1395/12/22
Peginterferon Beta-1a		INJECTION	94 mcg/ 0.5 ml	PARENTERAL	L03AB13		Treatment of relapsing-remitting multiple sclerosis			1395/12/22
Peginterferon Beta-1a		INJECTION	63 mcg/ 0.5 ml	PARENTERAL	L03AB13		Treatment of relapsing-remitting multiple sclerosis			1395/12/22
Pemetrexed	as disodium	INJECTION, POWDER, LYOPHILIZED	100 mg	PARENTERAL	L01BA04					1390/07/05
Pemetrexed	as disodium	INJECTION, POWDER, LYOPHILIZED	500 mg	PARENTERAL	L01BA04					1390/07/05
Penicillamine		CAPSULE	250 mg	ORAL	M01CC01
Penicillamine		TABLET	250 mg	ORAL	M01CC01
Penicillin 6-3-3		INJECTION, POWDER,		PARENTERAL	J01RA01	Benzathine penicillin G 600,000U+Potassium Penicillin G 300,000U+Procaine Penicillin G 300,000U
Penicillamine		TABLET, DELAYED RELEASE	300 mg	ORAL	M01CC01					1396/04/27
Penicillin G	Potassium	INJECTION, POWDER	1,000,000 U	PARENTERAL	J01CE01
Penicillin G	Benzathin	INJECTION,POWDER,EXTENDED RELEASE	1,200,000 U	PARENTERAL	J01RA01
Penicillin G	Procaine	INJECTION, POWDER	400,000 U	PARENTERAL	J01RA01	Potassium Penicillin G 100,000U+Procaine Penicillin G 300,000U
Penicillin G	Potassium	INJECTION, POWDER	5,000,000 U	PARENTERAL	J01CE01					1384/02/26
Penicillin G	Sodium	INJECTION, POWDER	5,000,000 U	PARENTERAL	J01RA01
Penicillin G	Benzathin	INJECTION,POWDER,EXTENDED RELEASE	600,000 U	PARENTERAL	J01RA01
Penicillin G	Procaine	INJECTION, POWDER	800,000 U	PARENTERAL	J01RA01	Potassium Penicillin G 200,000U+ Procaine Penicillin G 600,000U
Penicillin V	As Potassium	POWDER, FOR SOLUTION	125 mg/5ml	ORAL	J01RA01					1359/07/13
Penicillin V	Benzathine	POWDER, FOR SUSPENSION	200,000 IU/5ml	ORAL	J01RA01					1374/07/30
Penicillin V	As Potassium	POWDER, FOR SUSPENSION	250 mg/5ml	ORAL	J01RA01
Penicillin V	Benzathine	POWDER, FOR SUSPENSION	400,000 IU/5ml	ORAL	J01RA01					1374/07/30
Penicillin V	As Potassium	TABLET	500 mg	ORAL	J01RA01
Pentagastrin		INJECTION	0.25 mg/ml	PARENTERAL	V04CG04
Pentamidine	Isoethionate	INJECTION, POWDER, LYOPHILIZED	300 mg	PARENTERAL	P01CX01			Hospital use only
Pentazocine	As Lacate	INJECTION	30 mg/ml	PARENTERAL	N02AD01			Hospital use only
Pentazocine	HCl	TABLET	50 mg	ORAL	N02AD01
Pentoxifylline		TABLET, EXTENDED RELEASE	400 mg	ORAL	C04AD03
Peritoneal Dialysis I		SOLUTION		PARENTERAL	B05D	Na+ 132 mEq/L + Ca++ 3.5 mEq/L + Mg++ 1.5 mEq/L + Cl- 102 mEq/L + Lactate 35 mEq/L+ Dextrose anhydrous or monohydrate Eq. to 13.62 g/L Dextrose+Water For Inj. Q.S.To 1000ml
Peritoneal Dialysis I; Bicarbonate Based		SOLUTION		PARENTERAL	B05D	Glucose anhydrous 75.5 mmol/L Na+ 132 mmol/L + Ca++ 1,25 mmol/L + Mg++ 0.25 mmol/L + Cl- 95 mmol/L + (S)-Lactate 15 mmol/L+ HCo3- 25mmol/L				1389/08/24
Peritoneal Dialysis II		SOLUTION		PARENTERAL	B05D	Na+ 132 mEq/L + Ca++ 3.5 mEq/L + Mg++ 1.5 mEq/L + Cl- 102 mEq/L + Lactate 35 mEq/L+ Dextrose anhydrous or monohydrate Eq. to 22.70 g/L Dextrose+Water For Inj. Q.S.To 1000ml
Peritoneal Dialysis II; Bicarbonate Based		SOLUTION		PARENTERAL	B05D	Glucose anhydrous 126 mmol/L Na+ 132 mmol/L + Ca++ 1,25 mmol/L + Mg++ 0.25 mmol/L + Cl- 95 mmol/L + (S)-Lactate 15 mmol/L HCo3-25mmol/L				1389/08/24
Peritoneal Dialysis III		SOLUTION		PARENTERAL	B05D	Na+ 132 mEq/L + Ca++ 3.5 mEq/L + Mg++ 1.5 mEq/L + Cl- 102 mEq/L + Lactate 35 mEq/L+Dextrose anhydrous or monohydrate Eq. to 38.60 g/L Dextrose+Water For Inj. Q.S.To 1000ml
Peritoneal Dialysis III; Bicarbonate Based		SOLUTION		PARENTERAL	B05D	Glucose anhydrous 214 mmol/L Na+ 132 mmol/L + Ca++ 1,25 mmol/L + Mg++ 0.25 mmol/L + Cl- 95 mmol/L + (S)-Lactate 15 mmol/L + HCo3-25mmol/L				1389/08/24
Peritoneal Dialysis IV; Icodextrine Based		SOLUTION		PARENTERAL	B05D	Icidextrine 75 g/L+ Na+ 133 mmol/L + Ca++ 1,75 mmol/L + Mg++ 0.25 mmol/L + Cl- 96 mmol/L + Lactate 40 mmol/L
Peritoneal DialysisV-I; Bicarbonate Based (Lactate Free)		SOLUTION		PARENTERAL	B05D	Glucose anhydrous 83.25 mmol/L Na+ 134 mmol/L + Ca++ 1,75 mmol/L + Mg++ 0.5 mmol/L + Cl- 104.5 mmol/L + HCo3-34.5mmol/L				1395/09/01
Peritoneal DialysisV-II; Bicarbonate Based (Lactate Free)		SOLUTION		PARENTERAL	B05D	Glucose anhydrous 126.1 mmol/L Na+ 134 mmol/L + Ca++ 1,75 mmol/L + Mg++ 0.5 mmol/L + Cl- 104.5 mmol/L + HCo3-34.5mmol/L				1395/09/01
Peritoneal DialysisV-III; Bicarbonate Based (Lactate Free)		SOLUTION		PARENTERAL	B05D	Glucose anhydrous 235.9 mmol/L Na+ 134 mmol/L + Ca++ 1,75 mmol/L + Mg++ 0.5 mmol/L + Cl- 104.5 mmol/L + HCo3-34.5mmol/L				1395/09/01
Permethrin		CREAM	1%	TOPICAL	P03AC04			OTC medicines		1372/02/12
Permethrin		SHAMPOO	1%	TOPICAL	P03AC04			OTC medicines		1374/08/21
Permethrin		CREAM	5%	TOPICAL	P03AC04					1381/11/20
Perphenazine		TABLET	2 mg	ORAL	N05AB03
Perphenazine		TABLET	4 mg	ORAL	N05AB03
Perphenazine		INJECTION	5 mg/ml	PARENTERAL	N05AB03
Perphenazine		TABLET	8 mg	ORAL	N05AB03
Pethidine	HCl	INJECTION	25 mg/ml	PARENTERAL	N02AB02			Hospital use only		1386/03/23
Pethidine	HCl	INJECTION	50 mg/ml	PARENTERAL	N02AB02			Hospital use only
Phenazopyridine	HCl	TABLET	100 mg	ORAL	G04BX06					1375/12/12
Phenobarbital		TABLET	100 mg	ORAL	N03AA02
Phenobarbital	Sodium	INJECTION	100 mg/ml	PARENTERAL	N03AA02			Hospital use only
Phenobarbital		TABLET	15 mg	ORAL	N03AA02
Phenobarbital	As Sodium	INJECTION	200 mg/ml	PARENTERAL	N03AA02			Hospital use only
Phenobarbital	Sodium	INJECTION	200 mg/ml	PARENTERAL	N03AA02			Hospital use only
Phenobarbital		TABLET	60 mg	ORAL	N03AA02
Phenol		BULK			V03			Bulk medicines
Phenol Glycerin		SOLUTION/ DROPS	6.40%	OTIC	D08AE03	Phenol 6.4 g + Glycerin qs 100 g		OTC medicines
Phenolsulphonphthalein		INJECTION	6 mg/ml	PARENTERAL	V04CH03
Phenoxybenzamine	HCl	CAPSULE	10 mg	ORAL	C04AX02					1377/02/09
Phentolamine	Mesylate	INJECTION	10 mg/ml	PARENTERAL	C04AB01			Hospital use only
Phenylephrine	HCl	SPRAY	0.25%	NASAL	R01AA04			OTC medicines		1384/03/09
Phenylephrine	HCl	SOLUTION/ DROPS	0.25%	NASAL	R01AA04			OTC medicines		1362/08/22
Phenylephrine	HCl	SPRAY	0.5%	NASAL	R01AA04			OTC medicines		1384/03/09
Phenylephrine	HCl	SOLUTION/ DROPS	0.5%	NASAL	R01AA04			OTC medicines		1362/08/22
Phenylephrine	HCl	SOLUTION/ DROPS	5%	OPHTHALMIC	S01GA55
Phenylephrine	HCl	INJECTION	10 mg/ml	PARENTERAL	C01CA06			Hospital use only
Phenylephrine+Zinc		SOLUTION/ DROPS		OPHTHALMIC	S01GA55	Phenylephrine HCl 0.12%+ Zinc Sulfate 0.25%
Phenytoin	Sodium	CREAM	1%	TOPICAL	D03
Phenytoin	Sodium	CAPSULE	100 mg	ORAL	N03AB02
Phenytoin		SUSPENSION	125 mg/5ml	ORAL	N03AB02					1392/03/11
Phenytoin		SUSPENSION	30 mg/5ml	ORAL	N03AB02
Phenytoin	Sodium	CAPSULE	50 mg	ORAL	N03AB02					1362/10/11
Phenytoin	Sodium	INJECTION	50 mg/ml	PARENTERAL	N03AB02			Hospital use only
Phenytoin+Phenobarbital		TABLET		ORAL	N03AB52	Phenytoin Sodium 100mg+ Phenobarbital 50mg				1364/09/17
Phosphate (Organic)		INJECTION		PARENTERAL	B05XA14	(Sodium Glycerophosphate anhydrose 216mg)/ml
Phosphate [32P] Sodium		INJECTION, SOLUTION	5 mCi/ml	PARENTERAL	V10XX01				Radiopharmaceuticals	1383/09/22
Phosphate, Potassium		INJECTION		PARENTERAL	B05XA06	(KH2PO4 225mg+ K2HPO4 236mg) / ml		Hospital use only
Phosphate, Potassium Monobasic		TABLET	500 mg	ORAL	A12BA
Phosphate, Potassium Monobasic		BULK			V03			Bulk medicines		1368/06/19
Phosphate, Sodium		TABLET, EFFERVESCENT		ORAL	A12BA	NaH2PO4 1936 mg+ NaHCO3 350 mg+KHCO3 315 mg
Phosphate, Sodium Dibasic		BULK			V03			Bulk medicines		1368/06/19
Phosphate, Sodium monobasic		BULK			V03			Bulk medicines		1368/06/19
Phosphocysteamine		POWDER	150 mg	ORAL	A16AA04		Treatment of cystinosis.			1375/11/07
Phosphocysteamine		CAPSULE	150 mg	ORAL	A16AA04		Treatment of cystinosis.			1375/11/07
Phosphorous [32P] Chromic Phosphate Colloid		INJECTION,COLLOIDAL SOLUTION	5 mCi	INTRACAVITARY	V10AX01				Radiopharmaceuticals	1383/09/22
Pilocarpine	HCl	SOLUTION/ DROPS	1%	OPHTHALMIC	S01EB01
Pilocarpine	Nitrate	SOLUTION/ DROPS	1%	OPHTHALMIC	S01EB01
Pilocarpine	HCl	SOLUTION/ DROPS	2%	OPHTHALMIC	S01EB01
Pilocarpine	Nitrate	SOLUTION/ DROPS	2%	OPHTHALMIC	S01EB01
Pilocarpine	Nitrate	SOLUTION/ DROPS	4%	OPHTHALMIC	S01EB01		Treatment of xerostomia induced by radiation therapy for head and neck cancer. Treatment of xerostomia and keratoconjunctivitis sicca in Sjogren's syndrome patients.	Orphan medicines
Pilocarpine	HCl	SOLUTION/ DROPS	4%	OPHTHALMIC	S01EB01
Pimecrolimus		CREAM	1%	Topical	D11AH02					1388/02/30
Pimozide		TABLET	4 mg	ORAL	N05AG02
Pimozide		TABLET	2 mg	ORAL	N05AG02					1396/02/02
Pimozide		TABLET	1 mg	ORAL	N05AG02					1395/10/08
Pioglitazone	As HCl	TABLET	15 mg	ORAL	A10BG03					1384/04/12
Pioglitazone	As HCl	TABLET	30 mg	ORAL	A10BG03					1384/04/12
Pioglitazone	As HCl	TABLET	45 mg	ORAL	A10BG03					1384/04/12
Pipecuronium	Bromide	INJECTION, POWDER, LYOPHILIZED	4 mg	PARENTERAL	M03AC06			Hospital use only		1377/06/22
Piperacillin		INJECTION, POWDER,	1 g	PARENTERAL	J01CA12			Hospital use only		1364/12/04
Piperacillin		INJECTION, POWDER,	2 g	PARENTERAL	J01CA12			Hospital use only		1364/12/04
Piperacillin+Tazobactam		INJECTION, POWDER		PARENTERAL	J01CR05	Piperacillin (as Sodium ) 2g + Tazobactam (as Sodium ) 250mg		Hospital use only		1381/12/04
Piperacillin+Tazobactam		INJECTION, POWDER,		PARENTERAL	J01CR05	Piperacillin (as Sodium ) 3g + Tazobactam (as Sodium ) 375mg		Hospital use only		1381/12/04
Piperacillin+Tazobactam		INJECTION, POWDER		PARENTERAL	J01CR05	Piperacillin (as Sodium ) 4g + Tazobactam (as Sodium ) 500mg		Hospital use only		1381/12/04
Piperazine	As Citrate or Phosphate	TABLET	500 mg	ORAL	P02CB01
Piperazine	As Citrate	SYRUP	750 mg/5ml	ORAL	P02CB01
Piracetam		LIQUID	33.33%	ORAL	N06BX03					1363/09/11
Piracetam		SOLUTION	20.00%	ORAL	N06BX03					1396/05/28
Piracetam		TABLET	800 mg	ORAL	N06BX03					1363/03/20
Pirfenidone		TABLET	200 mg	ORAL	L04AX05		Idiopathic Pulmonary Fibrosis	Orphan medicines		1395/08/02
Pirfenidone		TABLET	267 mg	ORAL	L04AX05		Idiopathic Pulmonary Fibrosis	Orphan medicines		1397/02/11
Pirfenidone		TABLET	534 mg	ORAL	L04AX05		Idiopathic Pulmonary Fibrosis	Orphan medicines		1397/03/01
Pirfenidone		TABLET	801 mg	ORAL	L04AX05		Idiopathic Pulmonary Fibrosis	Orphan medicines		1397/02/11
Piroxicam		GEL	0.5%	TOPICAL	M02AA07			OTC medicines		1371/04/14
Piroxicam		CAPSULE	10 mg	ORAL	M01AC01					1366/03/31
Piroxicam		SUPPOSITORY	20 mg	RECTAL	M01AC01					1379/09/27
Piroxicam		INJECTION	20 mg/ml	PARENTERAL	M01AC01			Hospital use only		1375/07/01
Plasma		INJECTION		PARENTERAL	B05AX03		Blood component replacement	Hospital use only	Blood plasma (INN)	1394/11/13
Plasma, Crypoor		INJECTION		PARENTERAL	B05AX03		Blood component replacement	Hospital use only	Blood plasma (INN)	1394/11/13
Plasma, Cryprecipitate		INJECTION		PARENTERAL	B05AX03		Blood component replacement	Hospital use only	Blood plasma (INN)	1394/11/13
Plasma, Fresh Frozen		INJECTION		PARENTERAL	B05AX03		Blood component replacement	Hospital use only	Blood plasma (INN)	1394/11/13
Plastibase		OINTMENT		TOPICAL	D			Bulk medicines		1390/01/29
Platelet, CMV Negative		INJECTION		PARENTERAL	B05AX02		Blood component replacement	Hospital use only	Thrombocytes (INN)	1394/11/13
Platelet, Concentrated		INJECTION		PARENTERAL	B05AX02		Blood component replacement	Hospital use only	Thrombocytes (INN)	1394/11/13
Platelet, Irradiated		INJECTION		PARENTERAL	B05AX02		Blood component replacement	Hospital use only	Thrombocytes (INN)	1394/11/13
Platelet, Phresis		INJECTION		PARENTERAL	B05AX02		Blood component replacement	Hospital use only	Thrombocytes (INN)	1394/11/13
Platelet, Phresis and Irradiated		INJECTION		PARENTERAL	B05AX02		Blood component replacement	Hospital use only	Thrombocytes (INN)	1394/11/13
Platelet, Pooled		INJECTION		PARENTERAL	B05AX02		Blood component replacement	Hospital use only	Thrombocytes (INN)	1394/11/13
Platelet, Pooled and Leucocyte Reduced		INJECTION		PARENTERAL	B05AX02		Blood component replacement	Hospital use only	Thrombocytes (INN)	1394/11/13
Platelet, Pooled and Leucocyte Reduced and Irradiated		INJECTION		PARENTERAL	B05AX02		Blood component replacement	Hospital use only	Thrombocytes (INN)	1394/11/13
Plerixafor		INJECTION, SOLUTION	20mg/ml	PARENTERAL	A03AX16			Hospital use only		1393/01/24
Pneumococcal Vaccine		INJECTION		PARENTERAL	J07AL02				Polysaccharide cojugate adsorbed (10 Valents)	1361/08/20
Pneumococcal Vaccine		INJECTION		PARENTERAL	J07AL02				Polysaccharide cojugate adsorbed (13 Valents)	1361/08/20
Pneumococcal Vaccine		INJECTION		PARENTERAL	J07AL02				Polysaccharide adsorbed (23 Valents)	1361/08/20
Poliomyelitis Vaccine		INJECTION		PARENTERAL	J07BF03				Trivalent Killed
Poliovirus Vaccine		SOLUTION		ORAL	J07BF01				Live attenuated (monovalent, bivalent, trivalent)
Poly Ethylene Glycol		POWDER		ORAL	A06AD15				Macrogol 4000
Poly Ethylene Glycol		POWDER		ORAL	A06AD15				Macrogol 3350	1395/10/07
Poly Ethylene Glycol		BULK			V03			Bulk medicines		1384/08/24
Poly Ethylenglycol+Electrolyte 1		POWDER, FOR SOLUTION		ORAL	A06AD65	(Macrogol 3350, 13.125 g, Sodium chloride 0.3507 g, Sodium bicarbonate 0.1785 g, Potassium chloride 0.0466 g) / Sachet	Osmotic laxatives			1381/06/18
Poly Ethylenglycol+Electrolyte 2		POWDER, FOR SOLUTION		ORAL	A06AD65	(Macrogol 3350, 17.6 mmol, Sodium 125 mmol, Sulfate 40 mmol, Chloride 35 mmol, Bicarbonate 20 mmol, potassium 10 mmol ) / Lit.	Osmotic laxatives
Polymyxin B	Sulfate	INJECTION	500,000 U	PARENTERAL	S01AA18			Hospital use only	INJECTION/OPHTHALMIC DROPS
Polymyxin B+Neomycin+Hydrocortison		SOLUTION/ DROPS		OTIC	S02AA11	(Polymyxin B sulfate 10,000 U + Neomycin Sulfate 5 mg + Hydrocortisone 10 mg)/1 ml				1361/09/28
Polymyxin B+Neomycin+Hydrocortison		SUSPENSION/ DROPS		OTIC	S02AA11	(Polymyxin B sulfate 10,000 U + Neomycin Sulfate 5 mg + Hydrocortisone 10 mg)/1 ml				1379/09/27
Polysaccharide Iron Complex		CAPSULE	150 mg	ORAL	B03AB				100% Elemntal Iron	1396/12/13
Polysorbate 80		BULK			V03			Bulk medicines		1368/06/19
Poractant Alfa		INJECTION, SUSPENSION	80 mg/ ml	INTRATRACHEAL	R07AA			Hospital use only		1387/12/21
Posaconazole		TABLET, DELAYED RELEASE	100 mg	ORAL	J02AC04		Mucormyosis			1395/12/22
Posaconazole		SUSPENSION	40 mg/ml	ORAL	J02AC04		Mucormyosis			1396/02/02
Potassium acetate		INJECTION, SOLUTION, CONCENTRATE		PARENTERAL	B05XA17	(2Meq potassium + 2Meq acetate)/ml, 100 ml		Hospital use only		1389/03/31
Potassium Aminobenzoate		POWDER	3 g	ORAL	D11				Paba-k; Sachet
Potassium Aminobenzoate		TABLET	500 mg	ORAL	D11				Paba-k	1388/09/04
Potassium Aminobenzoate		CAPSULE	500 mg	ORAL	D11				Paba-k	1395/11/06
Potassium Chloride		TABLET, EXTENDED RELEASE	500 mg	ORAL	A12BA01
Potassium Chloride		TABLET, EXTENDED RELEASE	600 mg	ORAL	A12BA01					1385/08/17
Potassium Chloride		CAPSULE, EXTENDED RELEASE	600 mg	ORAL	A12BA01					1396/02/02
Potassium Chloride		INJECTION		INTRAVENOUS DRIP	B05XA01				Potassium Chloride 0.3 % in Dextrose 5 %	1392/05/29
Potassium Chloride		INJECTION		INTRAVENOUS DRIP	B05XA01				Potassium Chloride 0.15 % in Dextrose 5 %	1396/12/13
Potassium Chloride Concentrated		INJECTION, SOLUTION, CONCENTRATE	1 mEq/ml	INTRAVENOUS DRIP	B05XA01			Hospital use only		1385/02/12
Potassium Chloride Concentrated		INJECTION, SOLUTION, CONCENTRATE	2 mEq/ml	INTRAVENOUS DRIP	B05XA01			Hospital use only		1361/02/19
Potassium Citrate		TABLET, EXTENDED RELEASE	10 mEq	ORAL	A12BA02		For the dissolution and control of uric acid and cysteine calculi in the urinary tract.			1381/05/20
Potassium Citrate		POWDER	10 mEq	ORAL	A12BA02		For the dissolution and control of uric acid and cysteine calculi in the urinary tract. Sachet			1384/08/24
Potassium Citrate		TABLET, EXTENDED RELEASE	5 mEq	ORAL	A12BA02		For the dissolution and control of uric acid and cysteine calculi in the urinary tract.			1381/05/20
Potassium Citrate		TABLET	5 mEq	ORAL	A12BA02		For the dissolution and control of uric acid and cysteine calculi in the urinary tract.		In condition of providing clinical trial results	1395/11/12
Potassium Citrate		BULK			V03			Bulk medicines		1365/11/19
Potassium Permanganate		BULK			V03			Bulk medicines
Potassium phosphate		INJECTION, SOLUTION, CONCENTRATE		PARENTERAL	B05XA	(4.4Meq potassium + 3mmol phosphate)/ml, 100 ml		Hospital use only		1389/03/31
Povidone Iodine		SOLUTION	0.70%	TOPICAL	D08AG02			OTC medicines; Scrub solution		1389/03/31
Povidone Iodine		SPRAY	2.50%	TOPICAL	D08AG02			OTC medicines		1381/03/12
Povidone Iodine		SPONGE	7.50%	TOPICAL	D09AA09			OTC medicines
Povidone Iodine		SHAMPOO	7.50%	TOPICAL	D11AC06			OTC medicines		1369/10/30
Povidone Iodine		SOLUTION	7.50%	TOPICAL	D08AG02			OTC medicines ; Surgical Scrub		1369/10/30
Povidone Iodine		GEL	10%	VAGINAL	G01AX11			OTC medicines
Povidone Iodine		OINTMENT	10%	TOPICAL	D08AG02			OTC medicines		1369/10/30
Povidone Iodine		SOLUTION	10%	TOPICAL	D08AG02			OTC medicines		1369/10/30
Povidone Iodine		DOUCHE	10%	VAGINAL	D08AG02			OTC medicines		1392/05/29
Povidone Iodine		SUPPOSITORY	200 mg	VAGINAL	G01AX11			OTC medicines
Povidone Iodine		TISSUE	3 mg/cm2	TOPICAL	D09AA09			OTC medicines
Povidone Iodine Alcoholic		SOLUTION	10%	TOPICAL	D09AA09	Ethanol 300ml/L+ Povidone Iodine 100mg/ml		OTC medicines		1395/12/22
Povidone Iodine		PAINT BOTTLE	10%	TOPICAL	D08AG02			OTC medicines		1395/12/22
Pralidoxime	Chloride	INJECTION, POWDER	1 g	PARENTERAL	V03AB04			Hospital use only		1376/06/30
Pralidoxime	As Methylsulfate	INJECTION, POWDER	200 mg	PARENTERAL	V03AB04			Hospital use only		1393/10/14
Pramipexole	DiHCl	TABLET	0. 125 mg	ORAL	N04BC05				Equivalent to 0.088 mg Pramipexole	1385/09/07
Pramipexole	DiHCl	TABLET	0. 25 mg	ORAL	N04BC05				Equivalent to 0.18 mg Pramipexole	1385/09/07
Pramipexole	DiHCl	TABLET, EXTENDED RELEASE	0. 375 mg	ORAL	N04BC05				Equivalent to 0.26 mg Pramipexole	1389/06/15
Pramipexole	DiHCl	TABLET	0. 5 mg	ORAL	N04BC05				Equivalent to 0.35 mg Pramipexole	1385/09/07
Pramipexole	DiHCl	TABLET, EXTENDED RELEASE	0. 75 mg	ORAL	N04BC05				Equivalent to 0.52 mg Pramipexole	1389/06/15
Pramipexole	DiHCl	TABLET	1 mg	ORAL	N04BC05				Equivalent to 0.7 mg Pramipexole	1385/09/07
Pramipexole	DiHCl	TABLET, EXTENDED RELEASE	1.5 mg	ORAL	N04BC05				Equivalent to 1.05 mg Pramipexole	1389/06/15
Pramipexole	DiHCl	TABLET, EXTENDED RELEASE	3 mg	ORAL	N04BC05				Equivalent to 2.10 mg Pramipexole	1389/06/15
Prasugrel	As HCl	TABLET	10 mg	ORAL	B01AC22					1390/07/05
Prasugrel	As HCl	TABLET	5 mg	ORAL	B01AC22					1390/07/05
Praziquantel		TABLET	600 mg	ORAL	P02BA01		Treatment of neurocysticercosis. Anti-Taenicide	for Health Dept. of MOH only		1370/07/07
Praziquantel		TABLET	500 mg	ORAL	P02BA01		Treatment of neurocysticercosis. Anti-Taenicide	for Health Dept. of MOH only		1394/11/13
Prazosin	As HCl	TABLET	1 mg	ORAL	C02CA01					1359/07/13
Prazosin	As HCl	TABLET	5 mg	ORAL	C02CA01					1362/12/21
Prednimustine		CAPSULE	10 mg	ORAL	L01AA08					1365/09/16
Prednimustine		TABLET	10 mg	ORAL	L01AA08
Prednimustine		TABLET	100 mg	ORAL	L01AA08					1365/09/16
Prednimustine		TABLET	20 mg	ORAL	L01AA08					1365/09/16
Prednimustine		CAPSULE	50 mg	ORAL	L01AA08					1365/09/16
Prednimustine		TABLET	50 mg	ORAL	L01AA08
Prednisolone	Acetate	SUSPENSION/ DROPS	1%	OPHTHALMIC	S01BA04					1361/04/27
Prednisolone		TABLET	20 mg	ORAL	H02AB06					1387/05/06
Prednisolone		TABLET	5 mg	ORAL	H02AB06					1387/05/06
Prednisolone		TABLET	5 mg	BUCCAL	DO7AA03					1392/03/11
Prednisolone		TABLET	50 mg	ORAL	H02AB06					1369/02/09
Prednisone		TABLET	1 mg	ORAL	H02AB07					1374/12/20
Prednisone		TABLET	20 mg	ORAL	H02AB07					1387/05/16
Prednisone		TABLET	5 mg	ORAL	H02AB07					1387/05/16
Prednisone		TABLET	50 mg	ORAL	H02AB0
Pregabalin		CAPSULE	100 mg	ORAL	N03AX16					1388/04/21
Pregabalin		CAPSULE	150 mg	ORAL	N03AX16					1388/04/21
Pregabalin		CAPSULE	200 mg	ORAL	N03AX16					1388/04/21
Pregabalin		CAPSULE	225 mg	ORAL	N03AX16					1388/04/21
Pregabalin		CAPSULE	300 mg	ORAL	N03AX16					1388/04/21
Pregabalin		CAPSULE	50 mg	ORAL	N03AX16					1388/04/21
Pregabalin		CAPSULE	75 mg	ORAL	N03AX16					1388/04/21
Prilocaine+Felypressin		INJECTION		PARENTERAL	N01BB54	(Prilocaine HCl 30mg+Felypressin (0.03 IU.) 0.54 mcg)/ ml			Cartridge	1359/07/13
Primaquine	As Phosphate	TABLET	15 mg	ORAL	P01BA03		For use in combination with clindamycin hydrochloride in the treatment of Pneumocystis carinii pneumonia associated with AIDS.			1368/07/16
Primaquine	As Phosphate	TABLET	7.5 mg	ORAL	P01BA03		For use in combination with clindamycin hydrochloride in the treatment of Pneumocystis carinii pneumonia associated with AIDS.			1368/02/10
Primidone		SUSPENSION	125 mg/5ml	ORAL	N03AA03					1373/10/18
Primidone		TABLET	250 mg	ORAL	N03AA03
Primidone		SUSPENSION	250 mg/5ml	ORAL	N03AA03
Procainamide	HCl	INJECTION	100 mg/ml	PARENTERAL	C01BA02			Hospital use only		1364/11/06
Procainamide	HCl	CAPSULE	500 mg	ORAL	C01BA02					1377/11/18
Procarbazine	As HCl	CAPSULE	50 mg	ORAL	L01XB01
Progesterone		CAPSULE, LIQUID FILLED	100 mg	VAGINAL or ORAL	G03DA04					1389/11/4
Progesterone		SUPPOSITORY	100 mg	VAGINAL or RECTAL	G03DA04					1387/05/16
Progesterone		TABLET	100 mg	VAGINAL	G03DA04
Progesterone		CAPSULE, LIQUID FILLED	200 mg	VAGINAL or ORAL	G03DA04					1389/11/4
Progesterone		SUPPOSITORY	200 mg	VAGINAL or RECTAL	G03DA04					1381/10/22
Progesterone		INJECTION	25 mg/ml	PARENTERAL	G03DA04
Progesterone		SUPPOSITORY	400 mg	VAGINAL or RECTAL	G03DA04					1379/11/09
Progesterone		GEL	8%	VAGINAL	G03DA04					1396/03/13
Progesterone		BULK			V03			Bulk medicines		1372/02/12
Proguanil		TABLET	100 mg	ORAL	P01BB01			For Health Dept. of MOH only		1388/10/30
Proguanil		TABLET	120 mg	ORAL	P01BB01			For Health Dept. of MOH only		1388/10/30
Promethazine	HCl	TABLET	25 mg	ORAL	R06AD02
Promethazine	HCl	INJECTION	25 mg/ml	PARENTERAL	R06AD02					1364/03/12
Promethazine	As HCl	SYRUP	5 mg/5ml	ORAL	R06AD02
Propafenone	HCl	TABLET	150 mg	ORAL	C01BC03					1369/10/16
Propafenone	HCl	TABLET	300 mg	ORAL	C01BC03
Propamidine	Isethionate	SOLUTION/ DROPS	0.10%	OPHTHALMIC	S01AX15					1374/11/29
Propantheline	Bromide	TABLET	15 mg	ORAL	A03AB05
Propofol		INJECTION, SOLUTION	10 mg/ml	PARENTERAL	N01AX10			Hospital use only		1376/01/31
Propofol		INJECTION, SOLUTION	20 mg/ml	PARENTERAL	N01AX10			Hospital use only		1385/09/01
Propofol		INJECTION, SOLUTION	5 mg/ml	PARENTERAL	N01AX10			Hospital use only		1395/09/01
Propranolol	HCl	INJECTION	1 mg/ml	PARENTERAL	C07AA05					1369/10/16
Propranolol	HCl	TABLET	10 mg	ORAL	C07AA05
Propranolol	HCl	TABLET, EXTENDED RELEASE	160 mg	ORAL	C07AA05
Propranolol	HCl	TABLET	20 mg	ORAL	C07AA05					1385/02/12
Propranolol	HCl	TABLET	40 mg	ORAL	C07AA05
Propranolol	HCl	TABLET	80 mg	ORAL	C07AA05
Propranolol	HCl	TABLET, EXTENDED RELEASE	80 mg	ORAL	C07AA05
Propylene Glycol		BULK			V03			Bulk medicines
Propylthiouracil		TABLET	50 mg	ORAL	H03BA02
Prostaglandin E1		INJECTION	0.5 mg/ml	PARENTERAL	C01EA01		Ductus Arteriosus	Orphan medicines; Hospital use only	(Alprostadil)
Prostaglandin E1		INJECTION, POWDER	20 mcg	PARENTERAL	G04BE01		Erection Dysfunction	Orphan medicines; Hospital use only	(Alprostadil)	1386/04/13
Prostaglandin E1		INJECTION, SOLUTION, CONCENTRATE	20 mcg/ml	PARENTERAL	G04BE01		Erection Dysfunction	Orphan medicines; Hospital use only	(Alprostadil)	1385/11/18
Prostaglandin E2		GEL		VAGINAL	G02AِِD02			Hospital use only; With obstetricians prescriptions only	(Dinoprostone)
Prostaglandin E2		INJECTION	10 mg/ml	PARENTERAL	G02AِِD02			Hospital use only; With obstetricians prescriptions only	(Dinoprostone)
Prostaglandin E2		TABLET	3 mg	VAGINAL	G02AِِD02			Hospital use only; With obstetricians prescriptions only	(Dinoprostone)
Prostaglandin E2		TABLET, INSERT, EXTENDED RELEASE	10 mg	VAGINAL	G02AِِD02			Hospital use only; With obstetricians prescriptions only	(Dinoprostone)	1397/04/30
Prostaglandin F2α		INJECTION	5mg/ml	PARENTERAL	G02AD01			Hospital use only	Dinoprost Tromethamine	1389/10/25
Protamine	Sulfate	INJECTION	1000 UAH/ml	PARENTERAL	V03AB14			Hospital use only
Prothionamide		TABLET	125 mg	ORAL	J04AD01
Prothionamide		TABLET	250 mg	ORAL	J04AD01					1363/10/02
Prothrombin Complex Concentrated		INJECTION, POWDER	500 IU	PARENTERAL	B02BD					1386/12/06
Protirelin		INJECTION	0.2 mg/ml	PARENTERAL	V04CJ02
Pseudoephedrine	HCl	CAPSULE, LIQUID FILLED	30 mg	ORAL	R01BA02					1385/11/18
Pseudoephedrine	HCl	SYRUP	30 mg/5ml	ORAL	R01BA02					1369/10/30
Purified Talc		INJECTION, POWDER	5 g	PARENTERAL						1387/12/18
Pyrantel	As Pamoate	TABLET	125 mg	ORAL	P02CC01					1369/09/18
Pyrantel	As Pamoate	SUSPENSION	250 mg/5ml	ORAL	P02CC01					1369/09/18
Pyrazinamide		TABLET	500 mg	ORAL	J04AK01
Pyridostigmine	Bromide	TABLET	10 mg	ORAL	N07AA02					1372/06/21
Pyridostigmine	Bromide	TABLET, EXTENDED RELEASE	180 mg	ORAL	N07AA02					1388/02/30
Pyridostigmine	Bromide	TABLET	60 mg	ORAL	N07AA02
Pyrimethamine		TABLET	25 mg	ORAL	P01BD01
Pyrithione zinc		Shampoo	2%	TOPICAL	D11AX12			OTC medicines
Pyrvinium	As Pamoate	TABLET	50 mg	ORAL	P02CX01
Pyrvinium	As Pamoate	SUSPENSION	50 mg/5ml	ORAL	P02CX01
Quetiapine	as Fumarate	TABLET	100 mg	ORAL	N05AH04		Antipsychotic			1388/03/03
Quetiapine	as Fumarate	TABLET	150 mg	ORAL	N05AH04		Antipsychotic			1388/03/03
Quetiapine	as Fumarate	TABLET, EXTENDED RELEASE	200 mg	ORAL	N05AH04		Antipsychotic			1390/09/21
Quetiapine	as Fumarate	TABLET, EXTENDED RELEASE	150 mg	ORAL	N05AH04		Antipsychotic			1394/07/05
Quetiapine	as Fumarate	TABLET	200 mg	ORAL	N05AH04		Antipsychotic			1388/03/03
Quetiapine	as Fumarate	TABLET	25 mg	ORAL	N05AH04		Antipsychotic			1388/03/03
Quetiapine	as Fumarate	TABLET, EXTENDED RELEASE	300 mg	ORAL	N05AH04		Antipsychotic		for local production only	1391/05/02
Quetiapine	as Fumarate	TABLET, EXTENDED RELEASE	50 mg	ORAL	N05AH04		Antipsychotic		for local production only	1390/09/21
Quinacrine	Di HCl	TABLET	100 mg	ORAL	P01AX05
Quinidine	Sulfate	CAPSULE	200 mg	ORAL	C01BA01
Quinidine	Sulfate	TABLET	200 mg	ORAL	C01BA01
Quinidine	Bisulfate	TABLET, EXTENDED RELEASE	250 mg	ORAL	C01BA01					1369/10/16
Quinine	HCl	TABLET	250 mg	ORAL	P01BC01			For Health Dept. of MOH only		1367/08/15
Quinine		INJECTION	250 mg/ml	PARENTERAL	P01BC01			Hospital use only, For Health Dept. of MOH only
Quinine	HCl	TABLET	100 mg	ORAL	P01BC01			For Health Dept. of MOH only		1367/08/15
Quinine	HCl	TABLET	200 mg	ORAL	P01BC01			For Health Dept. of MOH only		1367/08/15
Quinine	Sulfate	TABLET	300 mg	ORAL	P01BC01			For Health Dept. of MOH only		1396/05/28
Rabeprazole	Sodium	TABLET, DELAYED RELEASE	20 mg	ORAL	A02BC04					1384/09/20
Rabies Immune globulin		INJECTION		PARENTERAL	J06BB05				Human
Rabies Vaccine		INJECTION		PARENTERAL	J07BG				HDC (Freeze-dried Killed Virus)	1366/01/23
Rabies Vero Vaccine		INJECTION		PARENTERAL	J07BG					1374/05/15
Raloxifene	HCl	TABLET	60 mg	ORAL	G03XC01		Reduction of the risk of breast cancer in postmenopausal women			1383/07/12
Raltegravir	As potassium	TABLET	400 mg	ORAL	J05AX08		HIV infection	For Health Dept. of MOH only		1393/10/14
Raltegravir	As potassium	TABLET, CHEWABLE	100 mg	ORAL	J05AX08		HIV infection	For Health Dept. of MOH only		1394/11/13
Ranibizumab		INJECTION, SOLUTION	10mg/ml	PARENTERAL	S01LA04		Macular Oedema	Hospital use only		1395/08/02
Ranitidine	As HCl	TABLET, EFFERVESCENT	150 mg	ORAL	A02BA02
Ranitidine	As HCl	CAPSULE, LIQUID FILLED	150 mg	ORAL	A02BA02					1385/09/15
Ranitidine	As HCl	TABLET	150 mg	ORAL	A02BA02
Ranitidine	As HCl	INJECTION	25 mg/ml	PARENTERAL	A02BA02					1369/02/23
Ranitidine	As HCl	CAPSULE, LIQUID FILLED	300 mg	ORAL	A02BA02				for local production only	1389/08/24
Ranitidine	As HCl	TABLET, EFFERVESCENT	300 mg	ORAL	A02BA02					1382/04/29
Ranitidine	As HCl	TABLET	300 mg	ORAL	A02BA02					1387/07/07
Ranitidine	As HCl	INJECTION	50 mg	INJECTION	A02BA02			Hospital use only	for local production only	1390/03/09
Ranitidine	As HCl	SOLUTION	75mg/5ml	ORAL	A02BA02					1385/09/01
Rasburicase		INJECTION, POWDER	1.5 mg	PARENTERAL	V03AF07					1386/12/07
Red Blood Cell		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Red Blood Cell, CMV Negative		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Red Blood Cell, Frozen		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Red Blood Cell, Frozen and Irradiated		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Red Blood Cell, Irradiated		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Red Blood Cell, Irradiated and Washed		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Red Blood Cell, Leukocyte Reduced		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Red Blood Cell, Leukocyte Reduced and Washed		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Red Blood Cell, Leukocyte Reduced and Washed		INJECTION		INJECTION	B05AX01		Blood component replacement	Hospital use only	Erythrocytes (INN)	1394/11/13
Remifentanil		INJECTION, POWDER	1 mg	PARENTERAL	N01AH06			Hospital use only		1381/06/18
Remifentanil		INJECTION, POWDER	2 mg	PARENTERAL	N01AH06			Hospital use only		1381/06/18
Remifentanil		INJECTION, POWDER	5 mg	PARENTERAL	N01AH06			Hospital use only		1381/06/18
Repaglinide		TABLET	0.5 mg	ORAL	A10BX02					1383/08/10
Repaglinide		TABLET	1 mg	ORAL	A10BX02					1383/08/10
Repaglinide		TABLET	2 mg	ORAL	A10BX02					1383/08/10
Reserpine		TABLET	0.1 mg	ORAL	C02AA02
Resorcinol		BULK			V03			Bulk medicines
Reteplase		INJECTION, POWDER	10.4 U	PARENTERAL	B01AD07			Hospital use only		1385/03/23
Rhenium [186 Re] Etidronate, (186Re-HEDP)		INJECTION, SOLUTION	(35-65) mCi	PARENTERAL	V10BX03				Radiopharmaceuticals	1389/10/25
Rhenium [186Re] Sulfur Colloid		INJECTION, COLLOIDAL SOLUTION	(5-10) mCi	INTRA-CAVITY	V10AX05				Radiopharmaceuticals	1389/10/25
Rhenium [188 Re] Etidronate, (188Re-HEDP)		INJECTION, SOLUTION	1 mCi/kg	PARENTERAL	V10BX03				Radiopharmaceuticals	1389/10/25
Rhenium[188Re] Sulfur Colloid		INJECTION, COLLOIDAL SOLUTION	(5-10) mCi	INTRA-CAVITY	V10AX05				Radiopharmaceuticals	1397/02/18
Ribavirin		INJECTION	100 mg	PARENTERAL	J05AB04			For Health Dept. of MOH only		1385/09/07
Ribavirin		CAPSULE	200 mg	ORAL	J05AB04			For Health Dept. of MOH only		1379/11/09
Ribavirin		TABLET	200 mg	ORAL	J05AB04			For Health Dept. of MOH only
Rifabutin		CAPSULE	150 mg	ORAL	J04AB04			For Health Dept. of MOH only
Rifabutin		TABLET	300 mg	ORAL	J04AB02			For Health Dept. of MOH only		1385/09/07
Rifampicin		CAPSULE	150 mg	ORAL	J04AB02
Rifampicin		SOLUTION/ DROPS	153 mg/ml	ORAL	J04AB02
Rifampicin		SYRUP	20 mg/ml	ORAL	J04AB02					1391/11/02
Rifampicin		CAPSULE	300 mg	ORAL	J04AB02
Rifampicin		INJECTION, POWDER	600 mg	PARENTERAL	J04AB02		For antituberculosis treatment where use of the ORAL form of the drug is not feasible.	Orphan medicines; Hospital use only
Rifapentine		TABLET	150 mg	ORAL	J04AB05			For Health Dept. of MOH only		1397/07/14
Rifaximin		TABLET	200 mg	ORAL	A07AA11					1391/02/07
Rifaximin		TABLET	550 mg	ORAL	A07AA11					1395/12/18
Riluzole		TABLET	50 mg	ORAL	N07XX02					1385/11/24
Ringer Lactate		INJECTION, SOLUTION	1000 ml	INTRAVENOUS DRIP	B05BB01	(Na+130mEq + Ca++3mEq + K +4mEq + Cl-109mEq + Lactate 28mEq)/L
Ringer Lactate		INJECTION, SOLUTION	250 ml	INTRAVENOUS DRIP	B05BB01	(Na+130mEq + Ca++3mEq + K +4mEq + Cl-109mEq + Lactate 28mEq)/L				1389/02/01
Ringer Lactate		INJECTION, SOLUTION	500 ml	INTRAVENOUS DRIP	B05BB01	(Na+130mEq + Ca++3mEq + K +4mEq + Cl-109mEq + Lactate 28mEq)/L
Ringers		INJECTION, SOLUTION	1000 ml	INTRAVENOUS DRIP	B05BB01	(Na+147mEq + Ca++ 4.5mEq + K+4mEq +Cl-156mEq)/L
Ringers		INJECTION, SOLUTION	250 ml	PARENTERAL	B05BB01	(Na+147mEq + Ca++ 4.5mEq + K+4mEq +Cl-156mEq)/L				1384/02/12
Ringers		INJECTION, SOLUTION	500 ml	INTRAVENOUS DRIP	B05BB01	(Na+147mEq + Ca++ 4.5mEq + K+4mEq +Cl-156mEq)/L
Risedronate	Sodium	TABLET	35 mg	ORAL	M05BA07					1387/12/21
Risedronate	Sodium	TABLET	5 mg	ORAL	M05BA07					1387/12/21
Risperidone		TABLET	1 mg	ORAL	N05AX08					1387/01/22
Risperidone		SOLUTION	1 mg/ml	ORAL	N05AX08					1391/02/25
Risperidone		TABLET	2 mg	ORAL	N05AX08					1387/01/22
Risperidone		INJECTION, POWDER, EXTENDED RELEASE	25 mg	PARENTERAL	N05AX08					1390/03/07
Risperidone		TABLET	3 mg	ORAL	N05AX08					1379/05/26
Risperidone		INJECTION, POWDER, EXTENDED RELEASE	37.5 mg	PARENTERAL	N05AX08					1390/03/07
Risperidone		TABLET	4 mg	ORAL	N05AX08					1379/05/26
Risperidone		INJECTION, POWDER, EXTENDED RELEASE	50 mg	PARENTERAL	N05AX08					1390/03/07
Ritodrine	HCl	TABLET	10 mg	ORAL	G02CA01					1363/12/12
Ritodrine	HCl	INJECTION	10 mg/ml	PARENTERAL	G02CA01			Hospital use only		1363/12/12
Ritonavir		CAPSULE	100 mg	ORAL	J05AE03			For Health Dept. of MOH only		1393/10/14
Rituximab		INJECTION	10 mg/ml	PARENTERAL	L01XC02		Treatment of immune thrombocytopenic purpura Treatment of non-Hodgkin's B-cell lymphoma. Treatment of chronic lymphocytic leukemia			1384/02/11
Rituximab		INJECTION	120 mg/ml	PARENTERAL	L01XC02		Treatment of immune thrombocytopenic purpura Treatment of non-Hodgkin's B-cell lymphoma. Treatment of chronic lymphocytic leukemia		Povided with Hyaluronidase to be Subcutaneous	1396/06/07
Rivaroxaban		TABLET	2.5 mg	ORAL	B01AF01		Antithrombotic		Only adjuvant with other anticoagualants	1397/07/28
Rivaroxaban		TABLET	10 mg	ORAL	B01AF01		Antithrombotic			1394/03/31
Rivaroxaban		TABLET	15 mg	ORAL	B01AF01		Antithrombotic			1394/03/31
Rivaroxaban		TABLET	20 mg	ORAL	B01AF01		Antithrombotic			1394/03/31
Rivastigmine	As Hydrogen Tartrate	CAPSULE	1.5 mg	ORAL	N06DA03					1379/12/07
Rivastigmine	As Hydrogen Tartrate	CAPSULE	3 mg	ORAL	N06DA03					1379/12/07
Rivastigmine	As Hydrogen Tartrate	CAPSULE	4.5 mg	ORAL	N06DA03					1379/12/07
Rivastigmine	As Hydrogen Tartrate	CAPSULE	6 mg	ORAL	N06DA03					1383/11/26
Rivastigmine	As Hydrogen Tartrate	SOLUTION	2 mg/ml	ORAL	N06DA03					1369/03/21
Rizatriptan	As Hydrogen Tartrate	TABLET	10 mg	ORAL	N02CC04					1381/04/23
Rizatriptan	As Benzoate	TABLET, ORALLY DISINTEGRATING	10 mg	ORAL	N02CC04					1390/1/29
Rizatriptan	As Benzoate	TABLET	5 mg	ORAL	N02CC04					1381/04/23
Rocuronium	Bromide	INJECTION, SOLUTION	10mg/ml	PARENTERAL	M03AC09					1393/10/14
Romiplostim		INJECTION, POWDER	250 mcg	PARENTERAL	B02BX04			Orphan medicines	With hematologists prescriptions only	1393/02/07
Romiplostim		INJECTION, POWDER	500 mcg	PARENTERAL	B02BX04			Orphan medicines	With hematologists prescriptions only	1395/1106
Ropinirole	As HCl	TABLET	0.25 mg	ORAL	N04BC04					1379/11/09
Ropinirole	As HCl	TABLET	0.5 mg	ORAL	N04BC04					1387/05/06
Ropinirole	As HCl	TABLET	1 mg	ORAL	N04BC04					1379/11/09
Ropinirole	As HCl	TABLET	5 mg	ORAL	N04BC04					1379/11/09
Ropivacaine	HCl	INJECTION, SOLUTION	2mg/ml	PARENTERAL	N01BB09			Hospital use only		1393/05/12
Ropivacaine	HCl	INJECTION, SOLUTION	5mg/ml	PARENTERAL	N01BB09			Hospital use only		1393/05/12
Ropivacaine	HCl	INJECTION, SOLUTION	7.5mg/ml	PARENTERAL	N01BB09			Hospital use only		1395/07/10
Ropivacaine	HCl	INJECTION, SOLUTION	10mg/ml	PARENTERAL	N01BB09			Hospital use only		1395/07/10
Rosuvastatin	As Calcium	TABLET	10 mg	ORAL	C10AA07					1392/12/11
Rosuvastatin	As Calcium	TABLET	20 mg	ORAL	C10AA07					1392/12/11
Rosuvastatin	As Calcium	TABLET	40 mg	ORAL	C10AA07					1392/12/11
Rosuvastatin	As Calcium	TABLET	5 mg	ORAL	C10AA07					1392/12/11
Rotavirus Vaccine		SOLUTION		ORAL	J07BH02				Live, Pentavalent	1395/08/02
Rotavirus Vaccine		POWDER, FOR SUSPENSION		ORAL	J07BH02				Live, Monovalent	1396/04/25
Rubella Virus Vaccine		INJECTION, POWDER		PARENTERAL	J07BJ01				Live
Rubidium (81Rb)/Krypton [81mKr]		GENERATOR	4-12 mCi	RESPIRATORY	V09EX01				Radiopharmaceuticals	1383/09/22
Salbutamol	As Sulfate	INJECTION	0.5 mg/ml	PARENTERAL	R03CC02			Hospital use only		1367/08/15
Salbutamol		INHALER	100 mcg/dose	RESPIRATORY	R03AC02
Salbutamol	As Sulfate	INHALER	100 mcg/metered inhalation	RESPIRATORY	R03AC02					1388/08/20
Salbutamol	As Sulfate	TABLET	2 mg	ORAL	R03CC02
Salbutamol	As Sulfate	SYRUP	2 mg/5ml	ORAL	R03CC02
Salbutamol	As Sulfate	INHALER	2.5 mg/2.5ml	RESPIRATORY	R03AC02					1385/03/23
Salbutamol	As Sulfate	INHALER	5 mg/ml	RESPIRATORY	R03AC02
Salbutamol+Beclomethasone		AEROSOL, SPRAY		RESPIRATORY	R03AK04	Salbutamol 100 mcg+Beclomethasone Dipropionate 50 mcg				1385/06/14
Salicylic Acid		PLASTER	12-40%	TOPICAL	D01AE12			OTC medicines		1387/09/23
Salicylic Acid		BULK			V03				Bulk medicines	1376/12/10
Salicylic Acid Compound		SOLUTION		TOPICAL	D01AE12	Salicylic Acid 16.7g+Lactic Acid 16.7g + Collodion qs to 100g		OTC medicines		1360/10/27
Salmeterol	As Xinafoate	INHALER	25 mcg/dose	RESPIRATORY	R03AC12					1376/06/09
Salmeterol	As Xinafoate	INHALER	50 mcg/dose	RESPIRATORY	R03AC12					1376/06/09
Salmeterol+Fluticasone		AEROSOL, METERED		RESPIRATORY	R03AK06	Salmeterol (as Xinafoate) 25mcg +Fluticasone Propionate 250mcg				1383/09/08
Salmeterol+Fluticasone		AEROSOL, METERED		RESPIRATORY	R03AK06	Salmeterol (as Xinafoate) 25mcg +Fluticasone Propionate 50mcg				1383/09/08
Salmeterol+Fluticasone		AEROSOL, METERED		RESPIRATORY	R03AK06	Salmeterol(as Xinafoate) 25mcg + Fluticasone Propionate 125mcg				1383/09/08
Salmeterol+Fluticasone		DISC		RESPIRATORY	R03AK06	Salmeterol(as Xinafoate) 50mcg + Fluticasone Propionate 100mcg /dose				1389/11/04
Salmeterol+Fluticasone		DISC		RESPIRATORY	R03AK06	Salmeterol(as Xinafoate) 50mcg + Fluticasone Propionate 250mcg /dose				1389/11/04
Salmeterol+Fluticasone		DISC		RESPIRATORY	R03AK06	Salmeterol(as Xinafoate) 50mcg + Fluticasone Propionate 500mcg /dose				1389/11/04
Salmeterol+Fluticasone		INHALATION, POWDER		RESPIRATORY	R03AK06	Salmeterol(as Xinafoate) 50mcg + Fluticasone Propionate100 mcg /dose				1397/09/03
Salmeterol+Fluticasone		INHALATION, POWDER		RESPIRATORY	R03AK06	Salmeterol(as Xinafoate) 50mcg + Fluticasone Propionate 250 mcg /dose				1397/09/03
Salmeterol+Fluticasone		INHALATION, POWDER		RESPIRATORY	R03AK06	Salmeterol(as Xinafoate) 50mcg + Fluticasone Propionate 500 mcg /dose				1397/09/03
Samarium [153 Sm]-Ethylenediamine tetramethylene phosphonate, (153Sm-EDTMP)		INJECTION, SOLUTION	1 mCi/kg	PARENTERAL	V10BX02				Radiopharmaceuticals	1389/10/25
Sapropterin	DiHCl	TABLET	50 mg	ORAL	A16AX07		for Phenylketonuria In patients responsive to tetrahydrobiopterin	Orphan medicines		1387/11/06
Sapropterin	DiHCl	TABLET	100 mg	ORAL	A16AX07		for Phenylketonuria In patients responsive to tetrahydrobiopterin	Orphan medicines		1395/06/24
Sapropterin	DiHCl	POWDER	100 mg	ORAL	A16AX07		for Phenylketonuria In patients responsive to tetrahydrobiopterin	Orphan medicines		1395/10/07
Sapropterin	DiHCl	POWDER	500 mg	ORAL	A16AX07		for Phenylketonuria In patients responsive to tetrahydrobiopterin	Orphan medicines		1395/10/07
Schick Test		INJECTION		PARENTERAL	V04CX					1361/08/20
Scopolamine		PATCH, EXTENDED RELEASE	1 mg/72h	TRANSDERMAL	N05CM05
Secretin		INJECTION, POWDER, LYOPHILIZED	100 U	PARENTERAL	V04CK01			Hospital use only
Selegiline	HCl	TABLET	5 mg	ORAL	N04BD01		As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism.			1370/10/01
Selenium	As Sodium Selenite Pentahydrate	INJECTION	50 mcg/ml	PARENTERAL	A12CE02			Hospital use only		1390/03/23
Selenium Sulfide		LOTION/ SHAMPOO	%2. 5	TOPICAL	D01AE13					1387/12/21
Serine		CAPSULE	600 mg	ORAL			Treatment of Serine deficiency	Orphan medicines		1387/11/06
Sertaconazole	Nitrate	CREAM	2%	TOPICAL	D01AC14					1382/03/04
Sertaconazole	Nitrate	TABLET	300 mg	VAGINAL	G01AF					1387/08/01
Sertaconazole	Nitrate	SUPPOSITORY	300 mg	VAGINAL	G01AF					1395/11/12
Sertaconazole	Nitrate	TABLET	500 mg	VAGINAL	G01AF					1382/03/04
Sertraline	As HCl	CAPSULE	100 mg	ORAL	N06AB06					1382/04/29
Sertraline	As HCl	TABLET	100 mg	ORAL	N06AB06					1379/12/21
Sertraline	As HCl	TABLET	25 mg	ORAL	N06AB06